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Abstract
The secretory pathway of cells is important for the trafficking of proteins to the cell 
surface. Virus-mediated perturbations in the secretory pathway can result in 
inhibition of expression of MHC I molecules on the cell surface, and/or inhibition of the 
secretion of cytokines, which may contribute to virus evasion of the immune response. 
Previous studies have shown that the 3A protein of polio- and coxsackieviruses, and 
the 2BC protein of foot-and-mouth disease virus (FMDV) block protein trafficking. 
Using cells transfected with a plasmid expressing 2BC and fluorescent microscopy. 
Western blotting and a range of protein expression systems, the effects of the FMDV 
2BC protein on the secretory pathway were investigated further. These studies 
confirmed that FMDV 2BC inhibits protein trafficking and demonstrated that 2BC co- 
localises with the ER protein calnexin and appeared to deplete the expression of the 
COP II marker SecSlA, the ERGIC marker ERGIC-53 and the COP I marker (3-Cop. 
Furthermore, FMDV 2BC and 2C expression inhibited the expression of secreted 
alkaline phosphatase (SEAP), used to monitor the secretory pathway. The effect of 
2BC on SEAP expression was not mediated at the transcriptional level. FMDV 2BC also 
suppressed the expression of a non-secretory reporter protein, p-galactosidase. In 
order to determine if these effects were mediated by ER stress and the unfolded 
protein response, the effect of FMDV infection on expression of ER stress proteins in 
cells was investigated. These preliminary studies suggested that FMDV infection 
stimulates or alters the expression of ER stress markers.
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Chapter One: Introduction
1.1 Foot-and-mouth disease
Foot-and-mouth disease (FMD) is a highly contagious and economically important 
disease of cloven-hoofed animals characterised by the appearance of vesicles on the 
feet and mouth. The first clinical description of FMD has been generally credited to 
Fracastorius in the 16*^  century (Fracastorius, 1546). However, the first understanding 
of the causative agent of FMD as a filterable agent, FMD virus (FMDV), was not until 
1897(Loeffleretal., 1897).
1.1.1 Epidemiology and Pathology
FMDV causes an economically important disease of ruminants and cloven footed 
livestock and also circulates within a number of wild animals (Thomson et al., 2003). 
While FMDV infection does not result in high levels of mortality in adult animals, the 
disease can have detrimental effects such as weight loss, decrease in milk yield and 
productivity. Mortality, however, can be high in foetuses and young animals due to 
myocarditis, (Gulbahar et al., 2007; Ryan et al., 2008; Ryan et al., 2007; Tunca et al., 
2008). FMDV is on the notifiable list of infectious diseases of animals of the Office 
International des Epizooties (OIE) and is the most important constraint to international 
trade in animals and animal products.
The 2001 FMDV outbreak in the UK caused significant damage to the British economy 
resulting in the loss of up to £2 - £3.1 Billion in lost GDP (Anderson, 2002; Thompson et 
al., 2002). However this loss of GDP was small in comparison to the economy as a 
whole as when the impact on tourism, constraints on trade and travel were taken into 
account, the real loss to the economy was closer to £20 billion (Thompson et al., 
2002).
FMDV is a highly infectious virus with a wide host range (Gibbs, 1931; Sutmoller et al., 
2003; Thomson et al., 2003; Wernery and Kaaden, 2004). Pigs are much less 
susceptible to aerosol infection than cattle and sheep, and usually become infected 
from the ingestion of FMDV-contaminated material or through direct contact with 
infected animals (Alexandersen et al., 2002a; Alexandersen and Donaldson, 2002; 
Alexandersen et al., 2002c). However, higher levels of aerosolised virus are produced 
by pigs than cattle or sheep (Alexandersen et al., 2002a; Alexandersen and Donaldson, 
2002) and this can enable the long distance spread of the disease without direct 
contact of animals depending upon the isolate, as was demonstrated with the FMDV 
outbreak on the Isle of Wight in 1981 which resulted from aerosolised virus produced 
from a herd of pigs in France (Donaldson et al., 1982; Gloster et al., 1982).
The incubation period for FMDV infection can be from anything between 2-15 days 
depending on the infectious dose and the route of infection (Gailiunas and Cottral, 
1966). Primary infection of FMDV occurs in the epithelial cells of the dorsal soft
palate, tonsils, and pharyngeal area (Arzt et al., 2010; Burrows et al., 1981; Murphy et 
al., 1999; Zhang and Kitching, 2001). The virus then migrates via the bloodstream, to 
secondary sites of infection such as stratified squamous epithelia of the mouth, feet 
and mammary glands (Alexandersen et al., 2003b; Arzt et al., 2009; Bachrach, 1968; 
Brown et al., 1996). Characteristic vesicles develop at these secondary sites of 
infection and severe lesions occur in areas subjected to trauma (Zhang and Kitching, 
2001) (Fig. 1.1). Clinical signs of infection also vary between species, pigs develop the 
most severe signs of disease with a loss of appetite, fever, and a severe lameness 
attributed to foot lesions. In contrast, large proportions of infected sheep often have 
very few lesions or none at all (Hughes et al., 2002).
Following the initial phase of FMDV infection, virus is normally cleared within two 
weeks. However, some animals do not completely clear the virus and an 
asymptomatic persistent infection develops, which ranges from months (sheep, goats) 
to years (cows, buffalo). Persistence is classified as the detection of live virus from 
oropharyngeal fluids at 28 days post infection (dpi) (Salt, 1993). In contrast to 
ruminants, persistent infection has not been directly detected in pigs (Alexandersen et 
al., 2003a; Condy et al., 1985; Mezencio et al., 1999; Thomson et al., 2003) although a 
"pseudopersistent state" has recently been identified with virus being recovered from 
lymphoid tissue despite a humoral response 17 dpi (Rodriguez-Calvo et al., 2011). 
Although carrier animals have not been shown to infect naïve animals under 
experimental conditions, there is limited evidence to suggest that this has
(A)
(B)
Figure 1.1 Lesions of FMD (A) Lesions formed on the feet of a pig 
infected with FMDV. (B) Oral lesions in cattle infected with FMDV 
(Alexandersen et al., 2003b).
occurred in the field (Alexandersen et al., 2002b; Dawe et al., 1994; Hedger and Condy,
1985).
1.1.2 Vaccination
The first FMDV vaccine consisted of formalin-inactivated virus obtained from the 
tongue epithelium of infected cattle (Waldmann et al., 1937). This vaccine was 
eventually replaced by a vaccine based upon inactivated virus cultured in bovine 
tongue epithelial cells (Frenkel, 1951).
The principle reason for stopping routine vaccination in Europe in 1992 was that FMDV 
may cause a prolonged, symptomless infection in vaccinated ruminants, which poses a 
risk of viral transmission. Therefore, vaccinated animals are not accepted by FMD-free 
countries and so their trade value is lost. However, the EU values FMD vaccine for 
control purposes and maintains FMD vaccine banks. Recently, the EU changed policy 
to use vaccine as the principle means of control after the UK FMD epidemic in 2001.
1.1.3 Host response to FMDV
The early immune response to FMDV infection is mediated by neutralising antibodies. 
An IgM followed by an IgA response is detectable 2-7 dpi in sera (Abu and Crowther, 
1981; Eblé et al., 2007; Juleff et al., 2009; Ostrowski et al., 2007; Sait et al., 1996) and 
may persist for an extended period of time (Collen et al., 1991; Eblé et al., 2007).
Serotype specificity increases towards the serotype of virus involved in infection, with 
IgG becoming the major neutralising antibody, which is detected from 4-7 dpi and 
peaks 7-14 dpi in serum and oropharyngeal fluid (Eblé et al., 2007). Antibody 
production is vital in the protection of cattle from FMDV infection (Juleff et al., 2009; 
McCullough et al., 1992) indicating the importance of B-cell responses. However, the 
relationship between serum antibody titre and protection is not straightforward as the 
serum antibody titre in vaccinated animals does not always correlate with protection 
and some carrier animals have been found with high levels of neutralising antibodies 
(Mohan et al., 2008).
FMDV-specific CD4  ^T-cells have been identified in cattle and pigs, (Collen et al., 1991). 
These helper-T cells, which recognise a range of viral epitopes located on the capsid 
and the non-structural proteins, are likely to be required for long term immunity to 
FMDV (Blanco et al., 2001; Collen et al., 1998; Zamorano et al., 1995). However, it has 
been shown in cattle that FMDV can induce a CD4  ^T-cell independent neutralising 
antibody response to FMDV infection (Juleff et al., 2009).
The involvement of CD8  ^T cells in FMDV infection is unclear. Childerstone et al (1999) 
showed that CD8  ^ T-cell enriched fractions from some cattle produced an MHC I- 
restricted proliferative response, which was FMDV specific. Recently, FMDV-specific 
interferon (IFN)-y-secreting CD8  ^ T-cells were detected in infected and vaccinated 
animals (Guzman et al., 2009; Guzman et al., 2008). It has been shown in mice that
the FMDV non-structural protein 2C contains an epitope for CD8  ^T-cells (Barfoed et 
al., 2006). There is some new evidence to suggest that before MHC I molecules are 
suppressed by FMDV proteases there is some CD8  ^ cell killing resulting from 
vaccination (Patch et al., 2011).
The innate response to FMDV is less well understood. FMDV infection leads to tissue 
damage and the release of inflammatory signals, which in-turn recruit mononuclear 
cells and neutrophils to infection sites. In vitro studies demonstrated that porcine 
macrophages are able to phagocytose FMDV (Rigden et al., 2002) and may be critical 
for clearing antibody-virus complexes (McCullough et al., 1988). However, Baxt (1995) 
found opsonised FMDV killed porcine macrophages.
Dendritic cells (DC) are major professional antigen presenting cells. Guzylack- Piriou 
(2006) demonstrated that immune-complexed FMDV could infect porcine 
plasmacytoid DC's and undergo an abortive replication cycle with the production of 
high levels of IFN-a (Guzylack-Piriou et al., 2006). However, examination of bovine 
monocyte-derived DCs (Robinson, 2008) found that infection with immune complexed 
FMDV leads to high levels of DC death and a reduced ability of these cells to induce 
FMDV-specific T-cell proliferation (Robinson et al., 2011). Bovine plasmacytoid DCs 
have also been shown to be a major source of type I IFN in response to the acute 
phase of FMDV infection (Reid et al., 2011).
The cytokine response may play a role in inhibition of viral replication and the 
clearance of persistent infection. IFN-a, -P, -y and IL-l-a are induced in response to 
FMDV infection in vivo and in vitro (Chinsangaram et al., 2001; Chinsangaram et al., 
1999; Moraes et al., 2007; Nfon et al., 2010; Reid et al., 2011; Zhang et al., 2002). The 
expression of IFN-a can result in the protection of cells from infection in pigs 
(Chinsangaram et al., 2003), and a reduction of pathogenic effects in cattle (Moraes et 
al., 2007; Wu et al., 2003) and in cell culture (Chinsangaram et al., 2003; Moraes et al., 
2003). IFN-y is able to severely restrict FMDV replication and can cure persistently 
infected bovine epithelial cells in vitro (Zhang et al., 2002). Interleukin (IL)-6 , 8  and 12 
have been detected in sera from pigs vaccinated with emergency high doses of 
inactivated vaccine, and it has been suggested that these cytokines may play a role in 
the early protection against FMDV infection before sufficient neutralising antibody 
developed in emergency vaccinated animals (Barnett et al., 2002).
There is little information on the role of Natural killer (NK) cells in FMDV. However, 
recent studies have shown that during FMDV infection, after an initial activation, the 
lytic activity of the NK cells appears to be impaired in pigs (Toka et al., 2009; Toka et 
al., 2007).
1.2 FMDV Biology
FMDV is one of the three members of the Aphthoviradae genera along with Bovine 
rhinitis B virus (Hollister et al., 2008) and Equine rhinitis A virus (Pringle, 1999), which
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belong to the Picornaviradae family. There are 11 other genera in this family; 
Enteroviradae, Cardioviradae, Hepatoviradae, Parechoviradae, Erboviradae, 
Kobuviradae, Teschoviradae, Sapeloviradae, Senecaviradae, Tremoviradae and the 
Avihepatoviradoe.
FMDV is a non-enveloped, acid-labile virus (Curry et al., 1995). The virion, with a size 
of approximately 30 nm, consists of a single strand of positive-sense RNA packaged 
with a covalently attached VPg in an icosahedrally symmetrical shell composed of sixty 
copies of each of the four structural proteins VPl, VP2, VP3, and VP4 (Racaniello, 
2001). Seven immunologically distinct FMDV serotypes have been identified: Types O, 
A, and C, South African Territories (SAT) 1-3 and Asia 1 (Knowles and Samuel, 2003).
1.2.1 FMDV genome
The linear genome, with a size of approximately 8,500 bp, encodes a single open 
reading frame (ORF), which is translated into a polyprotein (Forss et al., 1984) and 
processed by virus-specific proteases to generate capsid proteins (PI) and non- 
structural 'replicase' proteins (P2 and 3) (Fig. 1.2). The ORF is flanked by a 5' and a 3' 
untranslated region.
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Figure 1.2 Overview of FMDV polyprotein and protein products
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1.2.2 Cell entry of FMDV
FMDV attaches to cells via intergrin receptors avpl, avp3, avp6 , and avp8  (Berinstein 
et al., 1995; Jackson et al., 2004; Jackson et al., 2002; Jackson et al., 2000), or heparin 
sulphate (Curry et al., 1996; Jackson et al., 1996), and is internalised. The intergrin 
av33 receptor in cattle has been found in all epithelial tissues and blood vessels with 
the exception of the tongue, and avp6  was found to be on the surface of tissues 
important for infection such as the tongue and coronary band (O'Donnell et al., 2009). 
Studies have shown that it is likely that avp6  is the major receptor to FMDV binding in 
cattle (Monaghan et al., 2005).
FMDV intergrin binding occurs through interactions with the highly conserved RGD 
motif on the G-H loop of FMDV VPl (Pierschbacher and Ruoslahti, 1984). 
Internalisation via avp6  and avp8  occurs through clathrin-mediated endocytosis 
(Berryman et al., 2005; Johns et al., 2009; O'Donnell et al., 2005) and Fc receptor 
binding of antibody complexed virus (Baxt and Mason, 1995; Mason et al., 1993).
In tissue culture cells, in vitro, FMDV binds primarily to heparin sulphate (Jackson et 
al., 1996; Sa-Carvalho et al., 1997). After heparin sulphate binding, FMDV enters cells 
by caveola-mediated endocytosis. Cell-culture adapted strains of FMDV have an RSGD 
motif as opposed to an RGD motif for intergin binding (Fry et al., 2005).
1 1
1.2.3 FMDV Replication
Following endocytosis, the virus uncoats in the early endosome releasing the RNA 
genome into the cytoplasm (Baxt, 1987; Carrillo et al., 1985; Johns et al., 2009; 
O'Donnell et al., 2005). Replicase proteins induce membranous vesicles from the 
secretory pathway and viral replication is thought to occur at this site. The host 
secretory pathway is commonly modified during positive-strand RNA virus replication. 
These modifications are thought to provide a membranous framework which 
centralises host and viral proteins necessary for viral replication. Interestingly, 
poliovirus non-structural proteins 2BC, in combination with 3A, are able to induce 
membrane alterations in cells which are structurally identical to those induced during 
poliovirus infection (Belov et al., 2005; Bienz et al., 1987; Doedens and Kirkegaard, 
1995; Rust et al., 2001). The mechanism of exit of FMD virions from infected cells is 
unknown; however virus is thought to exit via cell lysis, in-vitro (Flint et al., 2004).
1.2.3.1 FMDV 5' Untranslated region (UTR)
FMDV contains a 5' UTR (Fig. 1.3) of over 1,300 bp in length (Forss et al., 1984) it 
contains a short section of approximately 360 bp in length known as the S-fragment 
which forms a large hairpin structure (Newton et al., 1985), followed by an RNase- 
resistant region of over 100 bases consisting of approximately 90% cytidine residues 
known as the poly(C) tract (Brown et al., 1974). It has been postulated that the poly(C) 
tract may be utilised to circularise the FMDV genome for replication (Mason et al., 
2003). After the poly(C) tract, there are 3-4 pseudoknots (Clarke et al., 1987) the
1 2
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polyprotein kn)
Figure 1.3 A schematic of the FMDV UTR region adapted from (Fernandez et al., 2011). 
S: S-region, Qn): poly(c)tract, Pk: Pseudoknots, cre: cis-acting replication elementA(n): 
poly(A)tail and the 1RES showing domains 2-5.
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function of which is currently unknown. However they may be involved in inducing 
frame shifts and may play a role in viral translation (Brierley et al., 2007). A c/s- acting 
replication element {cre) involved in RNA replication and structures involved in 
translation initiation can be found between the pseudoknots. The internal ribosome 
entry sequence (1RES) is possibly unique in being placed in the non-coding region 
(Mason et al., 2002).
1.2.3.2 Internal ribosome entry sequence (1RES)
1RES elements are possessed by a wide variety of RNA viruses (Balvay et al., 2007; 
Lukavsky, 2009; Martmez-Salas, 2008) and despite performing the same function, they 
do not have conserved nucleotide sequences or RNA structure. IRESs are classified 
into four groups, type I - the entero and rhinoviruses, type II - the cardo and 
apthoviruses, type III - hepatitis A virus (HAV) and type IV - hepatitis C virus (HCV) like 
(Belsham, 2009; Fernandez-Miragall et al., 2009). Despite the lack conserved primary 
sequence, the stem loops are conserved among the different picornavirus types 
(Belsham, 2009; Lukavsky, 2009; Martmez-Azorm et al., 2008).
FMDV possesses a group II 1RES (Filipenko et al., 1989; Rivera et al., 1988) which allows 
cap-independent translation of the FMDV ORF as the elongation initiation factor elF4G 
is cleaved by the leader protease preventing cap-dependent translation (Devaney et 
al., 1988; Gradi et al., 2004; Medina et al., 1993; Roberts and Belsham, 1995). The 
1RES enables the recruitment of translation machinery to an internal position in the
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mRNA. The FMDV 1RES contains a highly conserved region of secondary structure 
amongst the FMDV strains which is approximately 450 bp long and is arranged into 
five domains (Fig. 1.3). Domain 1 forms part of the cre (Mason et al., 2002). While 
domains 4 and 5 are not involved in the initiation of translation (Fernandez-Miragall et 
al., 2009), they have the capability to recruit translation initiation factors and may 
have a role in 1RES binding to the translational machinery. Domain 3 contains 
structural elements essential to 1RES initiation of translation (Lopez de Quinto and 
Martinez-Salas, 1997).
1.2.4 Structural proteins of FMDV
The structural proteins of FMDV are encoded by the PI region and are processed by 
the proteins 2A and 3C. The FMDV capsid is comprised of 60 copies of the four 
structural proteins VPl, 2, 3 and 4 encoded by 1C, ID, IB, and lA  respectively. Five 
protomers assemble into a pentamer and twelve pentamers form into the proviron 
(Guttman and Baltimore, 1977) or an empty capsid (Grubman et al., 1985) with VPl-3 
being exposed upon the virons surface and antigenic but VP4 is not (Jackson et al., 
2003).
1.3 The Role of FMDV non-structural proteins in disease pathogenesis
FMDV expresses several functional non-structural proteins and with the exception of 
the leader protease, are derived from the P2 and P3 regions of the genome. They are 
involved in RNA replication, and protein folding and assembly. The P2 region can be
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processed into three mature proteins 2A, 2B, and 2C (Rueckert and Wimmer, 1984) 
and the precursor protein 2BC. The P3 region can be processed into 3A, three 3B 
(VPg) proteins, 3C, 3D and the precursor proteins 3AB and 3CD.
1.3.1 Leader protease
The two in frame AUG codons from the leader protease coding region (Sangar et al., 
1987) allow translation of two alternative forms of the protease termed Lab and Lb. 
The leader protease is self cleaving from the elongating polyprotein (Strebel and Beck,
1986) and is the first component of the FMDV polyprotein. It is a papain-like cysteine 
protease and cleaves the translation initiation factor of the cap-binding complex elF4G 
leading to a shut off of cap dependent translation (Devaney et al., 1988; Glaser and 
Skern, 2000; Medina et al., 1993; Roberts and Belsham, 1995).
The leader protease of FMDV (Mason et al., 1997) has been shown to be superfluous 
to virus replication (Piccone et al., 1995). However its removal attenuates the 
pathogenesis of FMDV (Brown et al., 1996; de los Santos et al., 2007; Mason et al., 
1997; Piccone et al., 1995). This appears to be due, at least in part, to the inability of 
leaderless FMDV to prevent translation of IFN-a and 3 mRNA (Chinsangaram et al., 
2001; Chinsangaram et al., 1999), the failure to degrade NF-kB (de los Santos et al., 
2007) and decreasing transcription factors for IFN- a and 3 (Wang et al., 2010). It has 
also been shown that the FMDV leader protease is very similar to the cellular 
deubiquitinase, ubquitin specific protease 14 (Hu et al., 2005) and PLpro of SARS-CoV
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(Ratia et al., 2006) and acts as a viral deubiquitinase (Wang et al., 2011). The 
consequence of this deubiquitinase activity results in a suppression of type I IFN 
signalling (Wang et al., 2011).
1.3.2 FMDV 2A
The FMDV 2A protein is 18 amino acids in length and has a size of approximately 2 
kDa. It is a self-cleaving peptide which separates the P1-2A region from the P2-P3 
region and is caused by a ribosomal skip (de Felipe et al., 2003; Donnelly et al., 2001). 
In picornaviruses, such as enteroviruses and rhinoviruses the 2A protein is much 
longer than that of FMDV with a size of approximately 145 amino acids and has been 
shown to act as a protease and inhibit host cell translation through the cleavage of 
elF4G and elF4E in a similar manner to the Leader protease of aphthoviruses (Aldabe 
et al., 1995; Glaser and Skern, 2000; Groppo et al., 2011; Haghighat et al., 1996; 
Lamphear et al., 1993; Novoa et al., 1997). Coxsackie, poliovirus, and Enterovirus 71 
2A proteins have been shown to induce apoptosis in target cells (Burgon et al., 2009; 
Calandria et al., 2004; Chau et al., 2007; Goldstaub et al., 2000; Kuo et al., 2002). RNA 
nuclear export has also been shown to be inhibited by poliovirus 2A (Castello et al., 
2009).
1.3.3 FMDV 2BC
2BC (Appendix I and II) is a non-structural protein with an important role in the 
formation of the replication complex in picornavirus infection (Bienz et al., 1990;
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O'Donnell et al., 2011; van Kuppeveld et al., 1996a). The FMDV 2BC protein is the 
hydrophobic precursor protein of 2B and 2C and contains 472 amino acids with a size 
of 52 kDa and is implicated in immune evasion. It is processed to form 2B and 
membrane binding protein 2C (Cho et al., 1994) by 3C protease (Jecht et al., 1998; 
Schultheiss et al., 1995) although not all 2BC is processed (Moffat et al., 2007; Van 
Kuppeveld et al., 1996b). FMDV 2BC protein has been shown to locate to the ER 
(Moffat et al., 2005).
2BC proteins have been found to down-regulate the host cell secretory pathway in 
several viruses including poliovirus, coxsackievirus and FMDV. This, in turn, could 
reduce surface expression of MHC I and could suppress the surface expression of other 
immune molecules such as NKG2D ligand, as has been demonstrated with 
cytomegalovirus (CMV) (Chalupny et al., 2006; Dunn et al., 2003; Welte et al., 2003), 
and reduce the secretion of immune stimulatory molecules such as cytokines and their 
receptors. This inhibition of cytokines and secretory molecules may be a key factor in 
immune evasion and enable the virus to disseminate throughout its host.
FMDV-induced down-regulation of cell surface expression of MHC class I was first 
reported by Sanz-Parra, et al (1998). Later work by Moffat et al., (2005) suggested 
that this phenomenon may be mediated by the FMDV 2BC protein which down- 
regulates the host protein secretory pathway by interfering with secretory protein 
movement from the ER to the Golgi apparatus (Moffat et al., 2005). The 2BC protein
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of FMDV is responsible for the formation of punctate structures within an infected cell, 
co-localising with ER markers and are thought to result from modification of the ER 
(Moffat et al., 2005). This is consistent with the membrane modifying abilities of the 
2BC protein of HAV and poliovirus (Barco and Carrasco, 1995; Teterina et al., 1997a; 
Teterina et al., 1997b).
Several picornaviruses such as poliovirus, coxsackievirus and FMDV have been 
reported to induce apoptosis through a variety of mechanisms (Barco et al., 2000; 
Chau et al., 2007; Goldstaub et al., 2000; Grubman et al., 2008; Jin et al., 2007; Kuo et 
al., 2002; Li et al., 2002), including induction of the caspase-3 pathway by poliovirus 
and coxsackievirus (Calandria et al., 2004; Carthy et al., 1998). However, there is 
evidence to suggest that coxsackievirus possesses a mechanism to inhibit apoptotic 
death (Campanella et al., 2004; Koyama et al., 2001; Tolskaya et al., 1995). 
Coxsackievirus 2BC protein inhibits apoptosis by binding to caspase-3 (Sa la ko et al., 
2006). In addition, the 2BC and 2B protein of poliovirus, when expressed in yeast and 
mammalian cells, have been found to down-regulate protein trafficking at the Golgi 
(Barco and Carrasco, 1995). Initially this effect was attributed to 2B, however work by 
Cornell et al., (2006) with coxsackievirus showed that 2BC led to a greater down- 
regulation of protein secretion than 2B on its own. 2BC-induced down-regulation was 
found to be due to the inhibition of protein trafficking by association with the Golgi 
apparatus (Cornell et al., 2006).
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1.3.4 FMDV2B
The FMDV 2B (Appendix III) protein is a small hydrophobic protein of 154 amino acids 
with a size of approximately 17 kDa. However it is not yet clear where FMDV 2B 
protein localises, Moffat et al., (2005) saw that FMDV 2B protein was associated with 
the ER using ERp57 as an ER marker. However, studies by de Jong et al., (2008) were 
unable to determine the location of 2B using calreticulin as the ER marker. The 
difference in the abilities to identify the location of FMDV 2B may be due to the 
different tags on the C-termini of 2B in the two studies, or more likely that 2B could be 
found to co-localise with ERp57 in the Moffat study but not calreticulin in the de Jong 
study.
Most of what is known about 2B protein stems from studies with enteroviruses. It is a 
small hydrophobic protein (Gonzalez and Carrasco, 2003; van Kuppeveld et al., 1995) 
that is localised to the endoplasmic reticulum (ER) and Golgi (Bienz et al., 1987; de 
Jong et al., 2008; Rust et al., 2001; Schlegel et al., 1996). The 2B protein exists as a 
mature protein and as part of the precursor protein 2BC (Fig. 1.2). Studies with 
coxsackie and polioviruses have shown that the 2B protein plays an important role in 
the modification of intracellular membranes. The 2B proteins of poliovirus, 
coxsackievirus and human rhinovirus are closely related, while the 2B proteins of 
EMCV, HAV and FMDV have little similarity to the enteroviruses and rhinoviruses (de 
Jong et al., 2008). Coxsackievirus and poliovirus 2B proteins co-localise predominantly 
with the Golgi apparatus, whereas HAV 2B protein co-localises with calreticulin of the
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ER. In contrast, FMDV and EMCV 2B does not co-localise with calreticulin in the ER or 
the Golgi apparatus (de Jong et al., 2008).
The 2B protein has been shown to form pores in the ER, Golgi and possibly 
mitochondrial membranes in coxsackievirus (Lama and Carrasco, 1992; van Kuppeveld 
et al., 1997a; Van Kuppeveld et al., 1997b), poliovirus (Agirre et al., 2002; Aldabe et al., 
1996; Lama and Carrasco, 1992; Madan et al., 2010b) and HAV (Jecht et al., 1998; 
Madan et al., 2008; Martinez-Gil et al., 2011), through formation of multimers (Agirre 
et al., 2002; de Jong et al., 2004; de Jong et al., 2002; Nieva et al., 2003). These pores 
result in permeabilisation of membranes (Agirre et al., 2002; Aldabe et al., 1996; Jecht 
et al., 1998; van Kuppeveld et al., 1997a; Van Kuppeveld et al., 1997b) and the release 
of Ca^  ^from the ER and/or Golgi into the cytoplasm (Campanella et al., 2004; de Jong 
et al., 2008; de Jong et al., 2006; van Kuppeveld et al., 2005). While coxsackievirus, 
human rhinovirus and poliovirus significantly reduce the levels of Ca^  ^ in the lumen of 
the ER and Golgi apparatus, EMCV reduces Ca^  ^levels only in the ER, and HAV 2B does 
not affect Ca^  ^ levels in the ER or Golgi apparatus (Campanella et al., 2004; de Jong et 
al., 2008). The release of calcium ions from the ER (Campanella et al., 2004; de Jong et 
al., 2008; de Jong et al., 2006; van Kuppeveld et al., 2005; van Kuppeveld et al., 1997a) 
may be utilised to modulate apoptosis (Campanella et al., 2004).
Using the temperature sensitive Vesicular Stomatitis Virus G protein system (tsVSVG), 
the 2B proteins of FMDV, HAV and EMCV were found not to inhibit trafficking of the 
tsVSVG protein through the secretory pathway (de Jong et al., 2008; Moffat et al., 
2005). However, the 2B proteins of coxsackie-, polio- and human rhino-viruses
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inhibited trafficking of the VSV G protein through the Golgi complex (de Jong et al., 
2008; Doedens and Kirkegaard, 1995). While it has not been determined with any 
certainty that FMDV 2B protein affects the distribution of Ca^  ^or where it is targeted 
to, it is believed to be necessary for FMDV replication (de Jong et al., 2008; de los 
Santos et al., 2005).
1.3.5 FMDV 2C
FMDV 2C (Appendix IV) protein is 318 amino acids long and has a size of 35 kDa. 
FMDV 2C protein has been found in the ER and in bright punctate structures within the 
Golgi but does not block protein trafficking (Moffat et al., 2005). FMDC 2C protein has 
been shown to have ATPase activity, exhibits non-specific binding to RNA (Sweeney et 
al., 2010) and is predicted to have helicase activity (Norder et al., 2011). NTPase 
activity of the 2C protein of poliovirus has been demonstrated (Mirzayan and Wimmer, 
1992; Pfister and Wimmer, 1999; Rodriguez and Carrasco, 1993; Teterina et al., 1992), 
However, helicase activity has not been described for the 2C proteins of Echovirus 9 
(Klein et al., 1999) or Human Parechovirus 1 (Norder et al., 2011; Samuilova et al., 
2006; Sweeney et al., 2010).
The 2C protein (Fig. 1.2) is one of the most conserved non-structural proteins within 
the Picornaviradae (Gorbalenya and Lauher, 2010). The difficulty in determining the 
structure of 2C may be due to its association with cellular membranes (Cho et al., 
1994; Echeverri et al., 1998; Teterina et al., 1997b). FMDV 2C protein has been 
predicted to have an amphipathic helix (Teterina et al., 2006), a feature that has been
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shown in poliovirus (Echeverri et al., 1998; Echeverri and Dasgupta, 1995) and in 
Theiler's Murine Encephalomyelitis virus (Murray et al., 2009) to bind membranes. 
This helix is believed to be required for membrane rearrangement and formation of 
the replication complex (Bienz et al., 1990).
Studies by Banerjee et al., (Banerjee et al., 2004) suggest that poliovirus 2C plays a role 
in the down-regulation of 3C. This down-regulation of 3C could have implications for 
the processing of 2BC and so could potentially lead to an accumulation of unprocessed 
2BC within an infected cell.
1.3.6 FMDV 3A
FMDV 3A protein has a length of 153 amino acids (Belsham, 1993; Mason et al., 2003) 
with a size of approximately 17 kDa. Picornavirus 3A proteins (Fig. 1.2) are small 
membrane-binding proteins (Weber et al., 1996) and may be important for species 
specificity of virus infection (Beard and Mason, 2000; Lama et al., 1998; Maroudam et 
al., 2010; Nunez et al., 2001).
The 3A proteins of poliovirus and coxsackievirus have been shown to limit ER-to-Golgi 
protein trafficking (Choe et al., 2005; Cornell et al., 2006; Doedens and Kirkegaard, 
1995; Wessels et al., 2006c). Coxsackievirus and poliovirus 3A proteins have been 
shown to bind and inhibit GBFl which is required for ADP-ribosylation factor-1 
activation (Teterina et al., 2011; Wessels et al., 2007), which in turn is required for COP
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I vesicle formation (Wessels et al., 2006a). This inhibition in the formation of COP I 
vesicles leads to a down-regulation of protein secretion from the ER-Golgi 
intermediate compartment (ERGIC) to the Golgi (Wessels et al., 2006a; Wessels et al., 
2006c). Studies have shown that N-terminal residues of 3A are required for this 
inhibition of protein secretion (Choe et al., 2005; Deitz et al., 2000; Dodd et al., 2001; 
Wessels et al., 2006c). This down-regulation of host protein secretion, between the ER 
and Golgi, reduces the secretion of IFNs, surface expression of MHC I and TNF-a 
receptor molecules (Choe et al., 2005; Deitz et al., 2000; Dodd et al., 2001; Neznanov 
et al., 2001). This would allow infected cells to avoid detection by CD8 * T cells (Cornell 
et al., 2007) as described in section 1.1.3. However, not all picornavirus 3A proteins 
function similarly. For example, the 3A proteins of rhinovirus 14, HAV, FMDV and 
Theiler's virus do not contain the N-terminal residues thought to be important for 
down-regulating the secretory pathway and do not cause a block in the host secretory 
pathway (Choe et al., 2005; Moffat et al., 2005).
1.3.7 FMDV SB
FMDV contains three similar but non-identical copies of the 38 protein Bi, B2 and B3  
(Forss and Schaller, 1982) also known as VPg (Rueckert, 1996). FMDV 3B has a length 
of 23 amino acids and a size of 2.4 kDa (Forss and Schaller, 1982), it is covalently 
bound to the 5' end of the viral genome (Fig. 1.2) and acts as a primer for 3D 
polymerase for RNA synthesis (Wimmer, 1982). FMDV is the only known picornavirus 
to possess three copies of 38. While all three 3B copies are not essential for virus
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replication, their presence does appear to positively influence FMDV virulence 
(Pacheco et al., 2003; Pacheco et al., 2010).
1.3.8 FMDV 3C Protease
The FMDV 3C protease is 213 amino acids long and has a size of approximately 23 kDa 
(Forss et al., 1984). The 3C protease sequence is highly conserved across the 
Picornaviradoe (Ryan and Flint, 1997) and it is a trypsin-like serine protease (Bazan and 
Fletterick, 1988; Bazan and Fletterick, 1990; Gorbalenya et al., 1989). 3C is responsible 
for the cleavage of the picornaviral polyprotein into several viral proteins (Bablanian 
and Grubman, 1993; Clarke and Sangar, 1988; Vakharia et al., 1987) (Fig. 1.2).
As with the leader protease, 3C also down-regulates the transcription and translation 
of host genes, this contributes to inhibiting the host response to infection. In FMDV 
infection, 3C limits host cell gene expression at the transcriptional level by the 
cleavage of the histone H3 (Falk et al., 1990; Griger and Tisminetzky, 1984) and in 
poliovirus infection by the cleavage of CREB (Tesar and Marquardt, 1990). At a 
translational level, gene expression is also down-regulated by 3C cleavage of elF4A, 
elF4GI and elF5B (Belsham et al., 2000; de Breyne et al., 2008).
The 3C of EMCV, poliovirus and enterovirus 71 has also been shown to down-regulate 
type I IFN expression through the inhibition of retinoic acid inducible gene I (RIG-1)
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(Barrai et al., 2009; Le! et al., 2010; Papon et al., 2009), which recognises viral RNA 
present in the cytoplasm, and through the cleavage of Toll/IL-1 receptor domain 
containing adaptor inducing IFN-p (TRIF) and mitochondrial signalling proteins (MAVs) 
(Mukherjee et al., 2011).
1.3.9 FMDV 3D
The 3D protein is the virally encoded RNA-dependent RNA polymerase (Polatnick and 
Arlinghaus, 1967) with a length of 470 amino acids and a size of approximately 52 kDa 
(Forss et al., 1984). The 3D polymerase synthesises the positive and negative RNA 
strands (Paul, 2002). The cleavage of 3D is a partial process and both the precursor 
3CD and 3D are required for RNA synthesis (Pathak et al., 2007).
1.3.10 FMDV 3' UTR
The 3' end of the picornavirus genome contains a poly(A)tail which is believed to be 
involved in genome circularisation and RNA replication (Barton et al., 2001) and is 
separated from the 3D polymerase by a tRNA-like secondary structure (Pilipenko et al., 
1992). The FMDV genome encoded (Dorsch-Hasler et al., 1975) 3' UTR is 90 
nucleotides long and essential for infectivity (Saiz et al., 2001).
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1.4 The Secretory Pathway
The Endoplasmic Reticulum (ER) is the first compartment of the cell secretory 
pathway. The ER has an extensive network of cisternae and has a number of roles 
within the cell. Secretory proteins are synthesised on the rough ER and are 
transported into the ER lumen through the translocon where they are folded by 
chaperone proteins prior to export to the Golgi apparatus via the ER-Golgi 
intermediate compartment (ERGIC) (Fig. 1.4). The ER is one of the most important 
organelles for storage of calcium ions (Michalak et al., 2002). Within the ER, unfolded 
proteins interact with molecular chaperones and enzymes including binding 
immunoglobulin protein (BIP/GRP78), calreticulin, calnexin, ERp57, PDI and GRP94 to 
produce competent and functional proteins (Bedard et al., 2005).
As peptides are synthesised by membrane-bound ribosomes on the ER (Ganoza and 
Williams, 1969; Redman, 1969), the peptide chains cross the ER membrane and enter 
the ER lumen (Redman and Sabatini, 1966; Redman et al., 1966) via the Sec61 
complex. The Sec61 complex is comprised of a, p, and y heterotrimers and form the 
core of the mammalian ER translocon (Gilmore et al., 1982; Gôrlich and Rapoport, 
1993; Meyer and Dobberstein, 1980; Mitra et al., 2005; Rapoport et al., 1996; Walter 
and Blobel, 1981).
The ER lumen acts as an important calcium store. Calcium is stored in the ER, where it 
is buffered by calcium-binding chaperones such as calnexin and calreticulin, and is 
released through the IP3 receptor (Groenendyk et al., 2004). The ER Lumen contains
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Figure 1.4 The Secretory Pathway. (A) The translation of a peptide on the rough ER 
and translocation of the nascent peptide into the ER. (B) The secretory pathway, 
showing the transport of COP II molecules from the ER to the ERGIC; and the 
retrograde transport of COP I molecules from the Golgi apparatus to the ER.
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a number of chaperone proteins including BIP, calreticulin, calnexin, ERp57, PDI and 
GRP94, which ensure correct protein folding of any synthesised proteins prior to them 
being exported from the ER.
After proteins are synthesised and folded at the ER they are exported at ER exit sites. 
COP II is responsible for transport of these proteins from the ER to the ERGIC 
(Appenzeller-Herzog and Hauri, 2006; Barlowe et al., 1994; Lee et al., 2004). SecSl 
and Secl3 molecules along with Sec23 and Sec24 form part of the COP II trafficking 
complex (Barlowe et al., 1994; Townley et al., 2008) and along with Sari are the 
minimum machinery required for COP II dependent budding in vitro (Kuge et al., 1994; 
Matsuoka et al., 1998).
Sari is activated by Secl2 (Fig. 1.5 A), and inserts into the ER membrane (Weissman et 
al., 2001), resulting in membrane deformation which is required for budding of the ER 
membrane (Bi et al., 2002; Bielli et al., 2005). Through interaction with Sec23, Sari 
recruits the Sec23-Sec24 complex (Fig. 1.5 B) (Yoshihisa et al., 1993), which captures 
the COP II cargo and SNARE molecules and engages with membrane cargo (Fig. 1.5 C 
and D) (Miller et al., 2002; Miller et al., 2003; Mossessova et al., 2003). The outer coat 
of the COP II vesicle is then recruited to the budding vesicle consisting of a Secl3- 
Sec31 complex (Lederkremer et al., 2001) (Fig. 1.5 D).
Sec31 and Secl3 self assemble into a cage-like structure which forms the outer coat of 
the COP II complex (Stagg et al., 2006; Stagg et al., 2008). This coatamer of COP II
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Figure 1.5 Formation of the COP II complex budding from the ER. A) Initiation of 
budding by Sari. B) Recruitment of Sec23 and Sec24. C) Engagement with 
transmembrane cargo. D) Accumulation of transport proteins and membrane 
deformation. E) Recruitment of Secl3-Sec31 COP coat. F) Budding of COP I! vesicle.
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containing SecSl has been found to be required for ER-to-Golgi transport in several 
assays (Kuehn and Schekman, 1997; Salama et al., 1997; Tang et al., 2000). Soon after 
budding from the ER, COP II vesicles uncoat due to Sari GTP hydrolysis (Oka and 
Nakano, 1994) (Fig. 1.5 E).
The ERGIC is a complex membrane system, which is an intermediate between the ER 
and the Golgi (Saraste and Svensson, 1991; Schweizer et al., 1990), but is distinct from 
the ER and the Golgi (Schweizer et al., 1991). It is the first sorting station for 
retrograde and anterograde protein trafficking after the ER (Appenzeller et al., 1999; 
Aridor et al., 1995; Ben-Tekaya et al., 2005; Klumperman et al., 1998; Martmez- 
Menàrguez et al., 1999).
From the ERGIC, vesicular carriers are formed which fuse to the c/s-Golgi apparatus. 
The Golgi apparatus is involved in the modification, organisation and transport of 
proteins and membranes targeted to parts of the cell, such as the plasma membrane, 
lysosomes and endosomes or for cellular secretion. The Golgi primarily modifies ER 
derived proteins by glycosylation or phosphorylation but it is also involved in the 
transport of lipids around the cell. This regulated transport is important for 
appropriate protein localisation, secretion and signal transduction.
The fusion of vesicles to the Golgi apparatus requires Golgi matrix protein (GM130) 
(Marra et al., 2007; Puthenveedu et al., 2006). GIVI 130 is a member of the Golgin
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family of proteins which includes Giantin, p ll5  and GRASP65. GM130 is a c/s-Golgi 
matrix protein associated with the cytoplasmic face of the Golgi apparatus via 
GRASP65 and cycles between the c/s-Golgi and the ERGIC (Barr et al., 1998; Nakamura 
et al., 1995). Golgins are defined by their presence in the Golgi matrix and by their 
long coiled domains (Nakamura et al., 1995). GIVI 130 and Giantin interact with the 
transport factor p ll5  to enable ER-Golgi transport of COP I molecules and their fusion 
to the Golgi apparatus through interaction with GIVI 130 (Allan et al., 2000; Alvarez et 
al., 2001; Sônnichsen et al., 1998).
Membranes and proteins to be recycled back to the ER from the Golgi where they 
were originally synthesized are carried by COP I vesicles (Cosson and Letourneur, 1997; 
Letourneur et al., 1994; Pelham, 1994). The COP I coat of these vesicles consists of 
seven sub units a, (3, p', y, 6 , £, I, COP (Duden et al., 1991; Harrison-Lavoie et al., 1993; 
Malhotra et al., 1989; Serafini et al., 1991; Stenbeck et al., 1993) known collectively as 
a coatamer (Waters et al., 1991)et al, 1991). It is believed that COP I primarily recycles 
constituents required for the ER to allow the antegrade transport to continue from the 
ER to the Golgi (Gaynor et al., 1994; Letourneur et al., 1994; Pelham, 1994).
1.5 ER stress responses
1.5.1 The Unfolded Protein Response
ER stress is induced by several physical and pathological conditions resulting in the 
disruption of homeostasis within the ER. ER stress can be induced through the
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disruption of calcium trafficking, accumulation and aggregation of misfolded proteins, 
glucose starvation, hypoxia and defective protein secretion or degradation.
The disruption in protein folding mechanisms, leading to an accumulation and 
aggregation of misfolded proteins, can threaten cell survival and leads to the unfolded 
protein response (UPR). The UPR reduces protein translation to prevent an 
accumulation of proteins within the ER by phosphorylating elF-2a by Protein Kinase 
RNA-like endoplasmic reticulum kinase (PERK) (Harding et al., 2000b; Harding et al., 
1999) and inducing an activation of chaperone proteins such as BiP, which increases 
the folding capacity of the ER (Kozutsumi et al., 1988). There is now also evidence 
which indicates that ER stress is a trigger for autophagy (Bernales et al., 2006; 
Decuypere et al.; Ding et al., 2007; Kouroku et al., 2006; Ogata et al., 2006; Yorimitsu 
et al., 2006). If ER stress is too severe or protracted during the UPR, apoptosis ensues 
(Elyaman et al., 2002; Morishima et al., 2002).
1.5.1.1 BiP
BiP, also known as GRP78, has several roles including regulating the permeability of 
the ER membrane to nascent proteins via the translocon, facilitating the folding of 
nascent proteins and regulating calcium homeostasis. BiP acts as a sensor of unfolded 
proteins within the ER and has a high affinity for unfolded protein substrates. In an 
inactive state, BiP is bound to three key sensors for ER stress: inositol requiring 
enzyme 1 (Irel), activating transcription factor 6  (ATF6 ) and PERK on the ER membrane
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(Bertolotti et al., 2000; Sommer and Jarosch, 2002). BiP binds to ATF6 , PERK and IREl 
when in an inactive state. BiP binds to unfolded proteins and disassociates from ATF6 , 
PERK and IREl leading to their activation (Fig. 1.6).
1.5.1.2 PERK
PERK is activated by the release of BiP from its luminal region in the ER it oligermerises 
and phosphorylates elF2a (Cullinan et al., 2003; Harding et al., 2000b; Harding et al., 
1999; Shi et al., 1999). Phosphorylation of elF2a allows for the preferential translation 
of mRNA for ATF4 (Harding et al., 2000a) (Scheuner et al., 2001) which activates 
CHOP/GADD153 (c/EBP homologous protein/growth arrest and DNA damage-inducible 
protein 153) (Harding et al., 2000a; Jiang et al., 2004; Ma et al., 2002).
1.5.1.3 CHOP/GADD153
CHOP/GADD153 is strongly induced at a transcriptional level in response to ER stress. 
CHOP is activated by Irel, ATF6  and PERK. However PERK plays the dominant role in 
CHOP activation (Harding et al., 2000a; Scheuner et al., 2001). CHOP acts as a 
transcriptional factor that regulates genes involved in cell survival and death leading to 
apoptosis (Marciniak et al., 2004; McCullough et al., 1999; Zinszner et al., 1998).
34
ER stress
Protein aggregates
BiP
BiP BiP
m
m
XBPl Splicing
elF2a
Translational
inhibition ATF4
CHOP
Figure 1.6 Stress pathways within the ER. A variety of stress signals activate the 
unfolded protein response. The preferential association of BiP with misfolded proteins 
activates the sensor pathways of PERK, IREl and ATF6 .
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1.5.1.4 ATF6
ATF6 , when released by BiP (Shen et a!., 2002; Sommer and Jarosch, 2002), 
translocates to the Golgi apparatus where it is cleaved by proteases (Chen et al., 2002; 
Ye et al., 2000) to produce a 50 kDa fragment (ATF6  p50) (Haze et al., 1999) which 
binds ER stress response element (ERSE) promoters which activates proteins of the 
UPR (Fig. 1.6).
1.5.1.5 IREl
IREl is activated by the dissociation of BiP (Oikawa et al., 2009). IREl oligomerises (Liu 
et al., 2002; Shamu and Walter, 1996; Welihinda and Kaufman, 1996) and 
autophosphorylates activating its RNase region (Shamu and Walter, 1996; Welihinda 
and Kaufman, 1996). The phosphorylated IREl cleaves an intron from its substrate X- 
box binding protein (XBP) 1 mRNA (Fig. 1.6). The cleavage and splicing of XBPl results 
in a frame shift in the reading frame of XBPl resulting in translational activation of 
XBPl which binds to the ER stress response and unfolded response elements (Calfon 
et al., 2002; Reimold et al., 2000; Yoshida et al., 2001) up-regulating ER chaperones 
including BiP.
1.5.2 ER-associated degradation
In addition to the UPR, unfolded and misfolded proteins can be targeted by 
ubiqitination for degradation at the proteasome (Hiller et al., 1996). This is known as
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ER-associated degradation (ERAD). The ERAD consists of three main stages: 
recognition of misfolded substrates and targeting to the ERAD pathway, retro- 
translocation from the ER to the cytoplasm and ubiqitination and proteasomal 
degradation.
The majority of polypeptides entering the ER lumen are modified with glucoseg- 
mannoseg-N-acetylglucosaminez-oligosaccharides added onto asparagines side chains. 
In the calnexin/calreticulin cycle, rapid removal of the outer most glucose residues by 
glucosidases I and II produces an intermediate which recruits calnexin/calreticulin 
(Helenius et al., 2001; Kato and Kamiya, 2007). The removal of the remaining glucose 
residue by glucosidase II releases the glycoprotein from the lectin chaperones. These 
polypeptides have assumed their correct conformation and exit the ER for transport.
Misfolded glycoproteins are recognised by the luminal enzyme UDP- 
glucoseiglycoprotein glucosyltransferase (UGGT). UGGT adds a glucose residue to 
unglucosylated glycans, which causes the protein to re-enter the calnexin-calreticulin 
cycle for another round of correctional folding (Hammond et al., 1994; Hebert et al., 
1995). The cycle of release and binding of the glycoprotein to calnexin/calreticulin is 
repeated until correct folding is achieved (McCracken and Brodsky, 1996). Unresolved 
misfolded proteins are retro-translocated back into the cytoplasm via the Sec61 
translocon (Pilon et al., 1997; Plemper et al., 1997; Zhou and Schekman, 1999) or via 
Derlin (Lilley and Ploegh, 2005). In the cytoplasm the misfolded proteins are modified 
with polyubiquitin chains targeting them for proteasomal degradation. The presence
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of the 26S proteasome in the cytoplasm prevents the degradation of intermediately 
folded proteins within the ER (Kopito, 1997).
1.5.3 ER stress associated autophagy
It has been shown that autophagy can be induced by ER stress (Ogata et al., 2006; 
Yorimitsu et al., 2006). While the origin of autophagosome membranes have not been 
defined, there is evidence that the ER provides some membranes for the 
autophagasome and that autophagy is important for ER homeostasis (Ding et al., 2007; 
Dunn, 1990; Mijaljica et al., 2006; Yorimitsu and Klionsky, 2007b).
In yeast when the ERAD becomes saturated, autophagy removes soluble and 
aggregated unfolded proteins (Kruse et al., 2006). Autophagy also enables cells to 
maintain a steady state during a continuous accumulation of unfolded proteins within 
the ER (Bernales et al., 2006). While ER stress has been shown to induce autophagy 
and is induced via the PERK-elF2a pathway the downstream mechanism leading to 
autophagy has not yet been elucidated (Boyce et al., 2008; Kim et al., 2010; Kouroku et 
al., 2007; Marambio et al., 2010; Ogata et al., 2006; Py et al., 2009; Talloczy et al., 
2002; Wu et al., 2006).
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1.6 Picornaviral subversion of the secretory pathway
Many viruses have been shown to target the secretory pathway to utilise host cell 
membranes for their replication complexes and to limit the surface expression of 
immunogenic molecules. The UL16 protein of CMV has been shown to retain NKG2D 
ligands within the ER and c/s-Golgi. The ER retention of NKG2D molecules can result in 
an inhibition of NK response to Infection (Dunn et al., 2003; Welte et al., 2003). The 
adenovirus E19 protein interacts with MHC I molecules to retain them within the ER 
and prevent viral peptide loading onto MHC I (Andersson et al., 1985).
The 2B and 2BC proteins of coxsackie and polioviruses have been shown to form pores 
within the ER and Golgi resulting in an efflux of calcium ions from the ER and Golgi into 
the cytoplasm (Agirre et al., 2002; Aldabe et al., 1996; Aldabe et al., 1997; de Jong et 
al., 2006; van Kuppeveld et al., 2005). This results in a decrease of calcium contained 
in the ER and Golgi compartments, calcium fluxes to the mitochondria and an increase 
in the levels of calcium in the cytoplasm. This disruption of calcium homeostasis leads 
to an inhibition of the secretory pathway (de Jong et al., 2006). Other effects incurred 
from the disruption of the calcium signalling pathway include the modulation of 
apoptosis (Agol et al., 2000; Annis et al., 2001; Campanella et al., 2004; Tolskaya et al.,
1995) and potential induction of autophagy (Decuypere et al.; Gordon et al., 1993).
Several viruses are known to subvert the secretory pathway to induce membrane 
alterations to support the viral replication complex. Autophagy is an important
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process in the cell cycle involving degradation of long lived proteins and cellular 
components through the lysosomal machinery. Autophagy is utilised to manage cell 
starvation and as part of the innate immune response to infection (Kudchodkar and 
Levine, 2009; Sumpter Jr and Levine, 2010; Talloczy et al., 2002). During autophagy a 
double membrane autophagosome forms in the cytoplasm, recruiting cytoplasmic 
components and small organelles. The autophagosome fuses with lysosomes to 
degrade the autophagosome contents. Studies have suggested that the membranes 
recruited for the autophagosome are recruited from the ER (Dunn, 1990; Juhasz and 
Neufeld, 2006).
Autophagy can be triggered by a range of stimuli including the release of intracellular 
calcium (Gordon et al., 1993; Hoyer-Hansen and Jaattela, 2007) and ER stress (Ding et 
al., 2007; Kouroku et al., 2006; Ogata et al., 2006; Yorimitsu et al., 2006). Replication 
complexes have been shown to form from exploiting the autophagic pathway in FMDV 
(O'Donnell et al., 2011), poliovirus (Schlegel et al., 1996; Suhy et al., 2000; Taylor and 
Kirkegaard, 2007), Enterovirus 71 (Huang et al., 2009), arterivirus (Pedersen et al., 
1999), coxsackievirus (Kemball et al., 2010; Wong et al., 2008; Yoon et al., 2008), 
EMCV (Zhang et al., 2011), Dengue (Heaton and Randall, 2010), coronavirus (Prentice 
et al., 2004) and HCV (Dreux et al., 2009).
Many viruses utilise host cell membranes for their replication (Ahlquist, 2006; Miller 
and Krijnse-Locker, 2008). The replication of several viruses such as poliovirus and
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coxsackievirus are sensitive to the fungal metabolite Brefeldin A (BFA) (Irurzun et al., 
1992; Irurzun et al., 1993; Maynell et al., 1992). BFA inhibits the trafficking of proteins 
from the ER to Golgi apparatus which causes the tubules of the Golgi to fuse with the 
ER (Lippincott-Schwartz et al., 1989; Sciaky et al., 1997). BFA inhibits the activation of 
the GTPase ADP ribosylation factor 1 (Arfl), a regulator of protein transport (Balch et 
al., 1992). A rfl cycles between an inactive cytosolic GDP-bound and a membrane- 
associated GTP-bound active form. Arfls cycling is controlled by guanine nucleotide 
exchange factors (GEFs) and GTPase activating proteins (D'Souza-Schorey and 
Chavrier, 2006). The membrane associated GTP-bound A rfl is required to generate 
COP I coats in the Golgi apparatus by recruiting coatamer units and dimerises the 
membrane, playing a key role in COP I vesicle formation (Beck et al., 2008). BFA blocks 
the activities of GEFs and so locking A rfl in an intermediate inactive state (Peyroche et 
al., 1999).
It has been shown that coxsackievirus and poliovirus 3A protein blocks protein 
trafficking (Choe et al., 2005; Doedens et al., 1997; Doedens and Kirkegaard, 1995) by 
blocking the assembly of COP I by directly targeting GBFl an A rfl GEF (Teterina et al., 
2011; Wessels et al., 2007; Wessels et al., 2006a; Wessels et al., 2006b) and poliovirus 
3CD precursor protein has been shown to induce the translocation of A rfl (Belov et al., 
2007b). As a consequence anterograde trafficking of the ERGIC to the Golgi apparatus 
is inhibited resulting in the disassembly of the Golgi complex (Beske et al., 2007; 
Cornell et al., 2006; Doedens and Kirkegaard, 1995; Quiner and Jackson, 2010; Wessels 
et al., 2005). Unlike coxsackievirus and poliovirus; human rhinovirus (HRV), ECMV,
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FMDV, and HAV 3A proteins do not inhibit protein trafficking or prevent COP I 
assembly (Choe et al., 2005; Moffat et al., 2005; Wessels et al., 2006a).
In FMDV infection, it has been shown that 2BC and not 3A causes the block in protein 
trafficking (Moffat et al., 2005). BFA treatment of cells infected with FMDV or EMCV 
does not inhibit virus replication (Gazina et al., 2002; O'Donnell et al., 2001) and so it is 
likely that these viruses inhibit protein trafficking upstream of GBFl. The 
fragmentation of the Golgi apparatus makes membranes available for viral replication 
(de Jong et al., 2003; Hsu et al., 2010; Jauka et al., 2010; Quiner and Jackson, 2010) 
along with membranes of the ER which are involved in the formation of some RNA 
virus replication complexes (Knoops et al., 2010; Schlegel et al., 1996). The only group 
of viruses known to utilise the ERGIC as part of their replication are the coronaviruses, 
which utilise membranes from the ERGIC for the budding of newly formed virus 
particles viruses (Bost et al., 2001; Klumperman et al., 1994; Krijnse-Locker et al., 1994; 
Stertz et al., 2007).
Viruses have also been shown to interfere with the ER to ERGIC trafficking vesicle COP
II. Several viral homologues such as the Norwalk virus non-structural protein p22
mimic transport signals and so inhibit correct COP II formation (Sharp et al., 2010).
Other viruses, such as Ebola and Marburg viruses, utilise the COP II pathway for the
transport of viral proteins (Yamayoshi et al., 2008) and for the successful infection of
SV40 (Richards et al., 2002). Poliovirus has been shown to utilise membranes derived
from the ER, utilising the COP II complex in conjunction with the 2BC protein which
locates to the same region of COP II assembly on the ER (Rust et al., 2001). In addition,
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the plant picornavirus, potyvirus 6 K protein has been shown to utilise COP II in the 
formation of its replication complex (Wei and Wang, 2008).
In addition to the subversion of the secretory pathway to provide membranes to form 
replication complexes, viruses also subvert the secretory pathway as a mode of 
immune evasion. Viral infection has been shown to result in the down-regulation of 
MHC I molecules and prevent them from being displayed on the cell surface (Cornell et 
al., 2007; Konan et al., 2003; Sanz-Parra et al., 1998; Ziegler et al., 1997). ER stress can 
result in a reduction of surface expression of MHC I molecules (Ulianich et al., 2011). 
There is also evidence that poliovirus can suppress the cytokine response to infection 
by inhibiting cytokine secretion and limiting the surface expression of TNF receptors 
(Dodd et al., 2001; Neznanov et al., 2001).
FMDV 2BC protein or the co-expression of 2B and 2C, as stated previously, inhibit 
trafficking from the ER to the Golgi apparatus (Moffat et al., 2005; Moffat et al., 2007). 
As FMDV replication is not inhibited in the presence of BFA, it is likely that, unlike 
poliovirus infection which disrupts the secretory pathway between the ERGIC and 
Golgi (Beske et al., 2007) FMDV targets a region between the ER and the ERGIC. This 
can have the effect of preventing the secretion of cytokines, MHC I molecules, and 
other factors required to elicit an effective immune response to infection (Sandoval 
and Carrasco, 1997).
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1.7 Viral induction of ER stress
A number of viruses have been shown to induce ER stress during the course of 
infection (Bitko and Barik, 2001). ER stress can have a profound effect upon the 
functioning of a cell. Viral infections can affect the UPR in a variety of ways. Infection 
of cells with HCV activates the PERK and ATF6  pathways (Benali-Furet et al., 2005) 
leading to CHOP activation (Chan and Egan, 2005{Pavio, 2003 #13397; Ciccaglione et 
al., 2007; Pavio et al., 2003) but suppresses the IREl-XBPl (Tardif et al., 2004). HBV X 
protein also activates ATF6  and IREl-XPB pathways of the UPR (Li et al., 2007), while 
CMV infection activates PERK and the IREl-XBPl pathways but suppresses the ATF6  
pathway (Isler et al., 2005; Tirosh et al., 2005).
Coxsackievirus infection has been shown to up-regulate BiP expression, stimulate ATF6  
and PERK activity and also activate CHOP, leading to apoptosis (Zhang et al., 2010). 
Several other viruses stimulate ER stress such as Dengue, West Nile Virus and Japanese 
Encephalitis Virus, which have been found to induce the UPR and activate CHOP 
leading to apoptosis (Klomporn et al., 2011; Medigeshi et al., 2007; Su et al., 2002). ER 
stress can reduce protein trafficking as a consequence of the dispersal of the COP II 
complex (Amodio et al., 2009), induce autophagy and limit the expression of MHC I 
molecules (Ogata et al., 2006; Ulianich et al., 2011; Yorimitsu et al., 2006).
A number of viruses influence host cell calcium homeostasis including poliovirus 
(Aldabe et al., 1997; Irurzun et al., 1995), coxsackievirus (Campanella et al., 2004; de
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Jong et al., 2006), human rhinovirus 14 (de Jong et al., 2008), EMCV (de Jong et al., 
2008) and HCV (Benali-Furet et al., 2005; Gong et al., 2001). It is not currently known 
if FMDV causes an efflux of Ca^  ^ from the ER. Calcium depletion inhibits correct 
protein folding by interfering with BiP association with proteins and abrogates the 
interaction of calnexin and calreticulin with unfolded proteins (Corbett et al., 1999; 
Lodish et al., 1992; Suzuki et al., 1991; Vassilakos et al., 1998; Wetmore and Hardman,
1996). The depletion of calcium also interferes with retention of ER-resident proteins 
(Booth and Koch, 1989), ER to Golgi trafficking (Kuznetsov et al., 1992; Lodish and 
Kong, 1990) and chaperone function (Baksh et al., 1995; Corbett et al., 1999; Oliver et 
al., 1999; Ou et al., 1995; Suzuki et al., 1991; Zapun et al., 1998). The efflux of calcium 
ions from the ER to the cytoplasm can also lead to the activation of the apoptotic 
response within the mitochondria (Brisac et al., 2010; Sano et al., 2009). There is 
contradictory evidence for the role of calcium in the regulation of autophagy. 
However in stressed cells, it has been suggested that the increase in cytoplasmic 
calcium may induce autophagy (Decuypere et al.).
Infection of cells with viruses can stimulate the autophagic pathway (Jackson et al., 
2005; Lin et al., 2010). While this may be a response to infection in an attempt to clear 
the virus (Panyasrivanit et al., 2011), many viruses exploit the autophagic pathway for 
their replication. It has been shown that in many cases viral infection induces 
autophagy, which is utilised for virus replication complexes (Rodriguez-Rocha et al., 
2011; Zhang et al., 2011). The replication of many viruses including coxsackievirus 
(Wong et al., 2008; Yoon et al., 2008) Enterovirus 71 (Huang et al., 2009), EMCV
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(Zhang et al., 2011) and FMDV (O'Donnell et al., 2011) been shown to utilise 
autophagy in their replication complexes and components of the secretory pathway 
are also recruited to form replication complexes (Belov et al., 2007a; Belov and 
Ehrenfeld, 2007; Dunn, 1990; Unno et al., 2005; Yorimitsu and Klionsky, 2007a). This 
sequestering of the secretory pathway for the putative viral replication complex may 
also inhibit protein trafficking.
1.8 Aims
Previous studies have shown that the FMDV 2BC protein inhibits protein trafficking 
from the ER to Golgi apparatus (Moffat et al., 2005) and this inhibition can be 
reproduced by co-expression of FMDV 2B and 2C (Moffat et al., 2007). Immuno- 
fluorescent labelling has shown that FMDV 2BC induces punctate cytoplasmic staining 
and an accumulation of ER proteins within vesicular structures (Moffat et al., 2005). 
The specific location of 2BC protein within the cell is currently unknown and its 
potential affects upon the ER and the secretory pathway undefined. The aim of this 
project was to investigate the effects of 2BC expression on the secretory pathway and 
ER and to identify the cellular localisation of FMDV 2BC
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The specific objectives are to:
(i) Identify the cellular localisation of FMDV 2BC protein, using immuno-fluorescent 
microscopy to determine which cellular marker(s) FMDV 2BC protein colocalised with.
(ii) Determine the effects of FMDV 2BC protein upon the secretory pathway and 
attempt to quantify the extent that FMDV 2BC protiein prevents protein trafficking 
using a secreted alkaline phosphatase reporter system.
(iii) Determine if FMDV 2BC protein affects the ER stress response in cells, by 
determining if there is any fluctuation of ER stress markers in infected cells or cells 
expressing FMDV 2BC protein by Western blot.
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Chapter Two: Materials & Methods
2.1 Materials
2.1.1 Antibodies
Antibodies were used for a range of applications primarily for immuno-fluorescence 
microscopy and Western blots. Table 2.1 shows a list of primary antibodies used and 
their applications.
Table 2.1 List of Primary Antibodies and their applications
Name Species Isotype IF Working 
Dilution
WB Working 
Dilution
Supplier
Anti-3A
2C2 Mouse IgGza 1 : 1 0 0 0 1 : 1 0 0 0 E. Brocchi, IZSLE, 
Brescia, Italy
Anti-2C
3F7 Mouse IgGza 1 : 1 0 0 0 1 : 1 0 0 0 E. Brocchi, IZSLE, 
Brescia, Italy
1C8 Mouse IgGi 1 : 1 0 0 0 1 : 1 0 0 0 E. Brocchi, IZSLE, 
Brescia, Italy
3B3 Mouse IgGi 1 : 1 0 0 0 1 : 1 0 0 0 E. Brocchi, IZSLE, 
Brescia, Italy
DM11 Rabbit Polyclonal 1 : 1 0 0 N/A D. Mackay, lAH, 
Pirbright, UK
DM12 Rabbit Polyclonal 1 : 1 0 0 N/A D. Mackay, lAH, 
Pirbright, UK
Reporter protein 
antibodies
Anti-Alkaline
Phosphatse
Mouse IgGaa 1:4000 1 : 1 0 0 0 Sigma
Anti-VSVG (11) Mouse lgG2a 1 : 2 0 N/A (Lefrancois and Lyles, 
1982)
Cellullar marker 
antibodies
Anti-BIP Rabbit Polyclonal 1:250 1 : 1 0 0 0 Cell Signalling 
Technologies
Anti-Calnexin Rabbit Polyclonal 1:250 1 : 1 0 0 0 Cell Signalling 
Technologies
Anti-Calnexin
(TW20)
Rabbit Polyclonal N/A 1 : 1 0 0 0 T. Wileman, lAH, 
Pirbright, UK
Anti-Calreticulin Rabbit Polyclonal 1 : 2 0 0 1 : 2 0 0 0 Abeam
48
Anti-Erol-La Rabbit Polyclonal 1:250 1 : 1 0 0 0 Cell Signalling 
Technologies
Anti-IREla Rabbit Polyclonal 1:250 1 : 1 0 0 0 Cell Signalling 
Technologies
Anti-CHOP Mouse lgG2a N/A 1 : 1 0 0 0 Cell Signalling 
Technologies
Anti-CHOP Rabbit Polyclonal N/A 1 : 2 0 0 SantaCruz Biotech
Anti-PERK Rabbit Polyclonal N/A 1 : 1 0 0 0 Cell Signalling 
Technologies
Anti-pPERK Rabbit Polyclonal 1:250 1 : 1 0 0 0 Cell Signalling 
Technologies
Anti-PDI Rabbit Polyclonal 1:250 1 : 1 0 0 0 Cell Signalling 
Technologies
Anti-GRP94 Rabbit Polyclonal 1 : 1 0 0 1:5000 Sigma
Anti-GM130 Mouse IgGi 1:50 N/A University of Calgary
Anti-Sec31A Mouse IgGi 1:500 1:500 BD Biosciences
Anti-Sec61A Rabbit Polyclonal 1:250 1 :2 0 , 0 0 0 Thermo
Anti-ERp57 Rabbit Polyclonal 1 : 2 0 0 1 : 2 0 0 0 (Cobbold et al., 1996)
Anti-Giantin Mouse IgGi 1 : 1 0 0 0 N/A (Linstedt and Hauri 
1993)
Anti-Actin Mouse lgG2a 1 : 1 0 0 0 N/A Sigma
Anti-ERGIC53 Mouse IgGi 1 : 1 0 0 0 N/A (Linstedt and Hauri 
1993)
Anti-3-COP Rabbit Polyclonal 1 : 2 0 0 N/A T. Wileman, lAH, 
Pirbright, UK
Anti-a-Tubulin Mouse Polyclonal 1 : 2 0 0 0 N/A Sigma
Anti-y-Tubulin Mouse IgGi 1 : 2 0 0 1:5000 Sigma
Anti-Vimentin
(V9)
Mouse IgGi 1 : 1 0 0 0 N/A Sigma
Secondary antibodies (Table 2.2) were used to detect the primary antibody and were 
conjugated with either a fluorophore or horseradish peroxidise (HRP) to allow a signal 
to be detected by either confocal microscopy or from exposure to X-ray film, 
respectively.
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Table 2.2 List of Secondary Antibodies and their application
Name Species IF Working 
Dilution
WB Working 
Dilution
Supplier
Alexa Fluor Anti-Rabbit IgG 
488
Goat 1:500 N/A Invitrogen
Alexa Fluor Anti-Rabbit IgG 
568
Goat 1:500 N/A Invitrogen
Alexa Fluor Anti-Mouse IgG 
488
Goat 1:500 N/A Invitrogen
Alexa Fluor Anti-Mouse IgG 
568
Goat 1:500 N/A Invitrogen
Alexa Fluor Anti-Mouse IgGi 
488
Goat 1:500 N/A Invitrogen
Alexa Fluor Anti-Mouse IgGi 
568
Goat 1:500 N/A Invitrogen
Alexa Fluor Anti-Mouse lgG2a 
488
Goat 1:500 N/A Invitrogen
Alexa Fluor Anti-Mouse IgG  ^
568
Goat 1:500 N/A Invitrogen
Alexa Fluor Anti-Mouse IgG 
633
Goat 1:500 N/A Invitrogen
Anti-Rabbit IgG-HRP Goat N/A 1:2500. Promega
Anti-Mouse IgG -HRP Goat N/A 1:2500 Pro mega
2.1.2 Enzymes
Enzymes were used for a range of applications (Table 2.1.2). Restriction enzymes were 
used for cloning and restriction digest analysis. T4 DNA Polymerase was used for the 
generation of blunt ended DNA molecules, filling in 5' protruding ends, or the removal 
of 3' overhangs. Ligases were used to ligate DNA strands together.
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Table 2.1.2 List of Enzymes used and their function
Name Function Incubation
temperature
Supplier Recommended
Buffer
Bsml Restriction Digest 65°C NEB 2
EcoRl Restriction Digest 37°C Promega/NEB H/U ni versai
fcoRV Restriction Digest 37°C Promega/NEB D/3
Mlul Restriction Digest 37°C Promega D
Nhel Restriction Digest 37°C NEB 2
Notl Restriction Digest 37°C Promega D
Sail Restriction Digest 37°C Promega D
Smal Restriction Digest 25°C NEB 4
Xhol Restriction Digest 37°C Promega D
T4DNA
polymerase
Removal of Sticky 
ends
37°C Promega T4 DNA polymerase 
Buffer
T4 DNA ligase Ligation 16°C NEB Ligation Buffer
Thermpsensitve
alkaline
phosphatase
Dephosphorylation 37°C Promega Multicore
Superscript III Reverse
transcriptase
N/A Invitrogen N/A
2.1.3 DNA constructs
DNA constructs were used for functional assays and for cloning: pSEAP2-Control 
(Clontech); pIRES (Clontech); pcDNAS.l/Zeo (Invitrogen); pCK3 (Caroline Knox, 
University of St Andrews, U.K.); pT7S3 (Ellard et al., 1999); pJAT-LacZ (Masson et al., 
1992), pTs045 GYFP (Moffat et al., 2005).
51
2.1.4 Analytical Software
A number of software programmes were used to aid with the construction of 
constructs and to analyse data output from experiments. The programmes used and 
their purpose is listed in Table 2.1.4.
Table 2.1.4 Analytical Software and their function
Name Function
Chromas Sequence analysis
GIMP GNU Image manipulation programme
Inkscape Open source vector graphics editor
Leica Lite Confocal Microscopy
MiniTab 16 Statistical Analysis
Primers Primer design
Vector NTI Sequence analysis. Sequence alignment, Insilico DNA manipulation
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2.2. Methods
2.2.1 Mammalian Cell Culture
IBRS2 cells were grown in Glasgow media (see Appendix V), Max cells were grown in 
Iscove's Modified Dulbecco's Media (Gibco), Vero cells (ECACC No. 834113001) and 
BHK-21 cells (ECACC No. 85011433) were grown in Dulbeccos modified eagle media 
(DMEM) (see Appendix V) buffered with Hepes. All media was supplemented with 
10% foetal calf serum (PCS), 2 mM glutamine and 5 pg/ml lU penicillin-streptomycin, 
unless stated otherwise. Cells were grown at 37°C in a 5% CO2 static incubator.
2.2.2 Bacterial Cell Culture & Plasmid generation
2.2.2.1 Plasmid Transformation
JM109 competent cells (Promega) were thawed on ice and gently re-suspended. A 50 
pi aliquot was transferred to a chilled PCR tube together with 1 pi of plasmid DNA (5 
ng/pl) or 5 pi of ligated DNA and mixed gently. After incubating on ice for 10 min, the 
cells were heat shocked for at 42°C for 45 s and returned to ice for 2 min. A 500 pi 
aliquot of SOC media (see Appendix V) was added to the transformed cells which were 
then incubated at 37°C for 1 h in at 200 rpm in an orbital shaker. The transformed 
cells were pelleted by centrifugation for 10 min at 1000 g, resuspended in 80 pi of SOC 
media and incubated at 37°C overnight on LB-agar plates (see Appendix V) with 
ampicillin ( 1 0 0  pg/ml).
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2.2.2 2 Plasmid DNA Mini Prep purification
Minipreps were carried out on 3 ml of overnight culture using a Qiagen miniprep kit, 
following the manufacturer's instructions; centrifugation was at 16,000 g unless stated 
otherwise. Briefly, JM109 colonies were picked off LB-ampicillin (100 pg/ml) plates 
and cultured at 37°C overnight in 5 ml LB broth (See Appendix V) with ampicillin (100 
pg/ml) at 200 rpm in an orbital shaker. A 3 ml volume of culture was pelleted at 
16,000 g for 10 min. Pellets were resuspended in 250 pi Buffer PI (Qiagaen) 
containing RNase and mixed thoroughly. Buffer P2 (Qiagen) was added to the 
suspension, mixed and incubated for 5 min at room temperature. A volume of 350 pi 
of buffer N3 (Qiagen) was added to the solution and mixed thoroughly. The solution 
was centrifuged for 10 min at 16,000 g. The supernatant was then applied to a 
QIAprep spin column (Qiagen) and centrifuged for 1 min, the flow-through was 
discarded. The column was washed with 500 pi of buffer PB (Qiagen) by centrifuging 
for 1 min at 16,000 g, to remove any trace levels of nuclease activity. The column was 
further washed with 750 pi of buffer PE (Qiagen) and centrifuged for 1 min. The flow­
through was discarded and a further 1  min centrifugation removed any residual buffer. 
The DNA was eluted by adding 50 pi of buffer EB (Qiagen) to the column and 
incubated for 1 min at room temperature prior to centrifugation for 1 min. Plasmid 
concentrations were quantified by spectrophotometery at a wavelength of 260 nm. 
Double stranded DNA at a concentration of 50 pg/ml has an Absorbancezeo = 1, 
therefore the concentration was calculated using the formula:
Double stranded DNA (pg/ml) = 50 x Absorbancezeo x dilution factor
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Plasmid DNA (pDNA) was stored at -20°C and bacterial cultures transformed with 
pDNA was stored in a 1:1 solution of LB broth and glycerol at -80°C.
2.2.2 3 Maxi Prep Purification
Glycerol stock was streaked on an LB-ampicillin plate (100 pg/ml) and incubated 
overnight at 37°C. A colony was picked off the plate and inoculated into 5 ml LB- 
ampicillin broth and incubated at 37°C overnight in at 200 rpm orbital shaker. The 
overnight culture was used to inoculate 400 ml of LB-ampicillin broth (100 pg/ml) and 
incubated at 37°C overnight at 200 rpm in an orbital shaker. The bacterial culture was 
pelleted by centrifugation at 6,000 g for 15 min. The supernatant was removed and 
the pellet re-suspended in 10 ml of buffer PI. A 10 ml aliquot of buffer P2 was added 
to the suspension and mixed thoroughly and incubated at room temperature for 5 min 
to allow alkaline lysis to occur. A 10 ml volume of buffer P3 (Qiagen) was then added 
to neutralise the lysis reaction. After mixing thoroughly and incubating on ice for 20 
min, the lysate was centrifuged at 20,000 g for 30 min at 4°C. The supernatant was 
decanted and re-centrifuged at 20,000 g for 15 min at 4°C. The supernatant was 
applied to QBT equilibriated Qiagen-tip columns. The columns were washed with 2 x 
30 ml of buffer QC (Qiagen) to remove any contaminants and carbohydrates. The DNA 
was then eluted from the column in 15 ml of buffer QF (Qiagen). After the addition of
10.5 ml of isopropanol, the precipitated DNA was pelleted by centrifugation at 15,000 
g for 30 min at 4°C. The pellet was re-suspended in 5 ml 70% ethanol and centrifuged 
at 15,000 g for 10 min. The supernatant was removed and the pellet was air dried for 
30 min and then suspended in 500 pi of nuclease free water. The plasmid
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concentrations were quantified by spectrophotometery at a wavelength of 260 nm. 
The Maxi-prep plasmids were diluted to a standard concentration of 1 pg/pl and 
stored at -20°C.
2.2.3 Virus Culture
2.2.3.1 Virus Cultivation
Four 175 cm^ cell culture flasks of BHK-21 cells at approximately 90% confluence were 
washed three times with serum-free media. 1 ml of FMDV stock virus with a titre of 
2.73 xlO^ pfu/ml was added to 15 ml of serum-free media, and 4 ml of diluted virus 
was added to each flask. The virus was allowed to adsorb to the cells at 37°C for 30 
min. Complete DMEM-HEPES media was added and the cells incubated at 37°C for 8  
h. The flask was stored overnight at -80°C. The flasks were removed from the freezer 
and thawed. Once defrosted, the media was removed from the flask and centrifuged 
at 13,000 g for 5 min to remove any cell lysate. The virus supernatant was stored as 1 
ml aliquots at-80°C.
2.2.3 2 FMDV Plaque Assay
Plaque assays were used to quantify virus titre. BHK-21 cells were grown to 
approximately 90% confluence in 6 -well plates. The cells were washed three times 
with serum-free media. A 10 x serial dilution of virus was made in serum-free media. 
A 1 ml volume of each dilution was added per well in triplicate. The virus was 
adsorbed onto the cells at 37°C for 30 min. The virus was removed and the wells were
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washed twice with serum-free media. A 3 ml volume of Eagles overlay agarose (see 
Appendix V) was added to each well and allowed to set. After incubating the cells at 
37°C for 48 h, 2 ml of 10% formaldehyde solution was added to each well the cells 
were incubated at room temperature for 3-4 h. The agarose plugs and formaldehyde 
solution were removed and discarded. The cell sheets were stained with 2 ml 0.1% 
crystal violet solution per well for 10 min. The crystal violet solution was discarded 
and the wells rinsed with water. The 6 -well plates were allowed to dry and the 
plaques counted for each dilution. The virus titre was calculated by multiplying the 
mean plaque number by the dilution factor per ml.
2.2.4 Polymerase Chain Reactions (PCR)
The enzymes Proofstart™ (Qiagen) and KOD (Novagen) have proofreading capabilities 
and have a high fidelity and so were used for amplifying DNA when making new 
constructs. GoTaq polymerase (Promega) does not have proofreading abilities and 
was used for the analysis of constructs.
2.2.4.1 Proofstart™ Polymerase Chain Reactions
DNA amplification of SEAP and EYFP sequences were performed using Proofstart™ 
DNA polymerase (Qiagen) in 1 x PCR buffer following the manufactures instructions. 
Briefly each amplification reaction of 10 ng of DNA and 2.5 pM of forward and reverse 
primers was mixed with a PCR master mixture consisting of 21 pi nuclease free water.
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2.5 pi 10 X Proofstart™ buffer, 0.2 mM dNTPs and 1.25 U of ProofStart™ DNA 
polymerase.
The PCR used the programme:
Hotstart 95°C 5 min
Dénaturation 94 °C 45 s
Annealing Tm - 5°C 50 s :^35 cycles
Elongation 72°C 1 min 30 s ^
Extension 72°C 1 0  min
Store 4°C DO
The PCR products were resolved on a 1% agarose gel and visualised with ethidium 
bromide using a UV Gel Doc transilluminator (BioRad).
2 2.4.2 KOD polymerase PCR
DNA amplification of FMDV 2BC, 2C, 2B and EYFP sequences were performed using 1 U 
of high fidelity KOD Hotstart DNA polymerase (Novagen) following the manufacturer's 
instructions. DNA amplification was performed in 1 x PCR buffer, used 20 -100 ng of 
DNA and 0.3 pM each forward and reverse primer per 50 pi reaction mix containing 
0.2 mM dNTPs and 2.5 mM MgS0 4 .
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The PCR programme used was:
Hot start 95°C 4 min
Dénaturation 94°C 15 s '"
Annealing Tm-5°C 25 s >- 35 cycles
Elongation 72°C 30 s_^
Extension 72°C 4 min
Store 4°C oo
The PCR products were resolved as described in section 2.2.5.3.
2.2.4.S GoTaq Hot Start Polymerase PCR
GoTaq DNA polymerase (Promega) was used to detect specific inserts in plasmids 
transformed into bacterial colonies. DNA amplification was performed in, 1 x PCR 
buffer, 0.2 mM dNTPs, 1.25 mM MgCI, 1 U GoTaq DNA polymerase (Promega) and 1.25 
pM of forward and reverse primers in a total volume of 20 pi. Picked colonies were 
dipped in the PCR mixture prior to being used to inoculate 5 ml of LB-Ampicillin Broth 
( 1 0 0  pg/ml).
59
The PCR programme used was:
Hot start 95°C 2  min
Dénaturation 94°C 45 s
Annealing Tm -5°C 45 s
Elongation 72°C 1 min 40
Extension 72°C 5 min
Store 4°C OO
30 Cycles
PCR products were resolved as described in section 2.2.5.3,
2.Z.4.4 cDNA synthesis by RT-PCR
To synthesise cDNA from cellular RNA, approximately 1200 ng of total RNA was mixed 
with 1 pi of 10 mM dNTP mix (Promega), 0.5 pg of Random primers (Promega), and 
nuclease free water to a final volume of 13 pi. The reaction mixture was incubated at 
65°C for 5 min then incubated on ice for 1 min. A 4 pi volume of 5x first stand buffer 
(Invitrogen), 1 pi 0.1 M DTT (Invitrogen), 1 pi of RNase In (Promega) and 1 pi of 
Superscript III RT (Invitrogen) was added. The reaction was mixed by pipetting and 
incubated at 25°C for 5 min followed by 50°C for 1 h. The Superscript III RT was heat 
inactivated at 70°C for 15 min. The cDNA was incubated with 2 units if RNAse H 
(Promega) 20 min at 37°C to degrade the RNA template.
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2.2.5 Nucleic acid Manipulation
2.2.5.1 Restriction digest
Restriction digests were performed for mapping or cloning. DNA was digested with 2 
units enzyme/1.25 pg DNA in the appropriate Ix buffer supplied with the enzyme (see 
Table 2.1.2) and according to the manufacturer's instructions. The restriction digests 
were incubated at 37°C (unless otherwise stated by the manufacture) for 2 h.
2.2.5 2 T4 DNA polymerase treatment
T4 DNA polymerase catalyses the synthesis of DNA in the 5'-3' direction and has 3'-5' 
exonuclease activity. It is a useful tool to create 5' overhang fill-in and 3' overhang 
removal of DNA restriction digests to produce blunt-ended DNA fragments. Five units 
of T4 DNA polymerase (Promega) were added to 1 pg of DNA and 100 pM of each 
dNTP in Ix  T4 DNA polymerase buffer (Promega). The solution was incubated at 37°C 
for 5 min. The reaction was incubated at 75°C for 10 min to inactivate the T4 DNA 
polymerase.
2.2.5 3 Dephosphorylation of DNA
To prevent vector religation, thermo-sensitive alkaline phosphatase (TSAP) (Promega) 
was used to remove the terminal phosphates from the vectors before subsequent 
ligation reactions. This process removes the phosphate group from the 5' end of the 
DNA preventing the formation of a phosphodiester bond between the 5' phosphate 
group and the 3' hydroxyl group of the vector. After restriction digestion, 2 U of TSAP
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was added to the restriction digest and incubated at 37°C for 30 min. The reaction 
was then incubated at 75°C for 15 min to inactivate the TSAP.
2.2.S.4 Ligation of DNA into a vector
Ligation of vectors were performed using molar ratios of insertivector 1:1,1:3 and 3:1. 
(Maniatis, 1982). 100 ng of digested vector was combined with the DNA insert in the 
presence of Ix T4 DNA ligase buffer (New England Biolabs) and 2 U of T4 DNA ligase 
(NEB) in a total volume of 10-20 pi. The ligations were incubated at 16°C overnight. 
The ligations were then transformed into competent JM109 cells (Promega).
2.2.5 5 Gel Electrophoresis
Agarose gel electrophoresis is used to resolve DNA fragments by length. Agarose was 
melted in Ix  TAE (see Appendix V). When the agarose had cooled to 60°C, ethidium 
bromide was added to a final concentration of 1 pg/ml and mixed. Agarose was 
poured into the gel tray with combs fitted. Once the gel had set, the gel and running 
buffer (Ix TAE) were put in the gel tank. A 6 x loading dye (Promega) was added to 
samples as a loading buffer to make a Ix final loading volume. The samples of interest 
were loaded into a gel and a 10 pi aliquot of 1 Kb Marker (Promega/NEB) was included 
to determine the DNA fragment sizes. Gel electrophoresis for minigels was carried out 
at 100 V/cm for approximately 45 min. DNA fragments on an agarose gel were 
visualised with ethidium bromide. Images of the gels were recorded with a Gel Doc 
transilluminator (BioRad).
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2.2.5 6 DNA extraction from an agarose gel
DNA bands resolved on a 1% agarose gel were visualised on ethidium bromide stained 
agarose gels by UV transillumination. Fragments of interest were excised using a 
sterile razor blade. A GFX kit was used to isolate the DNA from the gel. Briefly, 500 pi 
of Capture Buffer 3 (General Electric) was added to up to 100 pg of gel slice containing 
DNA and incubated at 60°C until the gel slice dissolved. The solution was loaded onto 
the GFX Microspin column (GE) and incubated at room temperature for 1 min on the 
column. The column was centrifuged for 1 min at 16,000 g, washed with 500 pi of 
Wash Buffer Type 1 (GE) and centrifuged for 30 s at 16,000 g. The DNA was eluted in 
10-50 pi Elution Buffer Type 4 (GE) or Type 6  (GE). One tenth of the eluted DNA was 
run on a 1% agarose gel alongside a DNA semi-quantitative marker to estimate the 
DNA yield.
2.2.6 DNA Sequencing
2.2.6.1 ABI Sequencing
Sequencing reactions were performed using the Genome Lab DTCS-Quick Start Kit 
(Beckman Coulter). DNA was diluted to 100 fmol in 10 pi nuclease-free water. The 
plasmid was heated at 96°C for 1 min to denature the DNA. 5 pmol of primer, 4 pi of 
Quickstart (Beckman Coulter), 1 pi Reaction Buffer (Beckman Coulter) were added in a 
total volume of 2 0  pi.
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The following PCR programme was run:
Dénaturation 96°C 20 sec"^
Annealing Tm-5°C 20 sec
Elongation 60°C 4 min
Store 4°C
^  30 cycles
After the PCR, 5 pi of fresh stop solution (Beckman Coulter) was added. 60 pi of 95% 
ethanol was added to the mixture, mixed and centrifuged at 13,000 g, for 10 min at 
4°C. The supernatant was removed and the pellet washed in 70% ethanol. The 
ethanol steps were repeated and the pellet air-dried, then re-suspended in 40 pi 
sample loading solution (Beckman Coulter). Samples were transferred to a 96-well 
sequencing plate, overlaid with mineral oil and then loaded onto the Beckman CEQ 
8000 sequencer (Beckman Coulter). Results were analysed using Vector NTI software 
(Invitrogen).
2.2.6 2 BigDye® Sequencing
Some sequencing reactions were performed using a BigDye® terminator 3.1 cycle 
sequencing kit. The protocol was more reliable and produced longer reads than the 
ABI sequencing reactions. The PCR was comprised of 1.88 pi 5x sequencing buffer 
(Applied Biosystems), 0.25 pi BigDye Terminator 3.1 (Applied Biosystems), 1.5 pi 
primer at (0.6 pmol) 100 fmol DNA and water to final volume of 10 pi.
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The following PCR programme was run:
96°C 1 min
96°C 10s
50°C 5 s 
60°C 4 min 
4°C oo
j
25 cycles
A 5 pi volume of 125 mM EDTA and 60 pi of ethanol were added to each reaction, 
which was briefly vortexed and incubated in the dark at room temperature for 15 min. 
The samples were centrifuged for 30 min at 16,000 g and the supernatants were 
removed carefully. The pellet was washed in 70% ethanol and air dried in the dark for 
15 min. A 20 pi aliquot of Hi-Di formaldehyde (Applied Biosystems) was added to each 
reaction which was then loaded onto the ABI sequencer by the lAH Epidemiology 
sequencing service. Results were analysed using Chromas and Vector NTI sequencing 
software.
2.2.7 Protein Expression
2.2.7.1 Transfection of Plasmids into Mammalian cells
Plasmid transfection is an efficient method to deliver a gene of interest into a cell's 
nucleus for the expression of a protein of interest. Plasmid DNA is complexed with 
lipid reagents to enable plasmid entry into the cells of interest. The efficiency of 
transfection depends on both the cell type and the plasmid used.
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2.2.7.1.1 Lipofectamine 2000
The day prior to transfection, cell culture vessels were seeded with 2.5 x 10  ^- 5 x 10^  
cells/cm^ and were 70-90% confluent at the time of transfection. Optimal transfection 
conditions varied depending upon the cell type. Transfections in a 24-well plate were 
prepared by diluting 1 pi pDNA in 50 pi of serum-free media and mixing gently. 
Lipofectamine 2000 (Invitrogen) was mixed gently before use, then 1 pi of 
Lipofectamine 2000 was diluted in 50 pi of serum-free media. Both solutions were 
incubated at room temperature for 5 min. The diluted DNA and diluted Lipofectamine 
2000 were then combined and incubated at room temperature for 20 min. Cells were 
washed in serum-free media and then incubated in 300 pi of serum-free media at 37°C 
in a 5% CO2 static incubator, the transfection mix was added to the cells and the cells 
were returned to the incubator for 4-6 h. The transfection media was then replaced 
with 0.5 ml of complete media and the cells were returned to the incubator for 24-48 
h.
2.2.7.1.2 TmnslT®-LTl
The day prior to transfection, cell culture vessels were seeded with 2.5 x lO'* - 5 x 10^  
cells/cm^ and were 70-90% confluent at the time of transfection. Optimal transfection 
conditions varied depending upon the cell type. Transfections in a 24-well plate were 
prepared by diluting 1.5 pi of Trans\J®-lJl reagent in 50 pi of serum-free media and 
mixed gently by pipetting. 0.5 pg of pDNA was added to the mixture and mixed by 
pipetting. The pDNA- Trans\T®-lJl mixure was incubated at room temperature for 30
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min. The mixture was added drop wise to the cells in cell growth media in the 24-well 
plate. The cells were incubated at 37°C in a 5% CO2 static incubator for 24-48 h.
2.2.7.1.3 Transfast™
The day prior to transfection, the vial of TransFast™ was warmed to room 
temperature, 400 pi of Nuclease-Free Water was added to produce a final 
concentration of 1 mM. This solution was then vortexed for 10 s before being stored 
overnight at -20°C. Cell culture vessels were seeded with 2.5 x 10  ^- 5 x 10  ^cells/cm^ 
and were 70-90% confluent at the time of transfection. On the day of the transfection, 
the TransFast™ reagent was thawed at room temperature and vortexed. The 1.5 pi of 
TransFast™ was added to 0.5 pg pDNA to make a final volume of 200 pl/per well. The 
mixture was incubated for 15 min at room temperature. The media was removed 
from the cells in a 24-well plate, which were then washed with 1 ml of serum-free 
media. The 200 pi of DNA-TransFast™ was added to each well and after incubation at 
37°C for 1 h, 1 ml of complete media was added to each well and incubated at 37°C for 
48 h.
2.2.7 2 tsVSV G trafficking assay
The day prior to transfection, mammalian cells were seeded on coverslips in a 24-well 
plate at 2.5 x 10  ^ - 5 x 10  ^ cells/cm^ and were 70-90% confluent at the time of 
transfection. Cells were transfected with pTs045 GYFP (Moffat et al., 2005) using 
Lipofectomine 2000 as described in 2.2.7.1.1 and incubated at 40°C for 24 h. Cells
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were either fixed with 4% paraformaledhyde at room temperature for 1 h, for imaging, 
or the temperature was lowered to 30°C to allow the tsVSV G protein to fold correctly 
and be trafficked through the secretory pathway. If the incubation temperature was 
lowered, cells were incubated at 30°C for 6 h and fixed with 4% paraformaledhyde for 
1 h at room temperature, for imaging.
2.2.7 3 Great EscAPe supernatant and cell lysis
Cell culture media was removed from the wells of a 24-well plate containing cells, 
centrifuged at 16,000 g for 30 s to remove any cells and stored at -20°C for future 
analysis. The cells were washed with 1 ml of serum-free media and then 500 pi of Ix  
Reporter lysis buffer (Promega) with complete protease inhibitor cocktail was added 
to each well and incubated at 37°C for 20 min. The cell lysate was removed from the 
wells and centrifuged for 30 s at 16,000 g to clarify. The cell lysate and supernatants 
were then stored at -20°C for future analysis.
2.2.7.4 Great EscAPe™ 2.0
The Great EscAPe™ 2.0 assay (Clontech) was used to analyse the levels of secreted 
alkaline phosphatase (SEAP) expressed from bicistronic plasmids transfected into cells. 
The SEAP substrate solution containing 4-Methylumbelliferyl Phosphate (4-MUP) was 
equilibrated to room temperature. Of the sample, 25 pi of cell culture medium, or cell 
lysate, was transferred to a 96-well flat bottomed microtiter plate. A volume of 75 pi 
of Ix dilution buffer (Clontech) was added to each sample in the 96-well microtiter
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plate. The plate was sealed and incubated at 65°C for 30 min then cooled on ice for 2 
min. After equilibration to room temperature, 100 pi of SEAP substrate solution 
(Clontech) was added to each sample and incubated at room temperature for 30 min. 
The samples were analysed using a 96-well plate reader. Synergy 2 luminometer 
(BioTek) at 440 nm to detect and record the SEAP signal produced from the catalysis of 
the 4-MUP substrate by SEAP to produce the soluble fluorescent reaction product 
methylumbelliferone.
2.2.7.S p-gaiactosidase assay
Cells grown in 6-well plates were transfected with a plasmid encoding the LacZ gene 
and then incubated for 24-48 h. Cells were washed three times with ice cold PBS prior 
to lysis with Reporter lysis buffer (Promega) for 15 min. The lysates were transferred 
to 1.5 ml eppendorf tubes and pelleted. A volume of 200 pi of LacZ buffer (60 mM 
NazHPÛA, 40 mM NaH2 P0 4 , 10 mM KCI, 1 mM MgS0 4 ) and 50 pi 16 mg/ml o- 
Nitrophenyl p-D-Galactopyranoside (ONPG) was added to the lysates and incubated at 
37°C for 30 min. A volume of 125 pi of 1 M, Na2C0g was added to each reaction to halt 
the reactions. The reactions were analysed with absorbance at 420 nm. The relative 
light units, a proportional value for SEAP expression compared to the LacZ transfection 
rate were determined by the following formula:
Relative light units = luminescence reading from the Great Escape assav
O.D420. Value
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2.2.8 RNA Analysis
2.2.8.1 RNA extraction from mammalian cells
Cells were trypsinised from their tissue vessels by being washed three times with 
versine-trypsin (see Appendix V) and then incubated with trypsin at 37°C until the cell 
sheet became detached. The cells were pelleted at 10,000 g for 2 min and re­
suspended in PBS, this was repeated and the cells were re-suspended in 500 pi of PBS. 
A 100 pi volume of cells were removed for RNA extraction, with the remaining 400 pi 
used for protein analysis. The cells were pelleted for 2 min at 10,000 g and re­
suspended in 350 pi RLT buffer (Qiagen). The cells were loaded onto a Qiashredder 
(Qiagen) column and centrifuged for 2 min at 16,000 g. An equal volume of 70% 
ethanol was added to the homogenised lysates and was mixed by pipetting. The lysate 
was loaded onto an RNeasy spin column (Qiagen) in a 2 ml collection tube. The 
column was centrifuged for 15 s at 8,000 g, the flow-through was discarded. 700 pi of 
Buffer RWl (Qiagen) was added to the RNeasy column and the column centrifuged for 
15 s at 8000 g, the flow-through was discarded. 500 pi of RPE buffer (Qiagen) was 
added to the RNeasy column and the column was centrifuged for 15 s at 8000 g, the 
flow-through was discarded. A further 500 pi of RPE buffer was added to the RNeasy 
column and centrifuged for 2 min at 8000 g. The RNeasy column was placed into a 
new 2 ml collection tube and centrifuged for 1 min at 16,000 g to eliminate any 
carryover RPE buffer from the column. The column was placed into a collection tube. 
A volume of 40 pi of RNAse free water was added to the column membrane and 
centrifuged for 1 min at 8000 g to elute the RNA. The RNA was stored at -80°C until 
further use.
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2.2.8 2 Residual DNA removal from RNA samples
DNase was used to remove residual DNA from extracted cellular RNA prior to RT-PCR. 
A volume of 0.5 pi of Turbo DNase (Ambion) was added to the RNA sample in Ix Turbo 
DNAse Buffer (Ambion) and incubated at 37°C for 30 min. A further 0.5 pi of Turbo 
DNase was added to the sample and incubated for another 30 min at 37°C. A 0.1 
volume of re-suspended DNase inactivation reagent (Ambion) was added to the 
mixture and incubated for 5 min at room temperature mixing occasionally. The 
sample was centrifuged for 1.5 min at 10,000 g and the RNA was transferred to a fresh 
tube. The RNA was stored at -80°C until further use or used to synthesis cDNA.
2.2.9 Protein Analysis
2.2.9.1 Cell free protein expression of Radiolabelled proteins
TnT® coupled reticulocyte lysate is an in vitro mammalian system that provides 
coupled transcription and translation of any protein coding regions downstream of the 
T7 promoter, in a DNA sequence. A volume of 20 pi of TNT® T7 PCR Quick Master Mix 
(Promega) was thawed on ice. A 1 pg volume of pDNA was added to the Mastermix 
along with 1 pi Promix, 1 Mbq (Perkin Elmer) and nuclease-free water to a final 
volume of 25 pi. The reaction mixture was incubated at 30°C for 2 h. The reaction 
mixture was diluted to a final volume of 80 pi with the addition of 5x Sample 
preparation buffer and incubated at 96°C for 5 min to denature the proteins produced 
in preparation of SDS-PAGE. The samples were stored at -20°C until further use.
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2.2.9 2 Preparation of cell lysates
Cells were as described in section 2.2.8.1. The cells were pelleted at 2,000 g and re­
suspended in 500 pi PBS twice. The cells were centrifuged a third time and re­
suspended in 200 pi RIPA buffer (see Appendix V) with protease inhibitor cocktail and 
phosphatase inhibitors (see Appendix V) and then vortexed. The cells were incubated 
on ice for 30 min and pelleted at 16,000 g. The supernatant was removed and the 
lysate discarded. A volume of 100 pi of sample preparation buffer was added to the 
lysate, mixed and incubated at 96°C for 5 min to denature the proteins. The samples 
were stored at -20°C until further use.
2.2.9.3Tricine SDS-PAGE
To resolve proteins either a 10% or 12.5% gel was used, the formulation of the gels is 
shown in Table 2.9.3.
Table 2.9.3 Composition of a Tricine Gels
Gel Glycerol
(ml)
Tricine Gel 
Buffer (ml)
40% T Acrylamide 
Mix (ml)
dHzO (ml)
Stack 2 1.5 0.62 4.1
10% 2 5 3.8 4.2
12.5% 2 5 4.7 3.3
For every 10 ml of Gel, 100 pi of 15-20% Ammonium Per sulphate (APS) solution and
10 pi TEMED were used to polymerise the gel. The resolving gel was poured first and
overlayed with Butanol to produce a flat interface. Once the resolving gel had set, the
butanol was removed and the gel rinsed thoroughly with dHzO. The stacking gel was
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poured on top of the resolving gel and allowed to set with a comb to produce loading 
wells. The gel was run in cathode and anode buffer (see Appendix V) at 125 V until the 
running dye of the Colorburst™ marker (Sigma) reached the bottom of the gel.
Z.2.9.4 Autoflourograpy
The SDS-PAGE gel containing the resolved radiolabelled proteins was transferred to a 
container with destain solution (see Appendix V) and incubated on a shaker for 20 min 
at room temperature. The d esta in solution was discarded and the gel was washed 
three times with dHzO, the gel was covered with 1 M Sodium Salicylate solution and 
incubated for a further 20 min on the shaker. The gel was vacuum-dried onto blotting 
paper and exposed to X-ray film (Kodak) overnight. The film was developed to reveal 
the imprint of the radio-labelled proteins.
2.2 9.5 Western blotting
Proteins were resolved by SDS-PAGE and transferred to Hybond-C Extra™ (Amersham 
Biosiences) cellulose nitrate membrane in either Low or High molecular weight 
blotting buffer (see Appendix V) at 100 V for 90 min. The membrane was blocked 
overnight in Marvel Blocking Buffer (see Appendix V) at 4°C. The membrane was 
incubated with the primary antibody in 5% Marvel-PBS/TBS (see Appendix V) blocking 
solution at room temperature for 1 h, and then washed twice in 0.002% PBS/TBS- 
Tween 20. The membrane was incubated with the species-specific secondary antibody 
conjugated to HRP in Marvel-PBS/TBS blocking solution at room temperature for 1 h, 
then washed three times with PBS/TBS-Tween 20. The membrane was incubated for 3 
min with Supersignal® West Pico Chemiluminescent Substrate (Thermo Scientific) at
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room temperature. Protein bands were visualised by exposure to and development of 
X-ray film.
2.2.10 Immuno-fluorescent labelling of cells
Media was removed and the cells were fixed for 1 h in 4% paraformalehyde in PBS. 
Cells were washed with PBS and permeabilised with 0.1% Triton X-100 for 15 mins. 
The cells were blocked with 30% goat serum blocking solution for 30 min at room 
temperature. Primary antibody was diluted in goat blocking solution. The cells were 
incubated with primary antibody at room temperature for 30 min then washed three 
times with PBS. Secondary antibodies were diluted to 1: 500 in goat blocking solution 
and incubated with the cells for 30 min at room temperature. The cells were washed 
three times with PBS and the cell nuclei stained with DAPI (Sigma) at a concentration 
of 1 pg/ml for 10 min. The coverslips were rinsed with distilled water and mounted on 
slides with Vectashield (Vector Laboratories) or Fluoromount-G (Southern Biotech) and 
sealed with nail varnish. Slides were stored at 4°C in the dark then visualised via 
confocal microscopy. Cells were imaged analysed in a Leica TCS SP2 confocal 
microscope and analysed using Lecia Lite software.
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Chapter Three: Characterisation of FMDV 2BC protein
It is well established that the cellular secretory pathway can be disrupted by 
pircornaviruses (Beske et al., 2007; Dodd et al., 2001; Doedens et al., 1997; Doedens 
and Kirkegaard, 1995; Neznanov et al., 2001; Van Kuppeveld et al., 1997b) and the 
FMDV precursor protein 2BC has previously been shown to cause a block in protein 
trafficking (Moffat et al., 2005; Moffat et al., 2007). The retention of proteins within 
the secretory pathway may enable a virus to evade an immune response by reducing 
the secretion of cytokines and prevent the surface expression of MHC class I molecules 
(Cornell et al., 2007; Deitz et al., 2000; Dodd et al., 2001; Neznanov et al., 2001; Sanz- 
Parra et al., 1998; Ziegler et al., 1997).
Several studies have shown that modified membranes derived from the ER are used 
for viral replication (Belov and Ehrenfeld, 2007; Bienz et al., 1987; O'Donnell et al., 
2011; Pedersen et al., 1999; Salonen et al., 2004; Snijder et al., 2006). The FMDV 2BC 
protein localises to the modified ER (Moffat et al., 2005; Moffat et al., 2007). To 
identify which specific region(s) of the cell FMDV 2BC protein associates with in 
mammalian cells, the FMDV 2BC protein was expressed and its location within the cell 
was examined by immuno-fluorescent microscopy.
3.1 Sequencing of FMDV OIK 2BC
To ensure that the sequence of FMDV 2BC within the construct pCK3 which had been 
used in previous cloning experiments was identical to that of the published sequence
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of 2BC from FMDV OIK (GenBank: X00871.1), the 2BC coding region was re­
sequenced. The sequence was compared with that of FMDV OIK (GenBank: X00871.1) 
using Vector NTI Advance 11 (Invitrogen). A base substitution mutation was identified 
at position 1317 where a guanine replaced an adenine and this led to a K439Q 
substitution in the amino acid sequence.
3.2 Construction of pcDNA3.1-2BC
As a mutation was identified within the ORF of 2BC in pCK3, a new 2BC construct was 
generated from pT7S3 (Ellard et al., 1999). Sequence analysis and alignment 
confirmed that the pT7S3 2BC region was identical to the sequence published for 
FMDV 2BC. The 2BC sequence was amplified by PCR with KOD DIMA polymerase using 
primers incorporating the restriction site Nhe\, a Kozak sequence, a start codon at the 
5' end, and a stop codon and EcoRI restriction site at the 3' end of the PCR product 
(Table 3.1 and Fig. 3.1 A).
Table 3.1 Primers for PCR amplification of FMDV 2BC DNA sequence
Primer Tm (°C) Sequence Role/ Restriction Sites
TGIPDF-039 70.3 AAAGCTAGCATGCCCTTCTTI 1 ICTCC 2BC 5' Nhe\
TGIPDF-066 71.2 AAAGAATTCTCACTGCTTGAAGATCGGG 2BC 3' EcoRI
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Figure 3.1 Insertion of FMDV 2BC into pcDNAS.l. (A) FMDV 2BC DNA sequence was 
amplified from pT7S3 using specific primers TGIPDF-039 and TGIPDF-066. Restriction 
sites at the 5' ends of the primers incorporated Nhe\ and EcoRI onto the 5' and 3' ends 
of the amplified 2BC, respectively. A start codon (ATG) and Kozak sequence was 
introduced at the 5' end of the 2BC sequence and a stop signal (TAA) was introduced 
at the 3' end of the 2BC sequence. The 2BC ORF is highlighted in purple. The 2BC PCR 
product was directionally inserted into the multiple cloning site (MCS) of pcDNA3.1 at 
Nhe\/EcoR\ restriction sites to produce pcDNA3.1-2BC (B). (C) Nhe\/EcoR\ restriction 
digest of putative clones containing FMDV 2BC. Lane 1, a putative clone screened 
negative for FMDV 2BC. Lane 2, a positive putative clone for pcDNA3.1-2BC.
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The PCR product was inserted into the multiple cloning site (MCS) of pcDNAS.l 
(Invitrogen) at Nhe\/EcoR\ (Fig. 3.1 A) producing pcDNA3.1-2BC (Fig. 3.1 B). The clones 
containing the 2BC insert were identified by restriction digest (Fig. 3.1 C). An Nhe\ and 
EcoR\ restriction digest was expected to generate bands of 5015 bp and 1416 bp. 
Bands consistent with these sizes can be seen in lane 2 (Fig. 3.1 C), suggesting that 
FMDV 2BC was successfully cloned into pcDNA3.1. This was confirmed by sequence 
analysis.
3.3 Construction of pcDNA3.1-EYFP
To produce a control construct, the enhanced yellow fluorescent protein (EYFP) open 
reading frame was amplified by PCR using KOD DNA polymerase from pEYFP-Nl 
(Clontech). The primers used are described in Table 3.2 and these incorporated the 
restriction site EcoRI, at the 5" end and a stop codon and the restriction site 3' end of 
the PCR product (Fig. 3.2 A).
Table 3.2 Primers for PCR amplification of EYFP DNA sequence
Primer Tm (°C) Sequence Role/ Restriction Sites
TGIPDF-068 66.9 AAAGAATTCATGGTGAGCAAGGG EYFP 5'EcoR\
TGIPDF-069 67.1 AAAGAATTCTTACTCTTGTACAGCTCGTCC EYFP 3'EcoR\
The PCR product was inserted into the MCS of pcDNA3.1 at EcoRI (Fig. 3.2 A) producing 
pcDNA3.1-EYFP (Fig. 3.2 A). The clones containing the EYFP insert were identified by 
EcoRI restriction digest (Fig. 3.2 C). This digest was estimated to generate bands of 
5015 bp and 750 bp and these can be seen in lane 2 (Figure 3.2 C). This suggested that 
the successful cloning of EYFP was achieved into pcDNA3.1. Cellular
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Figure 3.2 Insertion of EYFP into pcDNA3.1. (A) The EYFP DNA sequence was 
amplified from pEYFP-Nl (Clontech) using specific primers TGIPDF-039 and TGIPDF- 
066. Restriction sites at the S' ends of the primers incorporated EcoR\ onto the S' and 
3' ends of the amplified EYFP. A Kozak sequence was introduced at the S' end of the 
EYFP sequence and a stop signal (TAA) was introduced at the 3' end of the EYFP 
sequence. The EYFP ORF sequence is highlighted in green. EYFP PCR product was 
inserted into the multiple cloning site of pcDNA3.1 at the EcoRI restriction site to 
produce pcDNA3.1-EYFP (B), (C) Undigested pcDNA3.1-EYFP (lane 1) EcoRI restriction 
digest analysis EYFP PCR product (lane 2) were digested with EcoRI and visualised with 
EtBr on a 1% agarose gel.
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expression of pcDNA3.1-EYFP and visualisation by confocal fluorescent microscopy 
was used to confirm that the construct was correctly expressing EYFP.
3.4 The effect of FMDV 2BC protein on transport through the secretory pathway
Using the well characterised temperature sensitive vesicular stomatitis virus 
glycoprotein (tsVSV G) transport assay, FMDV 2BC has been shown to block protein 
transport (Moffat et al., 2005). The glycoprotein (G) of the 045 temperature-sensitive 
mutant of vesicular stomatitis virus (tsVSV 045 G) has been commonly used to study 
the transport of proteins through the secretory pathway (Bergmann, 1989; de Silva et 
al., 1990; Hammond and Helenius, 1994b; Mezzacasa and Helenius, 2002; Moffat et 
al., 2005; Presley et al., 1997). When ts045 G is expressed in cells grown at 40°C the 
protein is misfolded and retained within the ER (Fig. 3.3 A). Lowering the incubation 
temperature to 30°C allows the correct folding of the ts045 G glycoprotein protein to 
occur (Fig. 3.5 B). The ts045 G glycoprotein forms a trimer at 30°C and is transported 
from the ER through the Golgi and to the cell surface (Fig. 3.5 C).
Previous studies (Moffat et al., 2005), used the pCK3 plasmid which expressed the 
FMDV 2BC protein with the K439Q mutation. To determine if the FMDV 2BC protein 
without the mutation also interrupted the secretory pathway, the tsVSV G trafficking 
experiments were repeated.
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Figure 3.3 Trafficking of tsVSV G through the secretory pathway. (A) tsVSVG misfolds 
at 40°C and is retained within the ER. (B) At 30°C, the G protein folds into a 
conformation that enables it to be trafficked though the secretory pathway and to the 
cell surface (C).
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Vero cells transfected with pTs045-GYFP (Moffat et al., 2005) expressing fluorescently 
tagged tsVSV G and incubated at 40°C for 24 h (Fig. 3.4), were analysed by 
fluorescence microscopy. The tsVSV G protein showed a reticular staining pattern (Fig. 
3.4A) that was indicative the ER. Co-staining for the luminal ER protein ERp57 
revealed that tsVSV G, when expressed at the non-permissive temperature was 
located at the ER (Fig. 3.4 A, C and D). Cell surface staining of the tsVSV G protein was 
not detected in cells grown at 40°C (Fig. 3.4 B) as shown by the lack of labelling of non- 
permeablised cells with monoclonal antibody specific for VSV G protein, II.
Vero cells which expressed tsVSV G for 24 h at 40°C and moved to 30°C for 6 h showed 
an altered tsVSV G location. Under these conditions the majority of the tsVSV G was 
located at the cell surface (Fig. 3.4 E, F and H). Surface expression of tsVSV G protein is 
shown by the staining of non-permeabilised cells by an anti-VSV G monoclonal 
antibody, I I  (Fig. 3.4 F). The majority of the fluorescence signal from the EYFP tag is 
also located to the cell surface (Fig. 3.4 E). The digital merge of panels E-G, also shows 
that tsVSV G is distributed around the periphery of the cell indicating that it has been 
trafficked to the cell surface.
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Figure 3.4 Transport of tsVSV G-EYFP protein at permissive and non-permissive temperatures. Vero cells 
expressing tsVSV G were incubated at 40°C for 24 h(A-D) and then incubated at 30°C for a further 6 h (E-H). 
Cells were fixed and stained with a goat anti-mouse antibody (11) specific for the G protein followed by Alexa-633- 
goat anti-mouse IgG (white). Total tsVSV G (A and E) was visualised through the natural fluorescence of 
EYFP (green). For the detection of ER (C and G), cells were permeabilised and stained with an antibody to 
ERp57, followed by Alexa-568 a goat anti-rabbit IgG. Cells were counterstained with DAPI (blue) to detect the 
nucleus. Scale Bar 10 pm.
This tsVSV G transport assay was then used to analyse the effects of FMDV 2BC on 
protein trafficking between the ER and the cell surface. Cells co-transfected with 
tsVSV G and FMDV 2BC were grown at 40°C for 24 h, moved to 30°C for a further 6 h 
and then examined by immuno-fluorescence microscopy (Fig. 3.5). TsVSV G protein 
co-expressed in cells with FMDV 2BC and incubated at 40°C, showed a reticular 
staining pattern (Fig. 3.4 panel A). The tsVSV G protein was not detected at the cell 
surface in cells grown at 40°C (Fig. 3.5 B). When comparing cells co-expressing tsVSV 
G and FMDV 2BC (Fig. 3.5) to cells expressing tsVSV G alone (Fig. 3.4), the tsVSV G 
protein appears to be more aggregated in cells co-expressing tsVSV G with FMDV 2BC 
(Fig. 3.5 A and D) than cells expressing tsVSV G alone (Fig. 3.3 A, D, E and H).
When cells transfected with the plasmids expressing tsVSV G and FMDV 2BC were 
grown at 40°C for 24 h and the temperature lowered to 30°C for 6 h, the tsVSV G 
protein was only detected on the surface of cells that were not expressing FMDV 2BC 
protein (Fig. 3.4 F and H, and Fig. 3.5 D and E). However, in cells that co-expressed 
tsVSV G and FMDV 2BC, tsVSV G was not detected at the cell surface either by the 
natural fluorescence of the EYFP tag (Fig. 3.4 E) or antibody labelling with II  (Fig. 3.4 D 
and E). This indicates that like the 2BC with the K439Q mutation, wildtype FMDV 2BC 
inhibited tsVSV G trafficking to the cell surface. There also appeared to be some 
aggregation of tsVSV G In cells co-expressing tsVSV G and FMDV 2BC at 30°C (Fig. 3.5 D 
and F). The aggregation of tsVSV G did not occur at 30°C in cells expressing tsVSV G in 
the absence of FMDV 2BC (Fig. 3.4 panels E and H).
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Figure 3.5 Trafficking of tsVSV G -EYFP at the permissive temperature, is blocked in cells expressing 
FMDV 2BC. Vero cells were transiently co-transfected with plasmids expressing tsVSV G-EYFP and FMDV 2BC 
for 24 h at 40°C (A-C) and then incubated at 30°C for a further 6 h (D-F). For the detection of surface tsVSV 
G-EYFP (B and E), cells were fixed and stained with goat anti-VSV G mouse antibody (11) specific for te G protein 
followed by a Alexa-633-goat anti-mouse IgG (White). Total tsVSV G-EYFP (A and D) was visualised through the 
natual fluorescence of EYFP (green). Following surface staining, cells were permeabilised and FMDV 2BC (C 
and F) was detected using a mouse anti-2C antibody (3F7), followed by Alexa-568 anti-mouse IgG (red). Cells 
were counter stained with DAPI (Blue) to detect the nucleus. Scale Bar 10 pm.
3.5 The localisation of FMDV 2BC within mammalian host cells
Previous studies demonstrated that the FMDV 2BC protein co-localised to the ER 
(Moffat et al., 2007). Flo we ver, following the identification of the mutation K439Q 
(Section 3.1) in the construct used for these experiments, it was important to confirm 
this localisation.
To identify which compartment(s) of the host cell FMDV 2BC protein localised to, 
IBRS2 and Vero cells were seeded on coverslips in 24 well plates and transfected with 
plasmids expressing 2BC or EYFP. The cells were then labelled for host cell markers 
and 2BC. Previously published data has shown that FMDV 2BC protein located to and 
appeared to modify the ER (Moffat et al., 2005; Moffat et al., 2007). Therefore, the 
location of 2BC in relation to the ER, the secretory pathway and the cytoskeleton were 
examined. Where possible, the localisation of FMDV 2BC protein was examined in 
porcine epithelial cells (IBRS2). However, where antibodies did not recognise the 
epitope of cellular markers in porcine cells, simian (Vero) epithelial cells were used as 
an alternative.
3.5.1 Endoplasmic Reticulum Lumen
The ER is the first component of the secretory pathway. The ER lumen contains a 
variety of chaperone proteins that are involved in the regulation of the correct folding 
of nascent secretory proteins and is an important store of calcium ions.
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3.5.1.1 Calreticulin
Vero cells were used for this study as the anti-calreticulin antibody did not detect 
calreticulin in IBRS2 cells. In cells expressing EYFP (Fig. 3.6 A), the distribution of 
calreticulin was similar to that in non-transfected, adjacent cells (Fig. 3.6 B and C). In 
cells expressing EYFP, calnexin appeared to have a reticular pattern (Fig. 3.6 C). In cells 
expressing FMDV 2BC (Fig. 3.6 D) there was some partial co-localisation of 2BC with 
calreticulin (Fig. 3.6 D and F), as seen from the yellow staining produced from the 
overlap of red and green staining (Fig. 3.6 F). The co-localisation of FMDV 2BC and 
calreticulin appeared to be quite diffuse. The highest levels of co-localisation occurred 
in a region to the right of the nucleus in the cell expressing FMDV 2BC, where there 
seems to be a slight aggregation of calreticulin (Fig. 3.6 E). However, the co­
localisation seen between calreticulin and 2BC may be a consequence of calreticulin's 
ubiquitous presence within the ER lumen.
3.5.1.2 ERp57
EYFP expressed in IBRS2 cells (Fig. 3.7 A) did not appear to co-localise with or alter the 
reticular distribution of ERp57 when compared to adjacent, non-transfected cells (Fig.
3.7 B and C). In cells expressing FMDV 2BC (Fig. 3.7 D), 2BC co-localised to punctate 
structures with ERp57 (Fig. 3.7 D-F), as can be seen from the yellow staining produced 
from the overlap of red and green staining (Fig. 3.7 F). It appeared that the FMDV 2BC
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Figure 3.6 FMDV 2BC partially co-localises with Calreticulin. Vero cells were transfected with 
pcDNAB.l-EYFP (A-C) or pcDNA3.1-2BC (D-F) for 24 h. Cells were permiabilised, fixed and stained. EYFP 
was visualised through the natural fluorescene of EYFP (A). Calreticulin (B and E) was detected with rabbit 
anti-caltreticulin followed by a goat anti-rabbit antibody conjugated to Alexa-568 (Red). FMDV 2BC (D) was 
detected using mouse antibody 3F7 followed by goat anti-mouse conjugated to Alexa-588 (Green). The 
cells were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F and are digital merges of 
all channels that comprise of panels A & B and D & E respectively. Scale Bar 10 pm.
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Figure 3.7 FMDV 2BC partially co-localises with ERp57. IBRS2 cells were transfected with pcDNAS.l-EYFP 
(A-C) or pcDNA3.1-2BC (D-F) for 24 h. Cells were permiabilised, fixed and stained. EYFP was visualised 
through the natural fluorescence of EYFP (A). ERp57 (B and E) was detected using anti-ERp57 antibody 
followed by a goat anti-rabbit antibody conjugated to Alexa-568 (Red). FMDV 2BC protein (D) was 
detected using a mouse anti-2C antibody 3F7, followed by a goat anti-mouse antibody conjugated to 
Alexa-488 (Green). The cells were counterstainined with DAPI (Blue) to detect the nucleus. Panels C and F 
and are digital merges of all channels that comprise of panels A & B and D & E respectively. Scale Bar 10 pm.
protein altered the distribution of ERp57 (Fig. 3.7 E) when compared with cells 
expressing EYFP and non-transfected cells (Fig. 3.7 B, C E and F). This co-localisation 
appeared to occur at the punctuate structure of the remodelled ERp57 (Fig. 3.7 D-F).
As Vero cells were being used as an alternate epithelial cell type to IBRS2 cells to 
analyse co-localisation of FMDV 2BC, it was important to have confidence that FMDV 
2BC would co-localise is a similar manner in Vero cells as in porcine cells. As ERp57 
was found to partially co-localise with FMDV 2BC in porcine cells (Fig. 3.7 F), it was 
important to confirm this effect in Vero cells. EYFP expressed in Vero cells did not 
alter the distribution of ERp57 (Fig. 3.8, A-C). In contrast, cells expressing FMDV 2BC 
protein (Fig. 3.8 D) showed some aggregation of ERp57 (Fig. 3.8 E) with punctate co­
localisation occurring between ERp57 and FMDV 2BC, which can be seen from the 
overlay of the green colour of FMDV 2BC and the red colour of ERp57 (Fig. 3.8 F). 
Thus, similar levels of co-localisation between ERp57 and FMDV 2BC protein could be 
seen in Vero and IBRS2 cells (Figs. 3.7 and 3.8).
3.5.1.3 GRP94
EYFP expressed in IBRS2 cells (Fig. 3.9 A) did not appear to co-localise with or alter the 
distribution of GRP94 when compared to adjacent, non-transfected cells (Fig. 3.9 B 
and C). Cells expressing FMDV 2BC appeared to be expressing GRP94 at a reduced
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Figure 3.8 FMDV 2BC partially co-localises with ERp57 in Vero cells. Vero cells were transfected with 
pcDNA3.1-EYFP (A-C) or pcDNA3.1-2BC (D-F) for 24 h. Cells were fixed permebilised, and stained. EYFP 
was visualised through the natural fluorescence of EYFP (A). ERp57 (B and E) was detected using rabbit 
anti-ERp57 followed by a goat anti-rabbit antibody conjugated to Alexa-568 (Red). FMDV 2BC protein was 
detected by mouse anti-2C antibody 3F7 followed by a goat anti-mouse antibody conjugated to Alexa-488 
(Green). The cells were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F and are 
digital merges of all channels that comprise of panels A & B and D & E respectively. Scale Bar 10 pm.
Figure 3.9 FMDV 2BC does not colocalise with GRP94. IBRS2 cells were transfected with pcDNA3.1-EYFP 
(A-C) or pcDNA3.1-2BC (D-F) for 24 h. Cells were fixed, permeabilised and stained. EYFP was visualised 
through the natural fluorescence of EYFP (A). GRP94 (B and E) was detected with rabbit anti-GRP94 
followed by a goat anti-rabbit antibody conjugated to Alexa-568 (Red). FMDV 2BC (D) was detected using 
mouse anti-2C antibody 3F7 followed by a goat anti-mouse antibody conjugated to Alexa-488 (Green).
The cells were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F and are digital 
merges of all channels that comprise of panels A & B and D & E respectively. Scale Bar 10 pm.
level (Fig. 3.9 D-E). However, FMDV 2BC protein did not appear to co-localise with 
GRP94.
3.5.2 The ER Membrane
The surface of the ER is where secretory proteins are synthesised by membrane- 
bound ribosomes of the rough ER. Nascent peptide chains are imported into the ER 
lumen via the translocon and folded into functional proteins. The ER membrane is also 
the site of ER exit sites for the movement of secretory proteins to the Golgi apparatus.
3.5.2.1 Calnexin
In IBRS2 cells (Fig. 3.10 A), EYFP expression did not appear to co-localise with or alter 
the distribution of calnexin when compared to adjacent non-transfected cells (Fig. 3.10 
B and C). In cells expressing FMDV 2BC (Fig. 3.10 D), there appeared to be an 
alteration in the distribution of calnexin within the cell (Fig. 3.10 E), with aggregation 
of calnexin occurring close to the cell nucleus. This aggregation of calnexin did not 
occur in cells expressing EYFP (Fig. 3.10 B). There appeared to be a high level of co­
localisation of FMDV 2BC protein with calnexin, which was seen by the yellow colour 
produced from the overlap of the green labelling of FMDV 2BC and the red labelling of 
calnexin (Fig. 3.10 F). The majority of the co-localisation of FMDV with calnexin 
appeared to occur at the punctate aggregated structures close to the cell nucleus (Fig.
3.10 D-F).
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Figure 3.10 FMDV 2BC colocalises with calnexin. IBRS2 cells were transfected with pcDNAB.l-EYFP (A-C) 
or pcDNA3.1-2BC (D-F) for 24 h. Cells were fixed, permeabilised and stained. EYFP was visualised through 
the natural fluorescence of EYFP (A). Calnexin (B and E) was detected with rabbit anti-calnexin followed 
by a goat anti-rabbit antibody conjugated to Alexa-568 (Red). FMDV 2BC (D) was detected using mouse 
anti-2C antibody 3F7 followed by a goat anti-mouse antibody conjugated to Alexa-488 (Green). The cells 
were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F and are digital merges of all 
channels that comprise of panels A & B and D & E respectively. Scale Bar 10 pm.
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Figure 3.11 FMDV 2BC colocalises with Calnexin. Vero cells were transfected with pcDNAB.l-EYFP (A-C) 
or pcDNA3.1-2BC (D-F) for 24 h. Cells were fixed, permeabilised and stained. EYFP was visualised through 
the natural fluorescence of EYFP (A). Calnexin (B and E) was detected with rabbit anti-calnexin followed 
by a goat anti-rabbit antibody conjugated to Alexa-568 (Red). FMDV 2BC (D) was detected using a mouse 
anti-2C antibody 3F7, followed by a goat anti-mouse antibody conjugated to Alexa-488 (Green). The cells 
were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F and are digital merges of all 
channels that comprise of panels A & B and D & E respectively. Scale Bar 10 pm.
Figure 3.12 FMDV 2BC does not colocalise with Sec61A. IBRS2 cells were transfected with 
pcDNAS.l-EYFP (A-C) or pcDNA3.1-2BC (D-F) for 24 h. Cells were fixed, permeabilised and stained. EYFP 
was visualised by the natural fluorescence of EYFP (A). Sec61A (B and E) was detected with rabbit 
anti-Sec61A followed by a goat anti-rabbit antibody conjugated to Alex-568 (Red). FMDV 2BC (D) was 
detected using mouse anti-2C antibody 3F7, followed by a goat anti-mouse antibody conjugated to 
Alexa-488 (Green). The cells were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F 
and are digital merges of all channels that comprise of panels A & B and D & E respectively.
Scale Bar 10 pm.
3.5.3 ER trafficking compartments
3.5.3.1 Sec31
After secretory proteins are synthesised at the ER they are exported at ER exit sites. 
The COP II complex is responsible for transport of these proteins from the ER to the 
ER-Golgi intermediate Compartment (ERGIC) (Appenzeller-Herzog and Hauri, 2006; 
Barlowe et a!., 1994; Lee et al., 2004). Sec31A forms part of the COP II complex.
By staining SecSlA, it was possible to analyse the effects of FMDV 2BC protein upon 
the COP II trafficking vesicle. Vero cells were used for this study as the anti-Sec31 
antibody did not detect porcine Sec31. EYFP expressed in Vero cells (Fig. 3.13 A) did 
not appear to co-localise with (Fig. 3.13 C) or affect the distribution of Sec31 (Fig. 3.13
B). Expression of FMDV 2BC (Fig. 3.13 D) changed the distribution of Sec31 in 2BC 
expressing cells (Fig. 3.13 E). From Panel E it appears that the cell on left has a weaker 
signal of Sec31A labelling than its adjacent partner. FMDV 2BC protein did not co­
localise with Sec31A (Fig. 3.13 F). It does appear, however that Sec31A levels are 
either reduced or dispersed, as the levels of Sec31A are lower than in Fig. 3.13, Panels 
B and C, or when compared to the adjacent cell which does not express FMDV 2BC.
3.5.4 ER-Golgi intermediate compartment (ERGIC)
The ERGIC is an intermediate between the ER and the Golgi (Saraste and Svensson, 
1991; Schweizer et al., 1990), but is also distinct from the ER and the Golgi
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Figure 3.13 Reduced labelling for Sec31A in 2BC expressing cells. Vero cells were transfected with 
pcDNAB.l-EYFP (A-C) or pcDNA3.1-2BC (D-F) for 24 h. Cells were fixed, permeabilised and stained. 
EYFP was visualised through the natural fluorescence of EYFP (A). Sec31A (B and E) was detected 
with mouse anti-Sec31A followed by a goat anti-mouse antibody conjugated to Alexa-568 (Red). 
FMDV 2BC (D) was detected using rabbit antibody DM11, followed by a goat anti-rabbit Alexa-488. 
The cells were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F and are digital 
merges of all channels that comprise of panels A & B and D & E respectively. Scale Bar 10 pm.
(Schweizer et al., 1991). It is the first sorting station for retrograde and anterograde 
protein trafficking after the ER (Appenzeller et al., 1999; Aridor et al., 1995; Ben- 
Tekaya et al., 2005; Klumperman et al., 1998; Martmez-Menarguez et al., 1999).
3.5.4.1 ERGIC-53
IBRS2 cells expressing EYFP (Fig. 3.14 A) did not show any alteration in the distribution 
of the cellular marker ERGIC-53 when compared to adjacent, non-transfected cells 
(Fig. 3.14 B). In these cells, ERGIC-53 was vesicular and located to a peri-nuclear 
location (Fig. 3.14 C). Cells expressing FMDV 2BC (Fig. 3.14 D) did not have detectable 
levels of ERGIC-53 when compared to adjacent non-transfected cells (Fig. 3.14 E).
3.S.4.2 P-COP
IBRS2 cells expressing EYFP (Fig. 3.15 A) did not show any differences in the 
distribution of 3-COP (Fig. 3.15 B). EYFP did not co-localise with 3-COP (Fig. 3.15 C). 
Cells that expressed FMDV 2BC (Fig. 3.15 D) showed a change in the distribution of 3- 
COP when compared to adjacent non-transfected cells. The 3-COP was dispersed and 
levels were reduced in 2BC-expressing cells. The majority of 2BC protein did not co- 
localise with 3-COP (Fig. 3.15 F).
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Figure 3.14 FMDV 2BC does not co-localise with ERGIC53. IBRS2 cells were transfected with 
pcDNA3.1-EYFP (A-C) or pcDNA3.1-2BC (D-F) for 24 h. Cells were fixed, permeabllised and stained. EYFP 
was visualised through the natural fluorescence of EYFP (A). ERGIC53 (B and E) was detected with mouse 
IgGl anti-ERGIC53, followed by a goat anti-lgGl antibody conjugated to Alexa-568 (Red). FMDV 2BC (D) 
was detected using mouse lgG2a 3F7, followed by a goat anti-lgG2a antibody conjugated to Alexa-488 
(Green). The cells were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F and are 
digital merges of all channels that comprise of panels A & B and D & E respectively. Scale Bar 10 pm.
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Figure 3.15 FMDV 2BC does not colocalise with 3-COP IBRS2 cells were transfected with pcDNA3.1-EYFP 
(A-C) or pcDNA3.1-2BC (D-F) for 24 h. Cells were fixed, permeabllised and stained. EYFP was visualised 
through the natural fluorescence of EYFP (A). 3-COP (B and E) was detected with rabbit anti-3-COP, 
followed by a goat anti-rabbit antibody conjugated to Alexa-568 (Red). FMDV 2BC (D) was detected using 
mouse anti-2C antibody 3F7, followed by using goat anti-mouse antibody conjugated to Alexa-488. The 
cells were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F and are digital merges of 
all channels that comprise of panels A & B and D & E respectively. Scale Bar 10 pm.
3.S.4.3 Golgi Matrix protein 130 (GM130)
To investigate if the FMDV 2BC protein is associated with the surface of the Golgi 
apparatus, EYFP and FMDV 2BC transfected cells were labelled for FMDV 2BC and for 
GM130. Expression of EYFP in IBRS2 cells (Fig. 3.16 A) did not affect the distribution of 
GM130 (Fig. 3.16 B) and did not produce any co-localisation (Fig. 3.16 C). Similarly, 
expression of FMDV 2BC (Fig. 3.16 D) did not appear to affect the distribution of, or co- 
localise with GM130. A GM130 peri-nuclear pattern can be seen in cells expressing 
EYFP (Fig. 3.16 B and C) or FMDV 2BC (Fig. 3.16 E and F), which is consistent with the 
pattern for the Golgi apparatus.
3.5.5 Cytoskeleton
The cytoskeleton is the scaffolding of the cell and provides it with its structure and 
shape. The eukaryotic cytoskeleton consists of three types of cytoskeletal filaments; 
microfilaments consisting of actin, intermediate filaments and microtubules. Theiler's 
virus, poliovirus and FMDV are known to associate with components of the 
cytoskeleton (Grigera and Sagedahl, 1986; Nedellec et al., 1998; Weed et al., 1985). 
Poliovirus and FMDV 3C protein has been shown to target the cytoskeleton, with 
poliovirus 3C cleaving microtubule associated protein 4 (Joachims et al., 1995) and 
expression of FMDV 3C protein resulted in a loss of y-tubulin (Armer et al., 2008). 
Coxsackievirus and human rhinovirus 2A protein have also been shown to cleave
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Figure 3.16 FMDV 2BC does not colocalise with GM130. IBRS2 cells were transfected with pcDNA3.1-EYFP 
(A-C) or pcDNA3.1-2BC (D-F) for 24 h. Cells were fixed, permeabilised and stained. EYFP was visualised 
through the natural fluorescence of EYFP. GM130 (B and E) was detected with mouse IgGl anti-GM130, 
followed by a goat anti-mouse IgGl antibody conjugated to Alexa-568 (Red). FMDV 2BC (D) was 
detectected using mouse lgG2a antibody 3F7, followed by goat anti-mouse lgG2a antibody conjugated to 
Alexa-488 (Green). The cells were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F 
and are digital merges of all channels that comprise of panels A & B and D & E respectively.
Scale Bar 10pm
intermediate filaments (Seipelt et al., 2000). To determine if FMDV 2BC protein 
affected the cytoskeleton, cells expressing FMDV 2BC protein were analysed by 
immuno-fluorescent microscopy.
3.5.5.1 Vimentin (V9)
IBRS2 cells that expressed EYFP (Fig. 3.17 A) did not show an altered distribution 
pattern of the intermediate filament vimentin when compared to adjacent cells not 
expressing EYFP (Fig. 3.17 B and C). EYFP did not co-localise with vimentin (Fig. 3.17
C). Similarly, expression of FMDV 2BC (Fig. 3.17 D) did not affect the distribution of 
vimentin (Fig. 3.17 E) or co-localise with it (Fig. 3.17 F).
3.5.52 a-tubulin
IBRS2 cells that expressed EYFP (Fig. 3.18 A) did not show an altered distribution or 
expression levels of a-tubulin (Fig. 3.18 B). Nor did EYFP co-localise with a-tubulin and 
remained cytoplasmic (Fig. 3.18 C). Similarly, expression of FMDV 2BC (Fig. 3.18 D) did 
not appear to affect the distribution of a-tubulin (Fig. 3.18 E) or co-localise with a- 
tubulin (Fig. 3.18 F).
3.5.5.3 Y-tubulin
IBRS2 cells that expressed EYFP (Fig. 3.19 A) did not show an altered expression or 
distribution of y-tubulin when compared to adjacent non-transfected cells (Fig. 3.19
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B). EYFP did not co-localise with y-tubulin (Fig. 3.19 C). Similarly, the expression of 
FMDV 2BC within IBRS2 cells (Fig. 3.19 D) did not affect the expression levels or 
distribution of y-tubulin within the cell (Fig. 3.19 E). FMDV 2BC did not co-localise with 
y-tubulin within the cell (Fig. 3.19 F).
The microtubule organising centre (MTOC) can be seen as a bright red spot close to 
the cell nucleus (Fig. 3.19 B, C and E, F), y-tubulin can also be seen distributed 
throughout the cell. Cells expressing either FMDV 2BC or EYFP did not appear to co­
localise with or affect the distribution MTOCs (Fig. 3.19 B -C and E-F).
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Figure 3.17 FMDV 2BC does not colocalise with Vimentin. IBRS2 cells were transfected with 
pcDNA3.1-EYFP (A-C) or pcDNA3.1-2BC (D-F) for 24 h. Cells were fixed, permeabilised and stained. EYFP 
was visualised through the natural fluorescence of EYFP (A). Vimentin (B and E) was detected with mouse 
IgGl anti-vimentin, followed by goat anti-mouse IgGl conjugated to Alexa-568 (Red). FMDV 2BC (D) was 
detected using mouse lgG2a anti-2C antibody antibody 3F7, followed by goat anti-mouse lgG2a 
conjugated to Alexa-488 (Green). The cells were counterstained with DAPI (Blue) to detect the nucleus. 
Panels C and F and are digital merges of all channels that comprise of panels A & B and D & E respectively. 
Scale Bar 10 pm.
Figure 3.18 FMDV 2BC does not colocalise with a-tubulin. IBRS2 cells were transfected with 
pcDNA3.1-EYFP (A-C) or pcDNA3.1-2BC (D-F) for 24 h. Cells were fixed, permeabilised and stained. EYFP 
was visualised through the natural fluorescence of EYFP (A), a-tubulin (B and E) was detected with mouse 
IgGl anti-a-tubulin, followed by goat anti-mouse IgGl conjugated to Alexa-568 (Red). FMDV 2BC (D) was 
detected using mouse lgG2a antibody 3F7, followed by goat anti-mouse lgG2a conjugated to Alexa-488. 
The cells were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F and are digital 
merges of all channels that comprise of panels A & B and D & E respectively. Scale Bar 10 pm
Figure 3.19 FMDV 2BC does not colocalise with y-tubulin. IBRS2 cells were transfected with 
pcDNA3.1-EYFP (A-C) or pcDNA3.1-2BC (D-F) for 24 h. Cells were fixed, permeabilised and stained. EYFP 
was visualised through the natural fluorescence of EYFP (A), y-tubulin (B and E) was detected with mouse 
IgGl anti-y-tubulin, followed by goat anti-mouse IgGl antibody (Red). FMDV 2BC (D) was detected using 
anti-2C mouse lgG2a antibody 3F7, followed by goat anti-mouse lgG2a antibody conjugated to Alexa-488. 
The cells were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F and are digital 
merges of all channels that comprise of panels A & B and D & E respectively. Scale Bar 10 pm.
3.6 Discussion
Since FMDV 2BC in the plasmid pCK was found to have a nucleotide base substitution 
which resulted in an amino acid substitution of a glutamine in the place of a lysine, it 
was necessary to create and characterise a new construct expressing FMDV 2BC. 
While both lysine and glutamine are polar amino acids, lysine has a positively charged 
side chain whereas glutamine's side chain has a neutral charge. This difference in side 
chain charge could potentially affect the folding of the subsequent protein. If there 
was differential folding of the protein, the tertiary structure may be affected and this 
may alter any active sites and could affect the location of the protein within the cell.
The study examined the effects of wild type FMDV 2BC protein on the secretory 
pathway by following the transport of fluorescently tagged tsVSV G protein from the 
ER to the cell surface. TsVSV G could be co-expressed with wildtype FMDV 2BC 
protein at 40°C and 30°C (Fig. 3.4). However, only approximately 2-5% of cells 
expressed both FMDV 2BC and the VSV G protein (data not shown). As shown 
previously (Bergmann, 1989; Moffat et al., 2005), the tsVSV G protein was retained 
within the ER at 40°C and trafficked to the cell surface at the permissive temperature 
of 30°C.
The trafficking assay clearly showed that the consensus FMDV 2BC viral protein was 
able to prevent the movement of tsVSV G protein from the ER to the cell surface and 
retained the trafficking molecule within the cell for at least 6 h. The majority of the
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trafficking molecules co-located with FMDV 2BC which itself partially co-localised with 
ER bound proteins as reported previously (Moffat et al., 2005; Moffat et al., 2007). In 
addition, the substitution mutation of the lysine amino acid being replaced by a 
glutamine in the FMDV 2BC amino acid sequence did not affect the trafficking of tsVSV 
G protein through the secretory pathway in Vero cells.
The FMDV 2BC protein was located in small punctate structures concentrated around 
the nucleus of the cell with some scattered throughout the cytoplasm. 2BC expression 
led to a re-distribution of ER, suggesting that the viral protein was modifying the ER. 
This is consistent with previously published work (Moffat et al., 2005; Moffat et al., 
2007). This study established that FMDV 2BC did not co-localise with other early 
secretory organelles other than the ER, unlike the 2BC protein of coxsackievirus which 
targets to the Golgi (Cornell et al., 2006). However, the COP II marker Sec31A and the 
ERGIC marker ERGIC-53 were dispersed from their perinuclear position in the 
cytoplasm in cells expressing 2BC. As no disruption was detected in the cytoskeletal 
components of cells expressing FMDV 2BC, these observations suggest that 2BC has 
co-localised with the ER and led to the dispersal of the COP II complex and ERGIC early 
secretory organelles.
FMDV 2BC expressed in transfected cells did not co-locate to the ER exit sites or the 
COP II complex marker Sec31, but led to the dispersal of Sec31 labelling. This suggests 
that FMDV 2BC protein affects the ER or ER exit sites upstream of the Sec31 assembly
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of the COP II complex. If FMDV 2BC was to interact with Sec24 or Secl6, this would 
lead to a block in the formation of the ER exit sites and subsequent formation of COP II 
vesicles and so their maturation into the ERGIC would be considerably reduced.
However, there appeared to be a high level of co-localisation with the calcium binding 
ER membrane protein calnexin (Fig. 3.10 and 3.11). Calnexin is a lectin-like chaperone 
protein of nascent membrane and soluble proteins of the secretory pathway 
(Bergeron et al., 1994; David et al., 1993; Rajagopalan et al., 1994). Interestingly, it has 
been shown that calnexin is required for the correct folding of tsVSV G protein 
(Hammond and Helenius, 1994a). The observations that tsVSV G protein trafficking is 
blocked by co-expression of FMDV 2BC protein (Moffat et al., 2005) (Section 3.4) and 
FMDV 2BC protein co-localises with calnexin (Fig 3.10 and 3.11) suggest that 2BC has 
the potential to inhibit tsVSV G trafficking through its co-localisation with calnexin.
Calnexin and calreticulin are involved in the folding of MHC I molecules along with 
ERp57 (Oliver et al., 1999; Oliver et al., 1997) in the peptide loading complex of MHC 
class I (Dong et al., 2009; Zhang et al., 2009a). The partial co-localisation of FMDV 2BC 
with ERp57 suggests that FMDV 2BC protein is locating to ERp57 which is in 
conjunction with calnexin but not calreticulin (Figs 3.6-3.S, 3.9 and 3.11, and 3.20). 
However, 2BC did not co-localise with Sec61A, a component of the translocon which is 
also bound to the ER membrane, suggesting that FMDV 2BC co-localises to regions of 
the ER in a non-generalised fashion.
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Cnx / Crt
Figure 3.20 The association of ERp57 with cainexin/caltericulin in the presence of 
Mono-glucosylated A/-glycans, adapted from (Hebert and Molinari, 2007). Cnx: 
Calnexin, Crt: Calreticulin.
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Calnexin and calreticulin are involved in calcium storage and homeostasis (Arnaudeau 
et al., 2002; Fliegel et al., 1989; Michalak et al., 2009; Wada et al., 1991). The 
localisation of FMDV 2BC with calnexin could affect the calcium binding abilities of 
calnexin. Any alteration in the calcium binding properties of calnexin or calreticulin 
could affect the calcium trafficking pathway, leading to a number of possible effects 
including, the prevention or induction of apoptosis (Biagioli et al., 2008; Campanella et 
al., 2004; Hajnoczky et al., 2003; Zhang et al., 2007; Zhou et al., 2009) and immuno­
suppression (Chami et al., 2006; Choi et al., 2005; Zhou et al., 2009). Other studies 
have shown that expression of poliovirus 2BC protein results in an increase in cytosolic 
calcium (Aldabe et al., 1997; Irurzun et al., 1995). This also is true for enterovirus 213 
protein (van Kuppeveld et al., 2005) and Coxsackievirus 2B protein (de Jong et al., 
2006).
Sec31 is a component of the COP II coatamer, part of the COP II trafficking complex 
(Stagg et al., 2006; Stagg et al., 2008). The COP II complex is responsible for the 
trafficking of proteins from the ER to the ERGIC and limiting of COP II traffic could 
result in a restriction of protein trafficking and secretion of molecules from the cell 
(Kuehn and Schekman, 1997; Townley et al., 2008). FMDV 2BC was not seen to co­
localise with Sec31 (Fig. 3.13). This corroborates studies by Knox (2005) who also could 
not demonstrate co-localisation of FMDV proteins with COP II. However, it appears 
that there was a down-regulation or dispersal of Sec31 labelling. Consequently, it is 
likely that there is also a subsequent dispersal of the COP II complex (Fig. 3.13).
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In addition to Sec31 dispersal, the ERGIC marker ERGIC-53 could not be detected in 
cells expressing FMDV 2BC (Fig. 3.14). ERGIC-53 molecules are trafficked from the ER 
in COP II vesicles (Schekman and Orel, 1996) to the ERGIC where they localise (Aridor 
et al., 1995; Ben-Tekaya et al., 2005; Klumperman et al., 1998). If COP II trafficking is 
impeded, there would be a depletion of ERGIC-53 as it is transported back to the ER by 
COP I (Cosson and Letourneur, 1997; Letourneur et al., 1994; Pelham, 1994). It is 
possible that the dispersal of the COP II complex could drain components required for 
the ERGIC and so could result in its dispersal. This reduction in Sec31 may also be due 
to ER stress (Amodio et al., 2009), which could result from an accumulation of 
misfolded proteins within the ER (Kozutsumi et al., 1988; Shen et al., 2004) as a 
consequence of FMDV 2BC association with calnexin. (3-COP also appeared to be 
dispersed or depleted. p-COP is a component of the COP I complex responsible for the 
trafficking of proteins and molecules between the ERGIC and Golgi apparatus. As 
Sec31 was dispersed upstream of COP I in the secretory pathway this may have a 
downstream effect upon the COP I complex and P-COP (Fig. 3.15). This may be as a 
consequence of a depletion of membrane components required for COP I formation 
which could result from a reduction COP II trafficking (Fig. 3.13).
GM130 is present on the c/s-Golgi and is required for the fusion of COP I molecules and 
its inhibition can result in the formation of vesicular structures and an inhibition of 
protein trafficking (Alvarez et al., 2001; Sônnichsen et al., 1998). The distribution of 
GM130 did not seem to be affected by the expression of FMDV 2BC. This is consistent 
with studies which demonstrate that FMDV replication is resistant to Brefeldin A
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(BFA), a fungal metabolite that blocks protein trafficking between the ERGIC and Golgi 
apparatus (O'Donnell et al., 2001).
BFA has been shown to inhibit BIGl (Morinaga et al., 1996) and inhibition of BIGl also 
results in the dispersal of p-COP whilst leaving GIVI 130 intact. In contrast, inhibition of 
GBFl results in the dispersal of GIVI 130 but not p-COP (Boal and Stephens, 2010; 
Citterio et al., 2008). It is possible that FMDV 2BC could be interacting with BIGl. 
However it is more likely that the upstream effects of the dispersal of Sec31 and 
ERGIC53 are having a knock on effect upon p-COP. It does not appear that FMDV 2BC 
protein localises to or alters the distribution of GM130 and this correlates with the 
studies by Knox (Knox et al., 2005), which showed that FMDV replication does not 
utilise membranes from the Golgi apparatus.
As it has been shown in previous studies that poliovirus, Theiler's virus (Nedellec et al., 
1998), coxsackievirus 2A protein (Seipelt et al., 2000), and the FMDV 3C protein can 
affect the cytoskeleton (Armer et al., 2008; Joachims et al., 1995), it was decided to 
determine if FMDV 2BC associated with or disrupted the cytoskeleton.
The expression of FMDV 2BC in IBRS2 cells did not demonstrate any interactions 
between the cytoskeleton and FMDV 2BC (Figs. 3.17 - 3.19). FMDV did not affect the 
distribution of any part of the cytoskeleton investigated. Vimentin, a constituent of 
intermediate filaments of the cytoskeleton, did not co-localise and did not appear to
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be affected by the presence of FMDV 2BC (Fig. 3.17). Similarly, a-tubulin was 
unaffected by the expression of FMDV 2BC (Fig, 3.18), as was y-tubulin with the 
MTOCs still intact (Fig. 3.19). Thus, FMDV 2BC protein did not appear to affect the 
distribution of components of the cytoskeleton (Figs 3.17 - 3.19).
These results support previous studies that have shown that the FMDV 2BC protein 
localises to regions around the ER (Moffat et al., 2007). The co-localisation of FMDV 
2BC with calnexin (Figs 3.10 and 3.11) and partial co-localisation with ERp57 (Fig. 3.7 
and 3.8) may play a role in regulating surface expression of MHC I during FMDV 
infection (Sanz-Parra et al., 1998). It is also interesting that FMDV 2BC protein appears 
to be involved in the down regulation of the COP II marker Sec31 (Fig. 3.13). This 
could be a either a direct effect due to the sequestering of membranes (Rust et al., 
2001) or could be an indicator of ER stress (Amodio et al., 2009). Together these 
effects could contribute to immune evasion by FMDV by down-regulating cell 
signalling to limit an immunological response to infection.
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Chapter Four: Analysis of the effects of FMDV OIK 2BC on protein expression
The FMDV non-structural protein 2BC has been shown to block ER-to-Golgi protein 
trafficking (Moffat et al., 2005). Previous studies have shown that infection of 
mammalian cells by FMDV or expression of the non-structural proteins 2BC or co­
expression of 2B and 2C together, disrupts protein secretion between the endoplasmic 
reticulum and the plasma membrane (Moffat et al., 2005; Moffat et al., 2007). In 
order to determine which region(s) of FMDV 2BC protein are responsible for the effect 
on the secretory pathway, we aimed to develop a quantitative assay to analyse the 
ability of 2BC mutants to inhibit host protein secretion. A bicistronic reporter plasmid 
was constructed to quantify the level of disruption to the host protein secretory 
pathway in cells expressing FMDV 2BC. The bicistronic plasmid was designed to 
encode the FMDV 2BC protein followed by an internal ribosome entry sequence (1RES) 
which would enable the expression of a downstream reporter protein, secreted 
alkaline phosphatase (SEAP), from the single transcript. Mutations could then be 
introduced into the 2BC sequence and allow us to examine the effects of these 
mutations upon the ability of the FMDV 2BC protein to retain SEAP within the host 
cell.
Bicistronic plasmids utilise an 1RES sequence to allow the translation of two genes 
from one transcript. The 1RES reduces the loss of gene expression caused by 
competition for the ribosome when using dual transfection. The bicistronic system 
could eliminate the possibility of single transfections occurring within one cell with 
one plasmid and not the other which could potentially occur using a dual transfection
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system. The pIRES (Clontech) enables the 5" capped mRNA translation of the first gene 
followed by cap-independent translation from the 1RES, of the second gene. Cap- 
independent translation is less efficient than 5" capped translation (Hennecke et al., 
2001; Mizuguchi et al., 2000), therefore, as FMDV 2BC is the protein of interest, its 
expression will be driven by capped translation and SEAP will be translated from the 
1RES.
To quantitatively investigate the extent to which 2BC blocks protein trafficking the 
Great EscAPe™ (Clontech) chemiluminescence detection kit was used to examine the 
levels of SEAP secreted into cell media or retained within cell lysates. Based on 
evidence from previous VSV G trafficking studies (Moffat et al., 2005), and Section 3.3, 
cells expressing FMDV 2BC protein should present the highest levels of SEAP retained 
within the cell, whilst cells transfected with the control construct expressing EYFP and 
SEAP should have low levels of SEAP retained within the cells.
4.1 Great EscAPe™ chemiluminescence detection kit
The Great EscAPe™ system uses a human placental form of secreted alkaline 
phosphatase (SEAP) as a reporter protein (Berger 1988). Alkaline phosphatase is a 
membrane bound glycosylated enzyme. SEAP is a truncated form of alkaline 
phosphatase which lacks the membrane anchoring domain so allowing alkaline 
phosphatase to be secreted from the cell. SEAP can be measured quantitatively in cell 
supernatants. The levels of SEAP in the supernatant have been shown to be directly
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proportional to intracellular levels of SEAP mRNA and protein (Berger et al., 1988; 
Cullen and Malim, 1992). SEAP is heat stable and is not inhibited by the phosphatase 
inhibitor L-Homoarginine (Cullen and Malim, 1992). Therefore, incubating any 
supernatant or lysate at 65°C with L-Homoarginine, will inactivate endogenous alkaline 
phosphatases whilst leaving SEAP activity unaffected.
4.2 Generation of Bicistronic Constructs
4.2.1 Construction of pIRES-SEAP
The original cloning strategy was to amplify SEAP by PCR from the plasmid pSEAP2- 
Control (Clontech) encoding the SEAP ORF, incorporating the restriction sites So/I and 
Not\ and a stop codon at the 3" end of the SEAP ORF using the primers shown in Table 
4.1. The SEAP PCR product produced was digested with Sail and Notl to produce 
respective sticky ends. The digested SEAP PCR product was ligated into multiple 
cloning site B (MCSB) of the pIRES vector (Clontech) containing an 1RES, at restriction 
sites Sail and Notl (Fig. 4.1).
Table 4.1 Primers for PCR amplification of SEAP sequence
Primer Tm (°C) Sequence Role/ Restriction Sites
TGIPDF-003 71.1 AAAGTCGACACCATGCTGCTGCT SEAP S' Sail
TGIPDF-004 71.7 AAAGCGGCCGCTCATGTCTG SEAP 3' Notl
The PCR conditions are described in Materials & Methods 2.2.4.2. Attempts to amplify 
the SEAP ORF from pSEAP2-Control using a number of DNA polymerases were made.
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Figure 4.1 Insertion of SEAP into pIRES (A) SEAP DNA sequence from pSEAP2-Control 
(Clontech) was amplified using specific primers TGIPDF-003 and TGIPDF-004. 
Restriction sites at the S' ends of the primers incorporated So/I and Not\ onto the S' 
and 3' ends of the amplified SEAP, respectively. The SEAP ORF is highlighted in yellow. 
SEAP PCR product was then directionally inserted into the multiple cloning site B (MCS 
B) of the pIRES construct at Sal\/Not\ restriction sites, to produce pIRES-SEAP (B).
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PCR reactions were performed with and without Q solution (Qiagen), a PCR additive to 
assist with the amplification of GC rich templates or templates with secondary 
structure. Gradient PCRs were performed with a range of annealing temperatures, 
nested PCR was also attempted. Very little or no SEAP PCR product was produced 
successfully from these reactions.
Amplification of the SEAP ORF is expected to yield a DNA fragment size of 1560 bp and 
pCR®4Blunt-T0P0® has a known size of 3956 bp. PCR products, with the approximate 
size of 1560 bp, were pooled from several gradient PCR reactions and ligated into 
pCR®4Blunt-T0P0® (Invitrogen) (Fig. 4.2) via the TOPO binding site. The presence of 
the SEAP insert was analysed by Not\-Sal\ restriction digest. Two bands with the size of 
approximately 1600 bp and 4000 bp were produced which corresponded to that of the 
anticipated size of SEAP and pCR®4Blunt-T0P0®, respectively (Fig. 4.2 C). Sequence 
analysis showed that these constructs did not contain the SEAP ORF.
As SEAP could not be amplified by PCR a second cloning strategy was used. The SEAP 
ORF was isolated by restriction digest and ligated into pIRES (Fig. 4.3 A-C). pSEAP2- 
Control was digested with EcoR\ and then Bsm\ and blunt ended with T4 DNA 
polymerase (Fig. 4.3 A). The SEAP ORF was then ligated into Sma\ digested (which 
produces blunt ends) pIRES using T4 DNA ligase (Fig. 4.3 B and C). Ligations were
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Figure 4.2 Insertion of SEAP into pCR4biunt-T0P0 A) pCR4Blunt-T0P0 vector with 
TOPO binding site shown. SEAP DNA sequence was amplified from pSEAP2-Control 
using specific primers TGIPDF-003 and TGIPDF-004, incorporating So/I and NoÜ onto 
the 5' and 3' ends of the amplified SEAP, respectively. B) SEAP PCR product was 
inserted into pCR4Blunt-T0P0 producing pcR4Blunt-T0P0-SEAP. C) Sall/Notl 
restriction digest analysis of pcR4Blunt-T0P0-SEAP clones. Lane 1, a clone lacking 
SEAP, Lane 2, a clone containing the putative SEAP fragment.
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Figure 4.3 Ligation of SEAP ORF into pIRES by restriction digest. A) The SEAP ORF was 
isolated from pSEAP2-Control by EcoRI and Bsm\ restriction digest and agarose gel 
purification. B) pIRES was linearised with Smo\ to produce a blunt ended pIRES vector. 
The SEAP ORF was treated with T4 DNA polymerase to produce blunt ends (highlighted 
in red) and then ligated into pIRES MCS B to produce pIRES-SEAP (C). The EcoRI and 
Bsm\ restriction sites were destroyed during the cloning procedure. D) Not\ and 
BamH\ restriction digest analysis of pIRES-SEAP. Lane 1, a clone with the incorrect 
restriction profile. Lane 2, a clone with the putative restriction profile of pIRES-SEAP. 
The relative positions of the Not\ and EomHI restriction sites in pIRES-SEAP are shown 
in C.
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transformed into competent JM109 cells and grown overnight, with ampicillin 
selection. Plasmid DNA was isolated from miniprepped bacterial cultures. The 
presence of SEAR in the correct orientation was determined by restriction digest with 
A/otl and Bom HI (Fig. 4.3 D). A Not\-BamH\ restriction digest of pIRES-SEAP with the 
SEAP ORE in the correct orientation should produce three bands with sizes of 4047 bp 
for a BomHI-BomHI fragment, 1398 bp for a BamH\-Not\ fragment and a 2264 bp Not\- 
BamHl fragment.
The BamH\-Not\ restriction digest of putative pIRES-SEAP produced bands of 
approximately 1400 bp, 2400 bp and 4000 bp (Fig. 4.3 D, Lane 2). These bands are 
similar to what would be expected if the SEAP ORF was inserted into pIRES in the 
correct orientation and confirms that pIRES-SEAP was created successfully.
4.2.2 Cloning of 2BC into pIRES-SEAP
The 2BC sequence from pT7S3 (encoding FMDV OIK 2BC) was amplified by PGR with 
KOD polymerase using the primers in Table 4.2 incorporating a start codon, a Kozak 
sequence and a Nhe\ restriction site at the 5' end, and a stop codon and an Mlu\ 
restriction site at the 3' end of the 2BC sequence.
Table 4.2 Primers for PGR amplification of FMDV OIK 2BG sequence
Primer Tm (°G) Sequence Role/ Restriction 
Sites
TGIPDF-039 70.3 AAAGCTAGCATGCCCTTCTTTTTCTCC 2BC 5' Nhe\
TGIPDF-002 68.6 AAAACGCGTTCACTGCTTGAAGAT 2BC 3' Mlu\
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The reaction conditions are described in Materials & Methods 2.2.4.2. The PCR 
product was directionally inserted into the multiple cloning site A (MCS A) of the 
pIRES-SEAP construct at Nhe\/Mlu\ (Fig. 4.4). The PCR product and pIRES-SEAP were 
digested with Nhe\ and Mlu\, purified and then ligated using T4 DNA ligase (Fig. 4.4 A 
and B). Putative clones containing the 2BC ORF were screened by Nhe\/Mlu\ 
restriction digest and were expected to produce fragments with sizes of 1416 bp and 
7716 bp, corresponding to the size of the FMDV 2BC ORF and pIRES-SEAP, respectively.
The Nhe\/Mlu\ restriction digest of putative p2BC-IRES-SEAP (Fig. 4.4 C Lane 2) 
produced DNA fragments with sizes of approximately 8000 bp and 1400 bp which 
correspond to the anticipated sizes of pIRES-SEAP and the 2BC ORF, respectively. This 
indicated that a DNA fragment, the size of 2BC ORF, was inserted into the pIRES-SEAP 
construct. The 2BC sequence of p2BC-IRES-SEAP was examined by sequence analysis 
and was found to be identical to the published sequence of FMDV OIK (GenBank: 
X00871.1).
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Figure 4.4 Insertion of FMDV 2BC into pIRES-SEAP (A) FMDV 2BC DNA sequence was 
amplified from pT7S3 using specific primers TGIPDF-039 and TGIPDF-002. Restriction 
sites at the 5' ends of the primers incorporated Nhe\ and Mlu\ onto the S' and 3' ends 
of the amplified 2BC, respectively. A start codon (ATG) and kozak sequence was 
introduced at the S' end of the 2BC sequence and a stop signal (TAA) was introduced 
at the 3' end of the 2BC sequence. The 2BC ORF sequence is highlighted in purple. The 
2BC PCR product and the pIRES-SEAP vector were digested with Nhe\ and Mlu\ and gel 
purified. The 2BC ORF was ligated into MCS A of the linearised pIRES-SEAP vector to 
produce p2BC-IRES-SEAP (B). (C) Nhe\ and Mlul restriction digest analysis of p2BC- 
IRES-SEAP. Lane 1, a clone lacking FMDV 2BC; Lane 2, a clone containing a putative 
2BC fragment.
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4.2.3 Cloning of EYFP into pIRES-SEAP
The EYFP ORF from pEYFP-Nl (Clontech) was amplified by PCR with KOD polymerase 
using the primers shown in Table 4.3 to incorporate restriction sites at the 5' ends of 
the primers incorporated Xho\ and Mlul onto the 5' and 3' ends of the amplified EYFP, 
respectively. A stop signal was also introduced at the 3' end of the EYFP sequence.
Table 4.3 Primers for the amplification of EYFP sequence
Primer Tm (°C) Sequence Role/ Restriction 
Sites
TGIPDF-025 69.4 AAACTCGAGACCATGGTGAGCAAG YFP 5' primer X/7 0 I
TGIPDF-026 71.5 AAAACGCGTTTACTTGTACAGCTCCGTC YFP 3' primer Mlul
The reaction conditions are described in Materials & Methods Z.2.4.2. The EYFP PCR 
product and pIRES-SEAP were digested with Xhol and Mlul (Fig. 4.5 A). The EYFP PCR 
product was ligated into pIRES-SEAP using T4 DNA ligase (Fig. 4.5 B). Putative clones 
containing the EYFP ORF were screened by Xhol/Mlul restriction digest (Fig. 4.5 C) and 
were expected to produce DNA fragments with sizes of 750 bp and 7716 bp, 
corresponding to the size of the EYFP and a fragment and pIRES-SEAP, respectively.
The Xhol/Mlul restriction digest produced DNA fragments with sizes of approximately 
8000 bp and 750 bp (Fig. 4.5 C, Lane 2) which correspond to the anticipated sizes of 
pIRES-SEAP and EYFP respectively. This indicated that a DNA fragment, the size of 
EYFP, was inserted into pIRES-SEAP. The EYFP-IRES-SEAP was transfected into Vero 
cells and after 24 h the presence of EYFP signal was examined using fluorescence
128
microscopy (data not shown). EYFP was detected in cells transfected with pEYFP-IRES- 
SEAP.
4.2.4 Cloning of 2C into pIRES-SEAP
The 2C ORF from the FMDV OIK strain was amplified by PCR with KOD polymerase 
from p2BC-IRES-SEAP using the primers shown in Table 4.4 to incorporate a start 
codon and Kozak sequence at the 5' end and a stop codon at the 3' end of the 2C ORF 
and the restriction sites Nhe\ and Mlu\.
Table 4.4 Primers for the amplification of FMDV 01K2C sequence
Primer Tm (°C) Sequence Role/ Restriction Sites
TGIPDF-054 68.3 AAAGCTAGCATGCTCAAAGCACG 2C 5' Nhe\
TGIPDF-002 68.6 AAAACGCGTTCACTGCTTGAAGAT 2BC 3' Mlu\
The reaction conditions are described in Materials & Methods 2.2.4.2. The cloning 
strategy and analysis were as described in 4.2.2 (Fig. 4.6).
The presence of 2C in the pIRES-SEAP backbone of putative clones was analysed by 
PCR (Fig. 4.6 C Lanes 3 and 4) using the primers in Table 4.4. The primers used were 
specific to FMDV 2C, any 2C PCR product should have a size of 954 bp. PCR screening 
of putative plRES-SEAP-2C clones produced a DNA fragment with a size of 
approximately 1000 bp which corresponds to the approximate anticipated size of the 
FMDV 2C sequence (Fig. 4.6 C Lane 4). The 2C ORF sequence was confirmed by 
sequence analysis when compared to the published sequence of FMDV OIK 2C 
(GenBank: X00871.1).
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Figure 4.5 Insertion of EYFP into pIRES-SEAP (A) EYFP DNA sequence was amplified 
from pEYFP-Nl (Clontech) using EYFP specific primers TGIPDF-025 and TGIPDF-026. 
Restriction sites at the 5' ends of the primers incorporated Xhol and Mlul onto the 5' 
and 3' ends of the amplified EYFP, respectively. A stop signal (TAA) was also 
introduced at the 3' end of the EYFP sequence. The EYFP ORF sequence is highlighted 
in green. p2BC-IRES-SEAP was digested with Xhol/Notl to remove the 2BC ORF from 
p2BC-IRES-SEAP and the pIRES-SEAP fragment was isolated on an agarose gel. The 
EYFP PCR product was digested with Xhol and Mlul and gel purified. EYFP was ligated 
into the Xhol /Mlul site of the linearised pIRES-SEAP to produce pEYFP-IRES-SEAP (B). 
(C) Restriction digest analysis of pEYFP-IRES-SEAP clone with Xhol and Mlul. Lanes 1: a 
clone lacking EYFP, Lane 2: a clone containing a putative EYFP fragment.
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Figure 4.6 Insertion of FMDV 2B or 2C into pIRES-SEAP (A) FMDV 2B and 2C DNA
sequences were amplified from pT7S3 using specific primers TGIPDF-039 and TGIPDF- 
059, and TGIPDF-052 and TGIPDF-002 respectively. Restriction sites at the 5' ends of 
the primers incorporated Nhe\ and Mlu\ onto the S' and 3' ends of the amplified 2B 
and 2C, respectively. A start codon (ATG) and kozak sequence was introduced at the S' 
end of the 2B and 2C sequences and a stop signal (TAA) was also introduced at the 3' 
end of the 2B and 2C sequences. The 2B or 2C ORF sequences are highlighted in blue. 
The 2B or 2C PCR products and the pIRES-SEAP vector were digested with Nhe\ and 
Mlu\ and gel purified. The 2B or 2C ORF was ligated into MCS A of the linearised pIRES- 
SEAP vector to produce p2B-IRES-SEAP and p2C-IRES-SEAP (B). (C) Restriction digest 
analysis of p2B-IRES-SEAP and PCR analyses of putative clones of p2C-IRES-SEAP. 
Putative p2B-IRES-SEAP clones were digested with Nhe\ and Mlu\, Lane 1, a clone with 
the incorrect restriction profile of 2B, Lane 2, a clone containing a putative 2B 
fragment The p2C-IRES-SEAP clones were screened by GoTaq™ PCR using the primers 
TGIPDF-054 and TGIPDF-002, Lane 3 a clone which screened negative for the 2C insert. 
Lane 4 a clone detecting a positive clone containing a putative 2C fragment.
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4.2.5 Cloning of 2B into pIRES-SEAP
The 2B ORF from the FMDV OIK strain was amplified by PCR with KOD polymerase 
from p2BC-IRES-SEAP using the primers from Table 4.5, incorporating start codon and 
a Kozak sequence at the 5' end, a stop codon at the 3' end of the ORF and the 
restriction sites Nhe\ at the 5' and 3' ends Mlu\ respectively.
Table 4.5 Primers for the amplification of FMDV OIK 2B sequence
Primer Tm (°C) Sequence Role/ Restriction 
Sites
TGIPDF-039 70.3 AAAGCTAGCATGCCCTTCTTTTTCTCC 2BC 5' Nhe\
TGIPDF-059 70.22 AAACGCGTTCACTGTTTCTCTGCTC 2B 3' Mlu\
The reaction conditions are described in Materials & Methods 2.2.4.2. The 2B PCR 
product and pIRES-SEAP were digested with Nhe\ and Mlu\. The digested 2B PCR 
product was then ligated into pIRES-SEAP with T4 DNA ligase (Fig. 4.6 B). The cloning 
strategy and analysis were as described in 4.2.2 (Fig. 4.6).
Putative clones containing the 2B ORF were screened by Nhe\/Mlu\ restriction digest 
and were expected to produce fragments with sizes of 462 bp and 7716 bp 
corresponding to the size of the FMDV 2B ORF and pIRES-SEAP, respectively. The 
Nhe\/Mlu\ restriction digest of putative p2B-IRES-SEAP (Fig. 4.6 C Lane 2) produced 
fragments with sizes of approximately 8000 bp and 470 bp which correspond to the 
anticipated sizes of pIRES-SEAP and the 2B ORF respectively. This indicated that a 
fragment, the size of 2B, was inserted into the pIRES-SEAP construct. The 2B sequence
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of p2B-IRES-SEAP was examined by sequence analysis and was identical to the 
published sequence of FMDV OIK (GenBank: X00871.1).
4.3 Analysis of protein expression in bicistronic plasmids by TnT® radio labelling
To ensure that both cap-dependent and 1RES dependent ORFs were expressed from 
bicistronic plasmids p2BC/2B/2C/EYFP-IRES-SEAP, they were expressed in the cell-free 
protein expression system TnT®Coupled Reticulocyte Lysate Systems (Promega) and 
radio labelled with the radioisotope ^^ S methionine. The TnT® T7 Quick coupled 
reaction is a cell-free system that contains all the necessary components for 
transcription and translation of a T7 driven ORF.
The expressed radio labelled protein products from the TnT® reactions were resolved 
on a 10% tricine gel and protein bands were visualised by exposure to and 
development of X-ray film. The predicted size of the FMDV 2BC, EYFP and SEAP 
proteins are approximately 52 KDa 28 KDa and 57 KDa, respectively.
The expression of p2BC-IRES-SEAP in TnT® lysates produced proteins of 52 and 57 kDa 
(Fig. 4.7 Lane 1). These proteins corresponded to the expected sizes of FMDV 2BC 
protein and SEAP, respectively, pEYFP-IRES-SEAP expressed proteins of 28 and 57 kDa 
respectively (Fig. 4.7 Lane 2). The size of these proteins corresponded to the 
anticipated sizes of EYFP and SEAP respectively. The expression of pcDNA3.1/Zeo-2BC
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Figure 4.7 Expression of radio labelled proteins from bicistronic plasmids in a cell 
free TnT®Coupled Reticulocyte Lysate System. Plasmids were incubated for 2 h at
37°C in the TnT®Coupled Reticulocyte Lysate System (Promega) and radio labelled with 
the radioisotope ^^ S methionine. The expressed protein products from the TnT® 
reactions were analysed on X-ray film exposed overnight to the radio-labelled proteins 
resolved on a 10% tricine gel. IVI) C14 Marker; 1) p2BC-IRES-SEAP; 2) pEYFP-IRES-SEAP; 
3) pcDNA3.1-2BC; 4) pcDNA3.1-EYFP; 5) pIRES-SEAP; 6) TNT reaction mixture without 
plasmid DNA; 7) dHzO without any TNT reaction mixture or plasmid DNA.
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(Fig. 4.7 Lane 3) produced a protein with a size of approximately 52 KDa corresponding 
to the expected size of FMDV 2BC. pcDNA3.1/Zeo-EYFP expressed protein (Fig. 4.7 
Lane 4) with a size of 28 kDa corresponding to the anticipated size of EYFP. The 
protein products from pIRES-SEAP produced a band with a size of approximately 57 
kDa (Fig. 4.7 Lane 5) this size corresponded to the anticipated size of SEAP. Expression 
of pIRES-SEAP also produced a larger protein of approximately 66 KDa (Fig. 4.7 Lane 5). 
This larger protein (Fig. 4.7 Lane 5) could be created from translation initiation 
occurring at the start codon, upstream of the 1RES and terminating at the SEAP stop 
codon. If translation read through the 1RES and the SEAP and terminated at the SEAP 
stop codon a protein of 66 kDa would be produced.
4.3.1 Analysis of bicistronic plasmids by Western blot
The expression of the proteins in cells transfected with p2BC-IRES-SEAP and pEYFP- 
IRES-SEAP was examined by Western blot to determine if specific antibodies could 
recognise the expressed proteins. Cells expressing p2BC-IRES-SEAP or pEYFP-IRES- 
SEAP for 24 h were analysed by Western blot. Cell lysates were made using sample 
preparation buffer with protease inhibitor cocktail and were resolved on a 10% tricine 
gel. FMDV 2BC, EYFP and SEAP were detected using anti-FMDV 2C, anti-EYFP or anti- 
alkaline phosphatase respectively. EYFP, 2BC and SEAP proteins were analysed by 
Western blot and visualised by development and exposure to X-ray film. Blots positive 
for SEAP should produce a protein with a size of approximately 57 KDa, FMDV 2BC, 52 
KDa and EYFP, 28 KDa.
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Figure 4.8 Location of ATG sites responsible for the translation of SEAP by cell free 
rabbit reticulate lysates.
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Cells transfected with p2BC-IRES-SEAP or pEYFP-IRES-SEAP produced a protein product 
which was recognised by the anti-2C FMDV antibody or anti-EYFP respectively and 
corresponded to the size expected for FMDV 2BC or EYFP respectively (Fig. 4.9 A and
B). However, the anti-alkaline phosphatase antibody recognised a protein which 
corresponded to the size expected for SEAP but this detected in untransfected cells as 
well as transfected cells (Fig. 4.9 C).
4.4 SEAP expression In cells transfected with bicistronic plasmids
To determine the active range of the Great EscAPe™ assay and the linear range of 
SEAP detection, a dilution series of the recombinant SEAP was setup in DMEM or 
Reporter Lysis Buffer (Promega). The samples ranged from 0.0005-1 pg SEAP (Fig. 
4.10) producing S-shaped curves. The DMEM media and SEAP had a shallower curve 
than the Reporter Lysis Buffer and SEAP. As a result there was a wider linear range of 
luminescence with DMEM and SEAP than that of Reporter Lysis Buffer and SEAP. The 
active range for linear detection of SEAP in DMEM was a range of 0.078-0.5 pg of 
SEAP. The active range for the linear detection of SEAP in lysis buffer was a range of 
0.00391-0.25 pg of SEAP.
To investigate the levels of SEAP expression, the bicistronic plasmids were transfected 
into mammalian cells with Lipofectamine 2000 and incubated for 24 h. The 
supernatants were collected and cell lysates made using Reporter Lysis Buffer. Levels 
of SEAP were measured using the Great EscAPe™ chemiluminescence detection kit.
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Figure 4.9 Western Blot analysis of proteins expressed in IBRS2 cells from bicistronic 
plasmids. Cells were transfected with either p2BC-IRES-SEAP or pEYFP-IRES-SEAP 
overnight. Cell lysates were made with sample preparation buffer and protease 
inhibitor cocktail. Proteins were resolved on a 10% tricine gel and probed with either 
anti-FMDV 2C, anti-EYFP or anti-Alkaline Phospatase. A) pEYFP-IRES-SEAP, B) p2BC- 
IRES-SEAP, C) Mock transfected cells.
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Figure 4.10 Secreted Alkaline phosphatase (SEAP) calibration curves Recombinant 
SEAP was serially diluted in either cell culture media (A) or in Reporter lysis buffer 
(Promega) (B). SEAP was measured in the supernatants with a Biotek Synergy 2 
luminometer using the chemoluminescence SEAP reporter assay and expressed as 
relative light units (RLU).
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Dilutions of samples were made to ensure that the levels of SEAP were within the 
linear range of the assay. Readings from diluted samples were adjusted by multiplying 
the values of the assay by their dilution factor. An example of the calibration curves 
that were used to calculate the quantity of SEAP from luminescence readings are 
shown in Fig. 4.11.
4.4.1 Comparison of intra and extracellular levels of SEAP expression
To investigate the extent to which the FMDV proteins 2BC, 2C and 2B could block 
SEAP secretion, p2BC-IRES-SEAP, p2B-IRES-SEAP, p2C-IRES-SEAP pEYFP-IRES-SEAP or 
pCMV-3A-UTR-SEAP (Cornell et al., 2006) were expressed in Vero cells for 24 h. The 
supernatants and the cell lysates of the transfected cells were then analysed for SEAP 
activity using the Great EscAPe™ assay (Fig. 4.12).
Cells transfected with pEYFP-IRES-SEAP expressed the highest levels of SEAP with the 
majority of the SEAP secreted from the cells. The cells transfected with the bicistronic 
plasmid encoding coxsackievirus 3A protein and SEAP, pCMV-3A-UTR-SEAP, had good 
levels of SEAP expression with approximately 48% of the SEAP retained within the cell. 
The retention of SEAP in cells transfected with pCMV-3A-UTR-SEAP demonstrates that 
SEAP protein secretion can be inhibited and can be detected in cell lysates co­
expressing a viral protein with SEAP. Unexpectedly, cells transfected with p2BC-IRES- 
SEAP, p2B-IRES-SEAP, p2C-IRES-SEAP had very low levels of total SEAP expression that 
were similar to mock transfected cells and fell below the detection limit of the assay.
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Figure 4.11 Secreted alkaline phosphatise calibration curves. To translate the 
luminescence produced from the Great EscAPe™ assay (Clontech) into quantifiable 
levels of SEAP, calibration curves were produced with recombinant SEAP in either cell 
culture media (A) or Reporter lysis buffer (Promega) (B) over the linear range of 
luminescence.
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Figure 4.12 SEAP expression in IBRS cells. IBRS2 cells were transfected with 
bicistronic plasmids and incubated overnight, in triplicate. SEAP was measured in the 
culture supernatants and cell lysates using the chemiluminescence SEAP reporter 
assay. The yield was expressed as pg of total SEAP culture using the positive control 
from the assay kit as a reference enzyme. The values on the graph are mean values of 
SEAP expression. Error bars +/- SD from mean.
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Linear ANOVA analysis with the Tu key method was performed using Minitab 16 to 
determine if there was a significant difference between the expression levels of SEAP 
in cells transfected with the bicistronic plasmids. There was no significant difference 
in the levels of SEAP detected in the cell supernatants between pEYFP-IRES-SEAP or 
pCMV-3A-UTR-SEAP. Also there was no significant difference in the levels of SEAP 
detected in cell supernatants between cells expressing p2BC-IRES-SEAP, p2B-IRES- 
SEAP, p2C-IRES-SEAP or mock transfected cells, pEYFP-IRES-SEAP and p3A-UTR-SEAP 
did however, express significantly more SEAP in their cell supernatants than p2BC- 
IRES-SEAP, p2BC-IRES-SEAP, p2C-IRES-SEAP or mock transfected cells p =<0.0001.
There was no significant difference in the levels of SEAP detected from cell lysates 
from cells transfected with pEYFP-IRES-SEAP, p2BC-IRES-SEAP, p2B-IRES-SEAP, p2C- 
IRES-SEAP or mock transfected cells. There was a significant amount of SEAP retained 
within the cell lysates of cells transfected with p3A-UTR-SEAP, when compared to 
mock transfected cells or cells expressing plasmids encoding the non-structural FMDV 
proteins p =<0.0001.
4.4.2 Analysis of SEAP expression by immuno-fluorescence microscopy
Cells transfected with bicistronic plasmids containing 2BC/2B or 2C did not express 
active SEAP (Fig. 4.12) after 24 h incubation. To examine if the transfected cells were 
expressing SEAP, cells were fixed, permeabilised and labelled with an antibody 
recognising SEAP. Cells, grown on coverslips, were transfected with p2BC-IRES-SEAP
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and p EYFP-IRES-SEAP and incubated for 24 h. Cells were fixed and labelled with an 
anti-2C antibody 3F7, an anti-alkaline phosphatase antibody (Sigma) and DAPI to stain 
the cell nuclei and were examined by immunofluorescence microscopy.
The cells transfected with pEYFP-IRES-SEAP co-expressed EYFP and SEAP (Fig. 4.13, A-
C) with high levels of SEAP and EYFP expression in cells across the coverslip. Cells 
transfected with p2BC-IRES-SEAP expressed 2BC, however, expression of SEAP in the 
same cells was not detected (Fig. 4.13 D-F). Despite the same transfection conditions 
used for both constructs, a lower percentage of cells expressed 2BC protein in cells 
transfected with p2BC-IRES-SEAP when compared with the proportion of cells 
expressing EYFP, in cells transfected with pEYFP-IRES-SEAP. It was also noted that 
there were less cells on the coverslips transfected with p2BC-IRES-SEAP than those 
transfected with pEYFP-IRES-SEAP (Data not shown). This could be due to a potential 
toxic effect exhibited on the cells by 2BC.
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Figure 4.13. SEAP can be deteced by immunoflunrescent microscopy in cells transfected with 
pEYFP-IRES-SEAP but not In cells transfected with p2BC 1RES SEAP. IBRS2 cells were transfected with  
pEYFP-IRES-SEAP (A-C) or p2BC 1RES SEAP (D-F) for 24 h. Cells were fixed, permiabilised and stained. EYFP 
was visualised through the natural fluorescence of EYFP (A). SEAP was detected using mouse anti alkaline 
phosphatase (Red) {B and EJ. FMDV 2BC was detected using rabbit anli-2C DM12 (Green) (DJ. Primary 
antibodies were detected using goat anti mouse conjugated to Aiexa-568 and goat anti rabbit conjugated 
to Alexa-488. The cells were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F and 
are digital merges of all channels that comprise of panels A & B and D & E respectively. Scale Bar 10 pm.
145
SEAP expression in 2BC-IRES-SEAP transfected ceiis was not detected by immuno­
fluorescence microscopy and this correlated with the low levels of SEAP activity 
detected by the Great EscAPe™ chemiluminescence detection kit. pEYFP-IRES-SEAP 
and p2BC-IRES-SEAP were created from the same pIRES-SEAP backbone and therefore 
it is unlikely that the lack of SEAP expression was due to a problem with 1RES or SEAP 
ORF functionality. TnT® reactions also demonstrated that SEAP was being expressed 
at the correct size from the 2BC-IRES-SEAP construct (Fig. 4.7). One possibility for the 
lack of SEAP expression in cells co-expressing FMDV 2BC protein(s) or its constituents 
may be due to the position of the viral proteins in the construct. Cap-dependent 
expression of the viral proteins may be inhibiting the 1RES translation of SEAP.
4.5 Cap-dependent expression of SEAP
p2BC-IRES-SEAP did not produce levels of detectable SEAP (section 4.4.1) when 
compared to pEYFP-IRES-SEAP. This lack of SEAP expression in the 2BC expressing 
plasmid could be caused by high expression levels of the viral protein and its potential 
inhibitory effects. To counteract the possible effects from over expression of the viral 
protein, the position of the 2BC and SEAP ORFs in the pIRES plasmid were switched to 
produce pSEAP-IRES-2BC. 1RES dependent translation has a lower efficiency than cap- 
dependent translation in a bicistronic vector (Hennecke et ai., 2001; Mizuguchi et ai., 
2000) and, as a consequence, SEAP expression levels should be higher than that of the 
viral protein and any inhibitory viral protein effects should be reduced. 2BC 
expression would be under the control of the 1RES and so its expression would be
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reduced. This would result in a two-foid effect by increasing the expression of SEAP 
and reducing the expression of 2BC.
4.5.1 Construction of pSEAP-IRES
The SEAP ORF was excised from pSEAP2-Control by restriction digest. pSEAP2-Control 
was digested with Bsm\, the open circular plasmid was then "blunt ended" with T4 
DNA polymerase prior to being cut with EcoR\ to excise the SEAP ORF. pIRES was 
digested with Mlu\ for 2 h. The open circular plasmid was "blunt ended" with T4 DNA 
polymerase and cut with EcoRI (Fig. 4.14 A-B). The excised SEAP ORF was then 
directionally ligated to the linearised piRES to produce pSEAP-IRES (Fig. 4.14 C and D). 
Putative clones containing the SEAP ORF were screened by EcoR/Bsm\ restriction 
digest and were expected to produce fragments with sizes of 1560 bp and 6100 bp 
corresponding to the size of the SEAP ORF and the pIRES, respectively.
The EcoR/Bsm\ restriction digest of putative pSEAP-IRES (Fig. 4.14 E Lane 2) produced 
DNA fragment with sizes of approximately 6000 bp and 1500 bp which corresponded 
to the approximate sizes of piRES and the SEAP ORF respectively indicating that a 
fragment the size of the SEAP ORF was inserted into the pSEAP-IRES construct (Fig. 
4.14 E, Lane 2). The construct was tested for SEAP expression in cells and found to 
successfully express SEAP.
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Figure 4.14 Ligation of SEAP ORF into pIRES by restriction digest. A) SEAP ORF was 
isolated from pSEAP2-Control by Bsm\ restriction digest, treated with T4 DNA 
polymerase to produce blunt ends (highlighted in red), then digested with EcoRI (B). 
pIRES was linearised with Mlu\ and treated with T4 DNA polymerase to produce blunt 
ends, then digested with EcoRI (C). The linearised pIRES and the SEAP ORF were 
isolated on an agarose gel. The SEAP ORF was ligated into the linear pIRES vector in 
MCS A, to produce pSEAP-IRES (D). E) EcoRI and Bsm\ restriction digest analysis of 
pSEAP-IRES. Lane 1, a cione lacking SEAP. Lane 2, a clone containing a putative SEAP 
fragment.
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4.5.2 Cloning of 2BC into pSEAP-IRES
The 2BC ORF was amplified by PCR with KOD polymerase from p2BC-IRES-SEAP using 
the primers from Tabie 4.6 incorporating a start codon, a Kozak sequence and the So/i 
restriction site at the 5' end and a stop codon and the A/otl restriction site at the 3' 
end.
Table 4.6 Primers for the amplification of FMDV OIK 2BC sequence
Primer Tm (°C) Sequence Role/ Restriction 
Sites
TGIPDF-055 74.99 AAAGTCGACATGCCCTTCTTTTTCTCCGA 2BC 5' So/I
TGiPDF-056 75.84 AAGCGGCCGCTCACTGCTTGAAG 2BC 3' A/otl
The reaction conditions are described in Materials and Methods Z.2.4.2. The PCR 
product was then directionally inserted into the multiple cloning site B (MCS B) of the 
pSEAP-IRES construct at Sal\/Not\ (Fig. 4.15). The PCR product and pSEAP-iRES were 
digested with So/I and A/otl purified and ligated together with T4 DNA ligase. The 
presence of 2BC in the pSEAP-iRES backbone was analysed by PCR (Fig. 4.15) using the 
primers in Tabie 4.6. The primers used were specific to FMDV 2BC, any 2BC PCR 
product should have a size of 1416 bp. PCR screening of putative pSEAP-IRES-2BC 
clones produced a PCR product of approximately 1400 bp which corresponds to the 
size of the FMDV 2BC sequence (Fig. 4.15 C). The 2BC ORF was sequenced and was 
identical to the published sequence (GenBank: X00871.1).
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Figure 4.15 Insertion of 2BC into pSEAP-IRES vector (A) 2BC DNA sequence was 
amplified from p2BC-IRES-SEAP using 2BC specific primers TGIPDF-055 and TGIPDF- 
056. Restriction sites at the 5' ends of the primers incorporated So/I and Not\ onto the 
5' and 3' ends of the amplified 2BC, respectively. A stop signal (TAA) was also 
introduced at the 3' end of the 2BC sequence. The 2BC ORF sequences are highlighted 
in purple. pSEAP-IRES was digested with Sall/Notl and isolated on an agarose gel. 
pSEAP-IRES was linearised by Sall-Notl restriction digest and isolated on an agarose 
gel. (B) 2BC was ligated into MCS B of pSEAP-IRES to produce pSEAP-IRES-2BC. (C) 
PCR analysis of putative pSEAP-IRES-2BC clones using primers TGIPDF-055 and TGIPDF- 
056. Lane 1, clone testing negative for 2BC. Lane 2, a clone testing positive for 2BC.
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4.5.3 Cloning of EYFP into pSEAP-IRES
EYFP was removed from a pIRES-EYFP construct (provided by C. Netherton, lAH 
Pirbrlght, UK) by restriction digest with Sail and Notl. pSEAP-IRES was also digested 
with Sail and Notl (Fig. 4.16). The EYFP was then directionally inserted into the 
multiple cloning site B (MCS B) of the pSEAP-IRES construct at Sall/Notl (Fig. 4.16).
Putative clones containing the EYFP ORF were screened by Sall/Notl restriction digest 
and were predicted to produce fragments with sizes of 750 bp and 7716 bp 
corresponding to the size of the EYFP ORF and pSEAP-IRES, respectively. The Sall/Notl 
restriction digest of putative pSEAP-IRES-EYFP (Fig. 4.16 C Lane 2) produced DNA 
frgments with sizes of approximately 8000 bp and 700 bp which correspond 
approximately to the anticipated sizes of pSEAP-IRES and the EYFP ORF, respectively. 
This indicated that a DNA fragment, the size of the EYFP ORF, was inserted into the 
pSEAP-IRES construct. The EYFP ORF sequence was confirmed by sequence analysis.
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Figure 4.16 Insertion of EYFP ORF into pIRES-SEAP by restriction digest. A) EYFP ORF 
was isolated from pIRES-EYFP by So/I and A/otl restriction digest and isolated from an 
agarose gel. pSEAP-IRES was linearised with So/I and /Votl and purified on an agarose 
gel. EYFP ORF was ligated into linearised pSEAP-IRES, MCS B to produce pSEAP-IRES- 
EYFP (B). C) So/I and Not/ restriction digest analysis of pSEAP-IRES-EYFP with So/I and 
Notl. Lane 1, a clone lacking EYFP, Lane 2, a clone containing a putative EYFP 
fragment.
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4.5.4 Cloning of 2B and 2C into pSEAP-IRES
2B and 2C ORFs were amplified by PCR with KOD polymerase from p2BC-IRES-SEAP 
using the primers shown in Table 4.7 incorporating a start codon, a Kozak sequence 
and a So/I restriction site at the 5' end and a stop codon and the Not\ restriction site at 
the 3' end.
Table 4.7 Primers for t ie amplification of FMDV OIK 2B/2C sequences
Primer Tm (°C) Sequence Role/ Restriction 
Sites
TGI PDF-060 76.80 TTTTGTCGACATGCCCTTCTTTTTCTCCGA 2B 5' So/I
TGIPDF-061 79.00 TTGCGGCCGCTCACTGTTTCTCTGCT 2B 3' Notl
TGIPDF-057 75.89 AAAGTCGACATGCTCAAAGCACGTGACATC 2C 5' So/I
TGIPDF-058 76.24 AAAGCGGCCGCTCACTGCTTGAAG 2C 3' Notl
The reaction conditions are described in Materials and Methods 2.2.4.2. The PCR 
products were directionally inserted into the multiple cloning site B (MCS B) of the 
pSEAP-IRES construct at Sall/Notl (Fig. 4.17). The PCR products and pSEAP-IRES were 
digested with So/I and Notl and ligated with T4 DNA ligase.
The presence of 2B in the pSEAP-IRES backbone of putative clones was analysed by 
PCR using the primers in Table 4.7. The primers used were specific to FMDV 2B, any 
2B PCR product should have a size of 462 bp. PCR screening of putative pSEAP-IRES-2B 
clones did not produce any PCR product. Restriction digest analysis of putative pSEAP- 
IRES-2B with So/I and Notl should produce a DNA fragment of 462 bp which is the 
expected size of FMDV 2B and a fragment of 7716 bp which is the expected size of
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Figure 4.17 Insertion of 20 into pSEAP-IRES (A) FMDV 2C DNA sequence was amplified 
by PCR from pT7S3 using specific primers TGIPDF-057 and TGIPDF-058. Restriction 
sites at the 5' ends of the primers incorporated Nhe\ and Mlu\ onto the 5' and 3' ends 
of the amplified 2C. A start codon (ATG) and kozak sequence was introduced at the 5' 
end of the 2C sequence and a stop signal (TAA) was also introduced at the 3' end of 
the 2C sequence. The 2C ORF sequence was highlighted in blue. (B) 2C PCR product 
was digested with Nhe\ and Mlu\ and purified on an agarose gel. 2C ORF was ligated 
into MCS B of pSEAP-IRES at Sa I//Not I restriction sites, (C) PCR analyses of putative 
clones of p2C-IRES-SEAP. The clones were screened by GoTaq™ PCR using the primers 
TGIPDF-057 and TGIPDF-058, Lane 1 a clone with screened negative for the 2C insert. 
Lane 2 a clone detecting the positive clone containing a putative 2C fragment.
154
pSEAP-IRES. 2B was not be detected by PCR or restriction digest and was not 
successfully inserted into pSEAP-IRES (data not shown).
The presence of 2C in the pSEAP-IRES backbone was analysed by PCR (Fig. 4,17) using 
the 2C primers in Table 4.7. The primers used were specific to FMDV 2C, any 2C PCR 
product should have a size of 954 bp. PCR screening of putative pSEAP-IRES-2C clones 
produced a PCR product of approximately 1000 bp which corresponds to the size of 
the FMDV 2C sequence (Fig. 4.17 C). The 2C ORF sequence was confirmed by 
sequence analysis as identical to the published sequence (GenBank: X00871.1),
4.6 Analysis of protein expression in bicistronic plasmids by TnT® radio labelling
To ensure that both cap-dependent and 1RES dependent ORFs were expressed from 
the bicistronic plasmids, pSEAP-IRES-2BC/EYFP, they were expressed in the cell-free 
protein expression system TnT®Coupled Reticulocyte Lysate Systems and radio 
labelled with the radioisotope ^^ S methionine.
The expressed radio labelled protein products from the TnT® reactions were resolved 
on a 10% tricine gel and protein bands were visualised by exposure to and 
development X-ray film. The predicted size of the FMDV 2BC, EYFP and SEAP proteins 
are approximately 52 KDa, 28 KDa and 57 KDa respectively.
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pSEAP-IRES-2BC, produced protein with sizes corresponding to that of SEAP and 2BC of 
approximately 57 and 52 KDa respectively (Fig. 4.18 Lane 1). pSEAP-IRES-EYFP (Fig. 
4.18, Lane 2) expressed bands with a size of approximately 57 and 28 KDa 
corresponding to the sizes of SEAP and EYFP respectively. The expression of 
pcDNA3.1-2BC (Fig. 4.18 Lane 3) produced a band with a size of approximately 52 KDa 
corresponding to the size of FMDV 2BC. pcDNA3.1/Zeo-EYFP expressed protein 
producing a band (Fig. 4.18 Lane 4) with a size of 28 kDa corresponding to the 
anticipated size of EYFP. The protein products from pSEAP-IRES produced a band with 
a size of approximately 57 kDa (Fig. 4.18 Lane 5) this size corresponded to the 
anticipated size of SEAP. The band produced in lane 5 by pSEAP-IRES has a size of 57 
KDa, which is the expected size of SEAP. The SEAP produced from pSEAP-IRES is the 
same size as that produced by pSEAP-IRES-2BC and pSEAP-IRES-EYFP as it is upstream 
of the 1RES and has a stop codon before the 1RES and so the 1RES region is not 
translated.
4.7 Cap-dependent expression of SEAP in cells transfected with bicistronic plasmids
SEAP activity was measured in cells, transfected with plasmids pSEAP-IRES-2BC and 
pSEAP-IRES-EYFP and incubated for 72 h and the levels of SEAP expression was 
detected using the Great EscAPe™ chemiluminescence detection kit (Fig, 4.19). The 
cells were incubated for up to 72 h to allow the 1RES dependent protein of interest to 
accumulate to a level at which they would be able to exert an effect as the rates of 
translation from an 1RES are lower than that of the cap.
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Figure 4.18 Expression of radio labelled proteins from bicistronic plasmids in a cell 
free TnT®Coupled Reticulocyte Lysate System. Plasmids were incubated for 2 h at
37°C in the TnT®Coupled Reticulocyte Lysate System (Promega) and radio labelled with 
the radioisotope ^^ S. The expressed protein products from the TnT® reactions were 
analysed on X-ray film exposed overnight to the radio-labelled proteins resolved on a 
10% tricine gel. M) C14 Marker, 1) pSEAP-IRES-2BC, 2) pSEAP-IRES-EYFP, 3) pcDNA3.1- 
2BC, 4) pcDNA3.1-EYFP, 5) pSEAP-IRES, 6) TNT reaction without plasmid DNA. 7) dHaO 
without any TNT reaction mixture or plasmid DNA.
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Figure 4.19 Cap-dependent SEAP expression from bicistronic plasmids. IBRS2 cells 
were transfected with bicistronic plasmids overnight in triplicate. SEAP was measured 
in cell culture supernatants and cell lysates chemoluminescence SEAP reporter assay. 
The yield was expressed as pg of total SEAP culture using the positive control from the 
assay kit as a reference enzyme. The values on the graph are mean values of SEAP 
expression. Error bars +/- SD from mean.
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The highest levels of SEAP were detected in cells transfected with pSEAP-IRES-EYFP 
(Fig. 4.19). In all cases the level of SEAP expression reduced over time, with the most 
pronounced drop in SEAP expression from cells transfected with pSEAP-IRES-EYFP 
from 24 to 48 h. Despite this, the levels of SEAP expressed in cells transfected with 
pSEAP-IRES-EYFP remained higher than those transfected with either pSEAP-IRES-2C or 
pSEAP-IRES-2BC. Cell lysates were made from cells transfected with respective 
plasmids at each time point and assayed for levels of SEAP expression. The level of 
SEAP detected in cell lysates was not significantly different from mock transfected cells 
(data not shown).
After 72 h of expression, the coverslips were labelled to detect SEAP and either EYFP, 
2C or 2BC by immuno-fluorescence microscopy. SEAP could be detected by immuno­
fluorescence microscopy in IBRS2 cells and as the levels of SEAP expression were 
dependent upon the 1RES driven protein it could not be used to estimate transfection 
efficiency. The proteins EYFP, 2BC and 2C could not be detected by immuno­
fluorescence microscopy (data not shown).
To determine if there was a significant change in the levels of SEAP expression over 
time in cells transfected with pSEAP-IRES-EYFP, pSEAP-IRES-2BC and pSEAP-IRES-2C 
Linear ANOVA analysis was performed with the Tu key method using Minitab 16. Cells 
transfected with pSEAP-IRES-EYFP expressed the highest levels of SEAP at 24 h post 
transfection, with a significant reduction in the levels of SEAP expression at 48 h p=
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<0.001. There was no significant difference in the levels of SEAP expression at 48 and 
72 h or in the levels of SEAP expression between 24 and 48 h post transfection in cells 
transfected with pSEAP-IRES-2BC. Between 48 and 72 h there was no significant 
difference in the levels of SEAP expression. However, between 24 and 72 h post 
transfection there was a significant reduction in levels of SEAP expression p =<0.006. 
Cells expressing pSEAP-IRES-2C did not present a significant reduction in SEAP 
expression from 24, 48 or 72 h post transfection.
To determine if there was a significant effect induced by FMDV 2BC or FMDV 2C 
compared to EYFP Linear ANOVA analysis was performed using Minitab 16. In the first 
24 h post transfection, cells transfected with pSEAP-IRES-EYFP expressed significantly 
more SEAP than cells expressing pSEAP-IRES-2BC or pSEAP-IRES-2C p = <0.002. There 
was not a significant difference between the levels of SEAP expression between cells 
transfected with either pSEAP-IRES-2BC or pSEAP-IRES-2C after 24 h.
48 h post transfection, cells transfected with pSEAP-IRES-EYFP expressed significantly 
more SEAP than cells transfected with pSEAP-IRES-2BC p =<0.026 but not significantly 
more SEAP than cells transfected with pSEAP-IRES-2C. There was no significant 
difference in the levels of SEAP expression between cells expressing pSEAP-IRES-2BC 
or pSEAP-IRES-2C.
72 h post expression, cells transfected with pSEAP-IRES-EYFP expressed significantly 
more SEAP than cells transfected with either pSEAP-IRES-2BC or pSEAP-IRES-2C p =
160
<0.002. There was no significant difference in the levels of SEAP expression in cells 
transfected with either pSEAP-IRES-2BC or pSEAP-IRES-2C.
4.8 Transcription of SEAP
Cap dependent and 1RES dependent SEAP expression presented a reduced level of 
SEAP expression in cells transfected with constructs containing 2BC. The presence of 
SEAP mRNA transcripts was examined by RT-PCR to determine if this inhibition of SEAP 
expression was occurring at a transcriptional level.
mRNA was extracted from cells transfected with either pEYFP-IRES-SEAP or p2BC-IRES- 
SEAP for 24 h. The mRNA was converted to cDNA with Superscipt® III reverse 
transcriptase. Control RT-PCRs were also performed without Superscipt® III to ensure 
that residual pDNA was not amplified during the subsequent PCR. EYFP, 2BC and SEAP 
were amplified using gene specific primers as described in table 4.8. The reaction 
conditions are described in Materials and Methods 2.2.4.2.
Table 4.8 Primers for the amplification of 2BC, EYFP and SEAP sequences from RT- 
PCR
Primer Tm (°C) Sequence Role/ Restriction 
Sites
TGIPDF-025 69.4 AAACTCGAGACCATGGTGAGCAAG EYFP 5'
TGIPDF-026 71.5 AAAACGCGTTTACTTGTACAGCTCCGTC EYFP 3'
TGIPDF-039 70.3 AAAGCTAGCATGCCCTTCTTTTTCTCC 2BC 5'
RT2BC-002 71.0 GGCAATGTGGACGTTCCCG 2BC 3'
TGIPDF-011 65.8 GACCATTGGCTTGAGTGCAG SEAP 5'
TGIPDF-016 67.1 CATGATCGTCTCAGTCAGTGCC SEAP 3'
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RT-PCR of mRNA extracted from cells transfected with pEYFP-IRES-SEAP, using EYFP 
specific primers TGIPDF-025 and TGIPDF-026, were expected to produce a DNA 
fragment with a size of 750 bp corresponding to the size of EYFP. RT-PCR of mRNA 
extracted from cells transfected with p2BC-IRES-SEAP were expected to produce a 
DNA fragment with a size of 700 bp using 2BC specific primers, TGIPDF-039 which sat 
at position 1-15 and RT2BC-002 which sat at position 721-702 of the 2BC ORF. RT-PCR 
of mRNA extracted from cells transfected with a plasmid containing the SEAP ORF 
using SEAP specific primers, TGIPDF-011 which sits at position 387-407 bp and TGIPDF- 
016 which sits at position 1063-1041 on the SEAP ORF, were expected to produce a 
DNA fragment with a size of 705 bp corresponding to the size of the SEAP ORF. Mock 
transfected cells were not expected to produce any bands for EYFP, 2BC or SEAP.
RT-PCR of cells transfected with pEYFP-IRES-SEAP produced DNA fragments of approx 
750 bp and 700 bp (Fig. 4.20 A) which corresponded to the expected sizes of EYFP and 
SEAP, respectively. RT-PCR of cells transfected with p2BC-IRES-SEAP produced DNA 
fragments of approx 700 bp and 700 bp (Fig. 4.20 B) which corresponded to the 
expected sizes of 2BC and SEAP, respectively. Whilst SEAP protein expression was only 
detected in cells
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Figure 4.20 FMDV 2BC protein does not prevent transcription of SEAP. The mRNA 
from cells transfected with pEYFP-IRES-SEAP (A) or p2BC-IRES-SEAP (B) was extracted 
and converted to cDNA with the reverse transcriptase Superscript® III. The cDNA was 
amplified using primers specific to either EYFP, 2BC or SEAP and resolved on a 1% 
agarose gel. (A) Lane 1, cDNA amplified with EYFP specific primers TGIPDF-025 and 
TGIPDF-026. Lane 2, amplified products of an RT-PCR (-reverse transcriptase) with 
primers TGIPDF-025 and TGIPDF-026. Lane 3, cDNA amplified with SEAP specific 
primers TGIPDF-011 and TGIPDF-016. Lane 4, Amplified products of an RT-PCR (minus 
reverse transcriptase) with primers TGIPDF-011 and TGIPDF-016. (B) Lane 1, 2BC 
amplified with primers TGIPDF-039 and RT2BC-002. Lane 2, 2BC amplified from the 
products of an RT-PCR with primers TGIPDF-039 and RT2BC-002 negative of 
Superscript® III. Lane 3, SEAP amplified with primers TGIPDF-011 and TGIPDF-016. 
Lane 4, SEAP amplified from the products of an RT-PCR with primers TGIPDF-011 and 
TGIPDF-016 negative of Superscript® III.
163
transfected with pEYFP-IRES-SEAP, SEAP, mRNA transcripts were detected in cells 
expressing pEYFP-IRES-SEAP and in cells transfected with p2BC-IRES-SEAP.
4.9 Discussion
Difficulties were encountered when constructing the pIRES-SEAP. It was not possible 
to amplify SEAP successfully by PCR and insert it into the pIRES backbone. This may be 
due to GC rich regions of the SEAP ORF and possible secondary structure. As a 
consequence, the SEAP ORF was removed from pSEAP2-control by restriction digest 
and inserted into the pIRES successfully. The final cloning strategy of ligating SEAP into 
pIRES from a digested plasmid was more time consuming than that of a ligation of a 
PCR product but had the advantage of a reduced possibility of mutations that could 
have been introduced by PCR. It was not possible to sequence the SEAP ORF in its 
entirety, possibly due to potential secondary structure; however, subsequent 
experiments measuring SEAP activity indicated that SEAP was expressed successfully 
as a reporter protein (Figs. 4.7, 4.12, 4.13, 4.18 and 4.19).
The pIRES-SEAP backbone was used to produce pEYFP-IRES-SEAP, p2BC-IRES-SEAP, 
p2B-IRES-SEAP and p2C-IRES-SEAP. When these constructs were expressed within a 
cell free system each one produced a protein with a size corresponding to SEAP and 
either FMDV 2BC, 2B, 2C or the control protein EYFP (Fig 4.7). This indicated that in a 
cell free system these proteins were being expressed as expected. When the 
bicistronic plasmids were expressed in mammalian cells and analysed by Western blot
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(Fig. 4.9) EYFP and FMDV 2BC were detected but only in those cells expressing YFP and 
2BC, respectively. SEAP was detected in cell lysates produced from cells transfected 
with p2BC-IRES-SEAP and pEYFP-IRES-SEAP but also unexpectedly from mock 
transfected cell lysates. Endogenous alkaline phosphatise is also expressed in all cells 
and it is likely that the majority of SEAP detected by Western blot is the endogenous 
protein. This experiment is not a reliable method for detecting the expression of the 
SEAP in transfected cells.
The chemoluminescent detection of SEAP (Fig. 4.12) showed that only cells expressing 
pEYFP-IRES-SEAP or pCMV-3A-UTR-SEAP expressed SEAP in the cell supernatants to 
significantly higher levels than in mock transfected cells. From the recovered cell 
lysates only cells transfected with pCMV-3A-UTR-SEAP expressed levels of SEAP 
significantly higher than mock transfected cells.
Significant levels of SEAP were secreted from cells transfected with pEYFP-IRES-SEAP 
and little was detected within the cell lysates. This confirms that EYFP expression in 
cells has no effect on the secretory pathway. pCMV-3A-UTR-SEAP expressed 
significantly more SEAP in both the cell supernatant and cell lysate than mock 
transfected cells. Coxsackievirus 3A protein is known to block protein secretion 
(Wessels et al., 2005) and result in the accumulation of proteins within the cell, 
specifically SEAP (Cornell et al., 2006). This retention of SEAP by Coxsackievirus 3A 
protein was demonstrated here (Fig. 4.12) with 48% of SEAP retained within the cell
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lysates. This demonstrated that using this system, SEAP could be retained by a viral 
protein and detected within cell lysates. The lack of any significant expression of SEAP 
from cells transfected with p2BC-IRES-SEAP, p2B-IRES-SEAP or p2C-IRES-SEAP was 
unexpected as like Coxsackievirus 3A protein FMDV OIK 2BC protein has been shown 
to limit protein trafficking from the ER to the cell surface (Moffat et al., 2005; Wessels 
et al., 2005)(Section 3.3). This lack of SEAP expression from constructs containing 
FMDV non-structural proteins was confirmed by immunofluorescence microscopy (Fig. 
4.13). As there was significantly less SEAP expressed by constructs co-expressing 
FMDV 2BC, 2B or 2C proteins than those co-expressing either EYFP or coxsackievirus 
3A proteins it was considered that the position of SEAP in the bicistronic constructs 
relative to the position of the viral ORF could be affecting SEAP expression.
SEAP was put under the control of cap-dependent translation and the viral proteins of 
interest under the control of the 1RES. Once again the constructs were analysed with a 
cell free protein expression system. All the constructs with the exception of pSEAP- 
IRES-2B, successfully expressed proteins of the anticipated sizes (Fig. 4.18). As seen 
using 1RES driven SEAP constructs, SEAP was expressed to the highest levels in 
constructs containing EYFP (Figs. 4.12 and 4,19). The levels of SEAP expressed were 
approximately 35 times higher when cap driven from bicistronic constructs than 1RES 
driven SEAP.
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All cells transfected with bicistronic plasmids exhibited a gradual decline in the levels 
of SEAP expression over time. This reduction in SEAP expression is likely to be a 
consequence of cell confluency and death, the aim was to examine the effects of 2BC 
expression on SEAP at 72 h. However, by this time point the cells were dying or 
damaged. Similarly to cells transfected with 1RES dependent SEAP plasmids (Fig. 4.12) 
it was seen in cells transfected with cap dependent SEAP plasmids that there was not 
significantly more SEAP detected in cell lysates compared to mock transfected cells. 
The lack of SEAP collected within cell lysates is likely to be as a consequence of SEAP 
being secreted from the cells, in the case of EYFP plasmids, or not expressed in the 
case of FMDV 2BC, 2B and 2C bicistronic plasmids.
Regardless of the position of FMDV 2BC or 2C ORFs in the bicstronic plasmids a similar 
pattern emerged. While both the viral protein and the SEAP reporter could be 
detected in a cell free protein expression system cells transfected with constructs 
containing these FMDV non-structural proteins did not express SEAP to the same 
extent as those containing EYFP. In and several instances SEAP was not expressed 
significantly more than mock transfected cells and this suppression of SEAP expression 
did not appear to occur at a transcriptional level (Fig. 4.20). It appears that the non- 
structural proteins FMDV 2BC and 2C have a profound effect upon protein expression 
of secretory molecules; however, the mechanism by which they prevent this protein 
expression is currently unknown.
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Chapter Five: Mechanisms responsible for the lack of SEAP expression in cells 
transfected with FMDV 2BC
5.1 Introduction
While it has been shown that FMDV OIK 2BC protein inhibits ER-to-Golgi trafficking 
(Moffat, 2005), (Section 3.3), expression of 2BC in cells was not predicted to inhibit 
expression of the reporter protein, SEAP. When expressed in IBRS cells from the 
biscistronic plasmid 2BC-IRES-SEAP, SEAP was not detected in the presence of FMDV 
2BC, 2BC"^ "^  (from pCK3) or FMDV 2C but was detected when expressed in IBRS2 cells 
from the bicistronic construct EYFP-IRES-SEAP, There are a number of potential 
factors that could contribute to the lack of SEAP expression in cells transfected with 
bicistronic plasmids containing 2BC These included; competition for the ribosome 
between the cap and IRES-dependent transcript (Choi and Engel, 1988; Hunt et al., 
1993) resulting in more efficient translation from the cap than the 1RES (Hennecke et 
al., 2001; Mizuguchi et al., 2000); there may be differences in transfection efficiency; 
inhibition of SEAP expression may be specific to this reporter molecule; or the 1RES in 
conjunction with FMDV 2BC (Gastello et al., 2009; Her et al., 1997; Satterly et al., 2007) 
may be post transcriptionally modified in the cell nucleus. Studies were therefore 
undertaken to determine if any of the above mentioned reasons were responsible for 
the lack of SEAP expression in cells transfected with FMDV 2BC.
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5.2 Expression of EYFP or 2BC and SEAP under the control of a T7 Promoter
To examine if 2BC was exerting an effect over the bicistronic plasmid in the nucleus 
leading to post transcriptional modifications of the 1RES and interfering with SEAP 
translation in the cytoplasm, the constructs were expressed in the cytoplasm under 
the control of the T7 promoter. Transcription and translation of plasmids in the 
cytoplasm would determine if nuclear transcription of the bicistronic plasmid lead to 
problems with correct mRNA processing and translocation of the transcript to the 
cytoplasm from the nucleus. Using a cell line that constitutively expressed T7 
polymerase and putting plasmid transcription under the control of the T7 promoter 
would allow transcription and translation of plasmid genes to occur only in the cell 
cytoplasm.
Post transcriptional modification could potentially prevent the transcript being 
translated at the ER. If the p2BC-IRES-SEAP DNA could be transcribed within the 
cytoplasm, this would eliminate the possibility of the RNA transcript becoming 
modified within the cell nucleus and would be free to reach the ER for translation.
5.2.1 Construction of pGEM-2BC-IRES-SEAP and pGEM-EYFP-IRES-SEAP
To enable the 2BC-IRES-SEAP and EYFP-IRES-SEAP ORFs to be transcribed within the 
cytoplasm, they were put under the control of a T7 promoter. Transcription of 
plasmids containing a T7 promoter is driven within the cytoplasm of cells that express 
T7 polymerase. The 2BC-IRES-SEAP and EYFP-IRES-SEAP ORFs were cloned into pGEM-
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T (Promega) which possesses a T7 promoter. These constructs were named pGEM- 
2BC-IRES-SEAP and pGEM-EYFP-IRES-SEAP (Figs. 5.1 and 5.2). These would facilitate T7 
driven cytoplasmic transcription of the 1RES transcripts and remove any potential 
problems with nuclear transcription,
5.2.2 Great escape assays in BHK and BSRT7/5 cells
BSRT7/5 cells (Buchholz et al., 1999) are BHK cells that express the T7 polymerase 
within their cytoplasm. The pGEM-EYFP-IRES-SEAP and pGEM-2BC-IRES-SEAP 
constructs were transfected into BSRT7/5 cells and pEYFP-IRES-SEAP and p2BC-IRES- 
SEAP were transfected into BHK cells and incubated for 24 h at 37°C. The supernatants 
and cell lysates were collected and the levels of SEAP were measured using the Great 
EscAPe™ chemiluminescence detection kit.
SEAP was detected in cell supernatants and lysates of BHK transfected with pEYFP- 
IRES-SEAP, with the highest level of SEAP detected in the supernatant. Transfection of 
p2BC-IRES-SEAP in BHK cells did not yield any SEAP in the cell lysate or the supernatant 
that was above the levels of expression from mock transfected cells (Fig. 5.3 A). 
pGEM-EYFP-IRES-SEAP and pGEM-2BC-IRES-SEAP constructs when transfected in 
BSRT7/5 cells had a similar expression pattern to that of the CMV-dependent 
constructs expressed in BHK cells. BSRT7/5 cells transfected with pGEM-EYFP-IRES- 
SEAP expressed SEAP in the cell supernatants; however SEAP could not be detected in 
the cell lysates. BSRT7/5 cells transfected with pGEM-2BC-IRES-SEAP did not express 
SEAP in the cell supernatants or lysates that were different from that detected in mock 
transfected cells (Fig. 5.3 B).
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Figure 5.1 Insertion of 2BC-IRES-SEAP into pGEM-T. A) 2BC-IRES-SEAP ORF was 
isolated from p2BC-IRES-SEAP by restriction digest with Nhe\. The Nhe\ digest was 
"blunt ended" with T4 DNA polymerase (highlighted in red) and then digested with 
Not\. B) pGEM-T was digested with A/col and "blunt ended" with T4 DNA polymerase 
then digested with Notl. The 2BC-IRES-SEAP ORF was ligated into the linear pGEM-T to 
produce pGEM-2BC-IRES-SEAP (C). D) Restriction digest analysis of pGEM-2BC-IRES- 
SEAP. Lanes 1 and 3, clones negative for pGEM-2BC-IRES-SEAP. Lane 2, Mlul 
restriction digest profile. Lane 3 PvuW restriction profile.
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Figure 5.2 Insertion of EYFP-IRES-SEAP into pGEM-T. A) EYFP-IRES-SEAP ORF was 
isolated from pEYFP-IRES-SEAP by restriction digest with Nhe\. The Nhe\ digest was 
"blunt ended" with T4 DNA polymerase (highlighted in red) and digested with Not\. B) 
pGEM-T was digested with Nco\ and "blunt ended" with T4 DNA polymerase and 
digested with Notl. The EYFP-IRES-SEAP ORF was ligated into the linear pGEM-T to 
produce pGEM-EYFP-IRES-SEAP (C). D) Restriction digest analysis of pGEM-EYFP-IRES- 
SEAP. Lane 1, a clone negative for pGEM-EYFP-IRES-SEAP. Lane 2, Mlul restriction 
digest profile of a putative pGEM-EYFP-IRES-SEAP clone. Lane 3, Apal restriction 
profile of a putative pGEM-EYFP-IRES-SEAP clone.
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Figure 5.3 Expression of SEAP in transfected BHK and BSRT7/5 cells. BHK (A) or
BSRT7/5 cells (B) were transfected with bicistronic plasmids and incubated overnight, 
in triplicate. SEAP was measured in the culture supernatants and cell lysates using the 
chemiluminescence SEAP reporter assay. The yield was expressed as pg of total SEAP 
culture using the positive control from the assay kit as a reference. The values on the 
graph are mean values of SEAP expression ± sd.
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To determine if the levels of SEAP in cells transfected with the bicistronic plasmids 
were significantly different, a linear ANOVA was performed using Minitab 16. BHK 
cells transfected with pEYFP-IRES-SEAP expressed significantly more SEAP in the 
supernatant than cells transfected with p2BC-IRES-SEAP or mock-transfected cells p 
<0.0001. There was no significant difference between the levels of SEAP expression in 
the cell supernatants of transfected cells and those of mock transfected cells. BHK 
cells transfected with pEYFP-IRES-SEAP expressed significantly more SEAP in the cell 
lysates than cell transfected with p2BC-IRES-SEAP or mock transfected cells p <0.0001. 
The level of SEAP in BHK cells transfected with p2BC-IRES-SEAP was not significantly 
different from mock transfected cells.
BSRT7/5 cells transfected with pGEM-EYFP-IRES-SEAP expressed significantly higher 
levels of SEAP in the supernatant than cells transfected with pGEM-2BC-IRES-SEAP or 
mock transfected cells p <0.0001. The level of SEAP in BSRT7/5 cells transfected with 
pGEM-2BC-IRES-SEAP were not significant different from mock transfected cells. There 
was no significant difference in the levels of SEAP in lysates of cells transfected with 
pGEM-EYFP-IRES-SEAP, pGEM-2BC-IRES-SEAP or mock transfected cells. Thus, these 
studies demonstrated that 2BC appeared to inhibit the expression of SEAP even when 
expression was under the control of the T7 polymerase.
5.3 Co-Transfection of cells with plasmids expressing EYFP or 2BC and SEAP
The studies described above indicated that the lack of expression of SEAP in cells 
transfected with FMDV 2BC was not the result of the SEAP mRNA being modified
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within the cell nucleus. Further studies were undertaken to determine If the Inhibitory 
effects of FMDV 2BC on SEAP expression was due to FMDV 2BC and SEAP mRNA 
having variable levels of affinity for the ribosome. Expression of both proteins was 
put under the control of cap dependent translation on separate plasmids, and the 
levels of protein expression was examined by Immunofluorescent microscopy and the 
Great EscAPe™ chemllumlnescence detection kit.
Cells were co-transfected with equal amounts pSEAP2-Control and pcDNA3.1-2BC, 
pCK3, pcDNA3.1-2C or pcDNA3.1-EYFP for 24 h. As the ORFs were expressed on 
separate plasmids, 2BC, 2C and EYFPs ORFs would be under the control of cap- 
dependent translation and so should have the same affinity for the ribosome. The cell 
supernatants and cell lysates were collected from cells co-transfected with two 
plasmids (pSEAP2-Control and either pcDNA3.1-2BC or pcDNA3.1-EYFP) and the levels 
of SEAP were measured using the Great EscAPe™ chemllumlnescence detection kit. To 
ensure that the levels of SEAP were within the linear range of the assay (Fig. 4.10), any 
samples with levels of SEAP outside of the linear range were adjusted to bring them 
Into the range of the assay.
5.3.1 Analysis of SEAP expression in co-transfected IBRS2 cells
IBRS2 cells transfected with pSEAP2-Control alone expressed significantly more SEAP 
In cell supernatants than cells co-transfected with pSEAP2-Control and pcDNA3.1-EYFP 
or pcDNA3.1-2BC/2C (p <0.0001) (Fig. 5.4). IBRS2 cells co-transfected with pcDNA3.1-
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Figure 5.4 Expression of SEAP in dual transfected IBRS2 cells. IBRS2 cells were 
transfected with two plasmids and incubated overnight, in triplicate. SEAP was 
measured in the culture supernatants and cell lysates using the chemllumlnescence 
SEAP reporter assay. The yield was expressed as pg of total SEAP culture using the 
positive control from the assay kit as a reference enzyme. The values on the graph are 
mean values of SEAP expression.
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EYFP and pSEAP2-control expressed significantly more SEAP in cell supernatants than 
cells co-transfected with pSEAP2-Control and pcDNA3.1-2BC/2C (p <0.0001).
There were no significant differences in the levels of SEAP expressed in cell 
supernatants from cells co-transfected with pSEAP2-control and pcDNA3.1-2BC/2C, or 
with pCK3, and mock-transfected cells. There were no significant differences In the 
levels of SEAP expression In lysates from cells transfected with pSEAP2-Control alone, 
and those co-transfected with pSEAP2-control and pcDNA3.1-EYFP, pcDNA3.1-2BC/2C, 
or pCK3 and mock transfected cells.
5.3.2 Analysis of protein expression by immuno-fluorescence microscopy in co­
transfected IBRS2 cells
Cells co-transfected with plasmids encoding 2BC or SEAP did not express significantly 
more SEAP than mock-transfected cells, as determined using the Great EscAPe™ 
chemllumlnescence assay (Fig. 5.4). Studies were undertaken to determine If SEAP 
could be detected by Immunofluorescent microscopy In cells co-transfected with 
either pcDNA3.1-EYFP or pcDNA3.1-2BC. This would enable us to determine the 
transfection efficiency and the level of co-expression of occurring In co-transfected 
cells.
IBRS2 cells were transfected with pcDNA3.1-2BC and pSEAP2-Control (Fig. 5.5 A-C), 
pcDNA3.1-EYFP and pSEAP2-Control (Fig. 5.5 D-F) or pcDNA3.1-2BC and
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Fig 5.5 FMDV 2BC does not co-express with SEAP. IBRS2 cells were transfected with pcDNA-EYFP and 
SEAP (A-C) or pcDNA-2BC and SEAP (D-F) for 24 h. Cells were fixed, permeablllsed and stained. EYFP was 
visualised through the natural fluorescence of EYFP (A). SEAP (B and E) was detected with antl-alkallne 
phosphatase (Red) followed by anti-mouse conjugated to Alexa-568. FMDV 2BC (D) was detected using 
rabbit antibody DM11 specific for 2C (Green) followed by antl-rabbit conjugated to Alexa-488. The cells 
were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F and are digital merges of all 
channels that comprise of panels A & B and D & E respectively. Scale Bar 10 pm.
pcDNA3.1-EYFP (Fig. 5.6) and incubated for for 24 h. Cells co-transfected with 
pcDNA3.1-2BC and pSEAP2-Control were fixed, permiabilised and labelled for 2BC 
using an anti-FMDV 2C antibody (Fig. 5.5 D and F) and an anti-alkaline phosphatase 
antibody (Fig. 5.5 B, C, E and F). EYFP was detected by Its natural fluorescence. EYFP 
(Fig. 5.5 A) and SEAP (Fig. 5.5 Panel B) were both expressed In IBRS2 cells and a high 
level of co-expression was detected In transfected cells (Fig. 5.5 C). IBRS2 cells co­
transfected with pcDNA3.1-2BC (Fig. 5.5 D) and pSEAP2-Control (Fig. 5.5 E), did not 
express detectable levels of SEAP In cells expressing 2BC (Fig. 5.5 F). Cells expressing 
SEAP were rare (Fig. 5.5 E) with very little SEAP expression detected across the 
coversllp and were only detected In the absence of 2BC expression. There appeared to 
be a lower percentage of cells expressing FMDV 2BC or SEAP proteins In cells co­
transfected with pcDNA3.1-2BC and pSEAP2-control than cells expressing EYFP and 
SEAP proteins from cells co-transfected with pcDNA3.1-EYFP and pSEAP2-control. This 
difference In levels of transfection efficiency was seen despite Identical transfection 
conditions used for both sets of plasmids. Interestingly, although equal numbers of 
cells were plated out at the beginning of the experiment, after a 24 h expression of 
proteins, those cells transfected with 2BC had at least 20% fewer cells present on the 
coversllp than cells expressing EYFP.
To determine If FMDV 2BC could be co-expressed with EYFP or If the Inhibition of 
protein expression was SEAP specific, IBRS2 cells were co-transfected with pcDNA3.1- 
EYFP and pcDNA3.1-2BC for 24 h, and expression of 2BC and YFP was examined by 
Immunofluorescence microscopy. 2BC and EYFP were both detected In IBRS2 cells
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Fig 5.6 FMDV 2BC protein co-expresses with EYFP. Cells were co-transfected with pcDNA3.1-EYFP and 
pcDNA3.1-2BC for 24 h. Cells were fixed, permeablised and stained. EYFP was visualised through the natural 
fluorescence of EYFP (A). FMDV 2BC (B) was detected using the mouse antibody 3F7 (Red). Primary antibody 
was detected using goat anti-mouse conjugated to Alexa-568. The cells were counterstained with DAPI (Blue) to 
detect the nucleus. Panel C is a digital merge of all channels that comprising of panels A and B.
Scale Bar 10 pm.
(Fig. 5.6) and co-expression of FMDV 2BC and EYFP was observed, although the levels 
of EYFP expression were not as high as that seen in cells co-transfected with 
pcDNA3.1-EYFP and pSEAP2-control.
As expression of 2BC and SEAP together was rareiy seen in celis co-transfected with 
pSEAP2-Control and pcDNA3.1-2BC, the effect of FMDV 2BC on expression of SEAP 
was determined in a cell-free system. These studies would demonstrate if FMDV 2BC 
had the capability to shut off transcription\transiation of pSEAP-control.
5.4 Analysis of protein expression of multiple plasmids by TnT® radio labelling
To determine if proteins expressed from pcDNA3.1-2BC or pcDNA3.1-EYFP and pIRES- 
SEAP could be co-transcribed and co-translated, their dual expression was examined in 
the cell-free protein expression system, TnT® Coupled Reticulocyte Lysate Systems. ^^ S 
methionine-labelled proteins were resoived by SDS-PAGE (10% tricine) and exposed to 
X-ray film (Fig. 5.7). pIRES-SEAP was used as rather than the pSEAP2-Control, used in 
the transfection studies, as piRES-SEAP possesses a T7 promoter which is necessary for 
protein expression in the TNT® system.
The expression of pcDNA3.1-2BC, pcDNA3.1-EYFP and pIRES-SEAP individuaily, are 
predicted to produce proteins with a size of 52 KDa, 28 kDa and 66 kDa respectively. 
The anticipated sizes were caiculated based upon the number of amino acids in their 
peptide sequences. TnT® lysates containing pcDNA3.1-EYFP and pIRES-SEAP produced 
proteins with a size of approximately 28 and 66 kDa, (Fig. 5.7, Lane 1). These proteins
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Figure 5.7 Expression of genes from plasmids using TNT T7 quick coupied reactions
Plasmids were incubated for 2 h at 37°C in the TnT® Coupled Reticulocyte Lysate 
System (Promega) and radio labelled with the radioisotope methionine. The 
expressed protein products from the TnT® reactions were analysed on X-ray film 
exposed overnight to the radio-labelled proteins resolved on a 10% tricine gel. M) C14 
Marker; 1) pcDNA3.1-EYFP and pIRES-SEAP; 2) pcDNA3.1-2BC and pIRES-SEAP; 3) 
PCDNA3.1-2BC and pcDNA3.1-EYFP; 4) pcDNA3.1-2BC; 5) pcDNA3.1-EYFP; 6) pIRES- 
SEAP; 7) pIRES.
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corresponded to the expected sizes of EYFP protein and SEAP expressed from pIRES- 
SEAP, respectiveiy. The dual expression of pcDNA3.1-2BC and pIRES-SEAP in 
TnT®lysates produced proteins with a size of approximately 52 and 66 kDa, 
corresponding to the expected sizes of FMDV 2BC and SEAP, respectively (Fig. 5.7, 
Lane 2). Incubation of lysates with pcDNA3.1-2BC and pcDNA3.1-EYFP (Fig. 5.7, Lane 
3) produced proteins with a size of approximately 52 KDa and 28 kDa, corresponding 
to the expected sizes of FMDV 2BC and EYFP, respectively.
Co-expression of 2BC with SEAP or EYFP was successfui and indicated that in a cell free 
system 2BC has little effect upon the expression of other ectopic genes. It was 
possible to co-express EYFP and SEAP (Fig. 5.7, Lane 1), and EYFP and SEAP in 
conjunction with FMDV 2BC in a cell-free system (Fig. 5.7, Lanes 2 and 3). The level of 
protein expression in single plasmid TnT reactions was greater than that observed in 
dual plasmid TnT reactions which contained EYFP or 2BC (Fig. 5.7, Lanes 1-5). SEAP 
expression alone (Fig. 5.7, Lane 6) appeared to be similar to SEAP expressed in dual 
reactions (Fig. 5.7, Lanes 1 and 2). The pIRES in the TnT® reaction produced two bands 
(Fig. 5.7 Lane 7) with sizes of approximately 30 kDa and 46 kDa, these bands 
correspond in size to with the protein produced by ampicillin gene on the pIRES which 
has a size of approximately 32 kDa and the protein from the neomycin resistance gene 
which has a size of approximateiy 50 kDa. These results show that in a cell free system 
FMDV 2BC can be co-expressed with either SEAP or EYFP and so it is unlikely that 
FMDV 2BC is inhibiting the transcription or translation of SEAP.
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5.4.1 TNT reactions in the presence of MIcrosomes
EYFP and SEAP were both successfully co-expressed with FMDV 2BC in a cell free 
system in both dual plasmid and bicistronic TnT reactions. FMDV 2BC is a membrane 
bound protein, when expressed in ceils, and locates to modified ER structures. To 
determine if interaction with membranes is required by FMDV 2BC protein to enable 
its inhibition of SEAP protein expression, the TnT experiment was repeated in the 
presence of microsomes. Bicistronic plasmids pEYFP-IRES-SEAP (Section 4.2.3) and 
p2BC-IRES-SEAP (Section 4.2.2) were expressed using the cell free TNT® Coupled 
Reticulocyte Lysate System and radio labelled with the radioisotope ^^ S. The 
bicistronic plasmids were expressed with and without canine pancreatic microsomal 
membranes (Promega). The expressed products protein products were anaiysed on X- 
ray film exposed to the radio labelled proteins resoived on a 10% tricine gel (Fig. 5.8 
and Fig. 5.9).
The expression of pEYFP-IRES-SEAP in TnT® lysates in the presence of canine 
pancreatic microsomal membranes produced proteins with sizes of approximately 28 
and 57 kDa (Fig. 5.8 Lane 1). These proteins corresponded to the expected sizes of 
EYFP and SEAP protein, respectively. pEYFP-IRES-SEAP was also expressed in absence 
of canine pancreatic microsomal membranes (Fig. 5.8 Lane 2) producing proteins with 
identical sizes to those expressed in the presence of microsomes. Once again these 
protein sizes corresponded to the expected sizes of EYFP and SEAP proteins 
respectively. pcDNA3.1-EYFP expressed alone (Fig. 5.8 Lane 3) produced a band of 28 
kDa corresponding to the expected size of EYFP. pIRES-SEAP expressed alone
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Figure 5.8 Expression of genes from bicistronic plasmids in the presence of canine 
pancreatic microsomal membranes using TNT T7 quick coupled reactions. Plasmids 
were incubated for 2 h at 37°C in the TnT® Coupled Reticulocyte Lysate System 
(Promega) with canine microsomal membranes and radio labelled with the 
radioisotope ^^ S methionine. The expressed protein products from the TnT® reactions 
were analysed on X-ray film exposed overnight to the radio-labelled proteins resolved 
on a 10% tricine gel. M) C14 Marker; 1) pEYFP-IRES-SEAP and microsomes; 2) pEYFP- 
IRES-SEAP; 3) pcDNA3.1-EYFP; 4) pIRES-SEAP; 5) dHzO only.
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Figure 5.9 Expression of genes from bicistronic plasimds in the presence of canine 
pancreatic microsomal membranes using TNT T7 quick coupled reactions. Plasmids 
were incubated for 2 h at 37°C in the TnT® Coupled Reticulocyte Lysate System 
(Promega) with canine microsomal membranes and radio labelled with the 
radioisotope ^^ S methionine. The expressed protein products from the TnT® reactions 
were analysed on X-ray film exposed overnight to the radio-labelled proteins resolved 
on a 10% tricine gel. : 1) p2BC-IRES-SEAP and microsomes, 2) p2BC-IRES-SEAP, 3) 
pcDNA3.1-2BC, 4) pSEAP-IRES, 5) dHzO only, were expressed using TNT Lysate (2 h, 
30°C) in the presence of ^^ S methionine. Translation products were resolved on a 10% 
Tricine gel and then detected by autoradiography. Lane M, C14 marker.
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produced a band with a size of approximately 66 kDa (Fig. 5.8 Lane 4) corresponding to 
the expected size of SEAP expressed from pIRES-SEAP. The negative control consisting 
of dH20, rather than plasmid, in the TnT® reaction mixture did not produce any 
protein products (Fig. 5.8 Lane 5).
The expression of p2BC-IRES-SEAP in TnT® lysates in the presence of canine pancreatic 
microsomal membranes expressed proteins with sizes of 52 and 57 kDa (Fig. 5.9 Lane 
1). These proteins corresponded to the expected sizes of FMDV 2BC and SEAP protein 
respectively. p2BC-IRES-SEAP was also expressed in the absence of canine pancreatic 
microsomal membranes (Fig. 5.9 Lane 2) proteins were expressed with identical sizes 
of those expressed in the presence of microsomes. pcDNA3.1-2BC expressed alone 
(Fig. 5.9 Lane 3) produced a protein with the approximate size of 52 kDa 
corresponding to 2BC. pSEAP-IRES expressed alone produced a protein with a size of 
approximately 52 kDa (Fig. 5.9 Lane 4), corresponding to SEAP expressed from pSEAP- 
IRES. The negative control consisting of dHzO in the TnT® reaction mixture did not 
produce any protein products (Fig. 5.9 Lane 5).
5.5 Dual expression of 2BC or EYFP with LacZ
SEAP expression was inhibited in cells when co expressed with FMDV 2BC, whereas 
YFP expression was not inhibited. The effect of FMDV 2BC on the expression of a 
second reporter molecule, LacZ, was examined to determine if the inhibition of protein 
expression was specific to SEAP. FMDV 2BC or EYFP was co-transfected with a plasmid
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containing the LacZ gene encoding for P-galactosidase. 3-galactosidase can be 
quantified through the catalysis of the substrate o-Nitrophenyl p-D-galactopyranoside 
(ONPG), measured with a colourmetric assay.
IBRS2 cells were co-transfected with equal amounts of the reporter plasmid, pJATLacZ 
(Didcock et al., 1999), and either pcDNA2Bc or pcDNAYFP and incubated for 24 h. The 
cells were lysed and analysed for levels of P-galactosidase activity. The standard curve 
of P-galactosidase, Absorbance at 420 nm is directly proportional to levels of p- 
galactosidase (Fig. 5.10 A).
The highest ievels of p-gaiactosidase were expressed by cells transfected with pJAT- 
LacZ alone (Fig. 5.10 B). High levels of P-galactosidase were also detected in cells co­
transfected with pcDNA3.1-EYFP. The levels of p-galactosidase expression in cells co­
transfected with pcDNA3.1-2BC, pcDNA3.1-2C and pCK3 were not significantly higher 
than those of mock transfected cells.
A single transfection of pJAT-LacZ expressed significantly more p-galactosidase than 
any of the dual transfections (p <0.0001). The co-transfection of EYFP and LacZ, 
produced significantly higher levels of p-galactosidase than mock transfected cells and 
cells co-transfected with 2BC, 2BC^^ and 2C (p <0.0001). Co-transfection with 2BC or 
2BC^^ did not produce significantly more p-galactosidase than mock transfected cells 
while cells co-transfected with 2C expressed significantly more p-galactosidase than
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Figure 5.10 Expression of (3-galactosidase in dual transfected IBRS2 cells. IBRS2 cells 
were co-transfected with pJAT-LacZ and a plasmid encoding EYFP or FMDV 2BC or 2C 
and incubated overnight, in triplicate. (3-galactosidase was measured in cell lysates 
using the (3-galactosidase reporter assay. The yield was expressed as miliunits of (3- 
galactosidase using the positive control from the assay kit as a reference enzyme. The 
values on the graph are mean values of (3-galactosidase expression.
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mock transfected cells but did not express significantly more (3-galactosidase than cells 
co-transfected with 2BC or 2BC™  ^(p <0.0001).
5.6 Discussion
Several factors were examined to try to determine why FMDV 2BC was inhibiting the 
expression of SEAP. Post transcriptional modification of the IRES-SEAP in the nucleus, 
perhaps caused by 2BC sequences could lead to inhibition of translation in the 
cytoplasm. By driving expression of plasmids with a T7 promoter and expressing the 
2BC-IRES-SEAP ORF with a T7 polymerase in the cytoplasm this negated the risk of the 
2BC-IRES-SEAP transcript being retained within the nucleus. The pattern of SEAP 
expression from CMV driven (5.3 A) and T7 driven (5.3 B) promoters showed a similar 
expression pattern of SEAP from the bicistronic plasmids indicating that nuclear post 
transcriptional modification did not affect SEAP expression levels.
IBRS2 cells co-transfected with EYFP and SEAP or 2BC and SEAP expressed a similar 
pattern (Fig. 5.4) of SEAP expression to that seen by bicistronic plasmids (Fig. 4.12). So 
it does not appear that the lack of SEAP expression seen in the bicistronic plasmids in 
relation to 2BC expression is due to the bicistronic system. IBRS2 cells co-transfected 
with 2BC and SEAP did not produce detectable levels of SEAP. However, co­
transfections between EYFP and SEAP or 2BC produced detectable levels of co­
expression (Fig. 5.5). In summary, 2BC inhibited the expression of both SEAP and (3- 
galactosidase but did not affect the expression of EYFP when the respective plasmids 
were transfected into cells. However, 2BC expression had no effect on the 
transcription and translation in TnT reactions with or without microsomes. This
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suggests that if 2BC is having an effect upon protein expression it may be targeting a 
specific cellular pathway or mechanism.
ER stress has been shown to inhibit SEAP expression, while EYFP expression is not 
affected by ER stress (Badr et al., 2007; Hiramatsu et al., 2006b; Yamazaki et al., 2009). 
Our studies have shown that the expression of 2BC leads to the inhibition of SEAP 
expression but not EYFP expression. FMDV 2BC is a membrane associated protein 
which is believed to modify the ER into punctate structures (Moffat et al., 2005). The 
effects of the FMDV interaction with the ER are unknown. However, other 
picornaviruses interact with the ER leading to a flux in Ca^  ^ levels which could trigger 
ER stress (Aldabe et al., 1997; de Jong et al., 2006). If FMDV 2BC interaction with the 
ER led to ER stress this mechanism could explain the effects of 2BC expression on SEAP 
and EYFP. This ER stress hypothesis could further be supported by the fact that SEAP 
and 2BC was co-expressed in the cell free system where ER stress would not occur.
A bicistronic system guarantees the expression of both proteins of interest within the 
same cell, which is essential when examining the effects of mutant 2BC proteins on 
the secretory pathway using a reporter protein. The lack of dual expression of SEAP 
and 2BC does justify in part, the decision to use a bicstronic system. It is likely that the 
dual transfection of cells with 2BC and SEAP was successful but that 2BC inhibited the 
expression of the reporter protein.
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The inhibition of protein expression was not just specific to secretory proteins. While 
SEAP is a secretory protein, p-galactosidase is not, and is retained within the 
cytoplasm. It is unclear why p-galactosidase expression is inhibited in the presence of 
2BC expression. However, autophagy can be a response to ER stress and can degrade 
proteins in the cytoplasm (Talloczy et al., 2002). Several positive strand RNA viruses 
have been shown to cause ER stress (Klomporn et al., 2011) including the picornavirus 
Enterovirus 71 (Jheng et al., 2010) and Coxsackievirus (Zhang et al., 2010).
It has also been shown that several picornaviruses including FMDV utilise the 
autophagic pathway possibly to sequester membranes for their replication complexes 
(Taylor and Kirkegaard, 2007). So it is not unlikely that FMDV 2BC protein may induce 
the autophagic pathway possibly though the induction of ER stress.
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Chapter 6: The role of FMDV 2BC protein on ER stress
ER stress can be caused by a number of factors including disruption of calcium 
homeostasis, accumulation and aggregation of misfolded proteins, glucose starvation, 
hypoxia and defective protein secretion or degradation. In response to ER stress the 
cell can respond with either, the UPR, ERAD or autophagy, as described in Chapter 1.
Viral infection of cells can cause ER stress (Bitko and Barik, 2001; Ciccaglione et al., 
2007; Li et al., 2005; Su et al., 2002; Waris et al., 2002; Xu et al., 1997). Recent 
examination of the role of ER stress in picornaviral infection has shown that 
coxsackievirus activates the UPR and the ER stress marker CHOP (Zhang et al., 2010), 
and enterovirus 71 induces ER stress and causes the up regulation of BiP (Jheng et al., 
2010). Picornaviruses perturb the secretory pathway and structures of the 
picornaviral replication complexes are derived from cellular organelles of the secretory 
pathway including the ER (Belov et al., 2007a; Bienz et al., 1987; Rust et al., 2001; 
Schlegel et al., 1996).
The expression of FMDV 2BC protein in cells affected the expression of other ectopic
proteins such as SEAP and p-galactosidase. However, as described in chapter 5,
inhibition of SEAP expression was not due to 2BC preventing transcription, but most
likely as a result of abnormal post translational modification and accelerated
degradation of SEAP (Kitamura and Hiramatsu, 2011). Furthermore, 2BC also appeared
to affect the translation of p-galactosidase. Recent research has shown that
expression of SEAP can be used as a maker for ER stress (Badr et al., 2007; Hiramatsu
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et al., 2006a; Hiramatsu et al., 2006b; Kitamura and Hiramatsu, 2011). The 
suppression of SEAP expression has been shown to be inversely proportional to the 
induction of BiP and GRP94 and directly proportional to levels of ER stress (Hiramatsu 
et al., 2006b). In addition, Amiodo, et al (2009) showed that induction of ER stress 
can result in the depletion of COP II trafficking vesicles, as was seen in cells expressing 
2BC (Fig. 3.12).
ER stress markers can be differentially expressed under varying conditions which can 
be detected by Western blot. For example, the prolonged exposure of cells to BFA can 
cause ER stress and alter the expression of various ER stress markers. To determine 
the extent to which FMDV and FMDV 2BC induced the UPR, ER stress markers from 
infected or transfected cells were examined by Western blot and confocal microscopy.
6.1 FMDV infection up regulates BiP in IBRS2 cells
To determine if FMDV infection induced an ER stress response, FMDV-infected cells 
were analysed at various time points over the course of infection for expression of 
proteins that are known to be altered in response to ER stress.
IBRS2 cells were infected with FMDV OIBFS at a multiplicity of infection of (MOI) 3. 
The virus was adsorbed for 30 min at 37°C and harvested at various times post 
infection. Cell lysates were examined by Western blot with antibodies specific for a 
range of ER stress markers. The level of infection at each time point was determined
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by the presence of the non-structural protein FMDV 2C. Cells were fixed and labelled 
with anti-FMDV 2C antibody, 3F7, and analysed by immuno-fluorescence microscopy 
(Fig. 6.1). The proportion of cells expressing 2C increased over time and the number 
of cells attached to cover slips decreased as the virus killed the cells.
IBRS2 cells, mock infected with lysates of uninfected BHK cells were analysed by 
Western blot. No detectable change in the levels of BiP, ERp57 or PDI expression at 
anytime points was produced. BFA-treated cells (positive control) showed an increase 
in the levels of BiP expression (Fig. 6.2) when compared to mock-infected cells. 
However, there was no difference in the levels of PDI or ERp57 in BFA-treated cells 
when compared to mock-infected cells. IBRS2 cells infected with FMDV OIBFS 
produced increased levels of BiP at 1 h post infection which then reduced at 2-4 h 
post-infection to levels similar to those seen at 0 h (Fig. 6.2 A).
There was no detectable change in the level of ERp57 expression over the duration of 
the viral infection. Following virus adsorption, PDI levels were similar to that of the 
mock-infected cells. However, during 1 and 2 h post infection the level of PDI was 
decreased when compared to mock-infected cells. At 3 h and 4 h post infection, PDI 
levels increased although not to the level observed immediately after adsorption. The 
levels of PDI were similar in BFA-treated cells when compared to mock-infected cells. 
(Fig. 6.2). A number of other ER stress markers, including IREl, Sec31, calnexin.
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calreticulin, GRP94, Erol, CHOP and PERK, were examined but could not be detected 
by Western blot in porcine cells.
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Figure 6.1 Infection time course of IBRS2 cells with FMDV OIBFS. IBRS2 cells were infected with FMDV 
OIBFS with a 30 min adsorption time. Non-stuctural protein FMDV 2C was detected with a mouse 
anti-FMDV 2C antibody (3F7) followed by a goat anti-mouse antibody conjugated to Alexa-488 (Green). 
The cells were counterstained with DAPI (Blue) to detect the nucleus. Scale Bar 20 pm.
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Figure 6.2 Western Blot analysis of ER stress markers expression levels during OIBFS 
infection of IBRS2 cells. Cells were infected OIBFS with an MOI of 3 and virus was 
adsorbed for 30 min in serum free media (A). As a control, uninfected IBRS2 cell 
lysates were allowed to adsorb to IBRS2 cells for 30 min (B). Following adsorption, 
virus or control cell lysate was removed and replaced with complete media. At 
intervals of 1 h, cell lysates were made. Proteins were resolved on a 10% tricine gel. 
Protein loading was equalised by actin probing with anti-actin antibody. The lysates 
were also probed with antibodies specific for ER stress markers. A) M: Mock-infected 
cells, B) M: uninfected cells, BFA: 2 pg/ml Brefeldin A treatment of cells for 24 h.
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6.1.2 Expression of FMDV 2BC and 2C in IBRS2 cells
During FMDV infection 2BC is rapidly cleaved by the 3C protease to produce 2B and 
2C. To demonstrate the expression of FMDV 2BC protein during infection of IBRS2 
cells with FMDV OIBFS, ceil lysates were analysed by Western blot using the anti-2C 
antibody 3F7, Bands corresponding to viral proteins were not detected at 0 h (Fig. 
6.3). However at 1-2 h post adsorption, a faint band could be seen with a size of 
approximately 52 kDa, the anticipated size of 2BC. At 2-4 h post-infection, a band 
corresponding to the anticipated size of FMDV 2C, of approximately 35 KDa, was 
detected. The 35 kDa band became more pronounced from 2-4 h, as the 52 kDa band 
disappeared (Fig. 6.3). This is comparable to the cleavage of 2BC to produce 2C.
6.1.3 FMDV infection of IBRS2 cells may activate the XBPl pathway
During ER stress, BiP dissociates from IREl (Liu et al., 2002; Oikawa et al., 2009; Shamu 
and Walter, 1996; Welihinda and Kaufman, 1996), resulting in activation of IREl, which 
oligomerises and catalyses and splices XBPl mRNA, removing a 26 bp intron which 
causes a frame shift resulting in the transcriptional activation of XBPl (Shamu and 
Walter, 1996; Welihinda and Kaufman, 1996). XBPl binds to ER response elements 
and upregulates the expression of a number of chaperone proteins (Calfon et al., 
2002; Reimold et al., 2000; Yoshida et al., 2001). To determine if FMDV triggers XBPl 
splicing, the presence of spliced and unspliced XBPl was analysed in cells infected with 
FMDV OIBFS by RT-PCR. mRNA extracted from ceils at 1 h intervals after FMDV 
infection, was converted into cDNA by RT-PCR.
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Figure 6.3 Western Blot analysis of 2BC and 2C proteins expressed in IBRS2 cells 
following infection with OIBFS. Cells were infected with FMDV OIBFS with an MOI of 
3. The virus was adsorbed for 1 h in serum free media then replaced with complete 
media. At intervals of 1 h after infection, cell lysates were made and proteins were 
resolved on a 10% tricine gel and probed with an anti-FMDV 2C antibody.
2 0 0
The cDNA was amplified using the primers shown in Table 6.1 (provided by F. Zhang, 
lAH, Pribright, U.K.) with KOD DNA polymerase. When XBPl is spliced by IREl, a 26 bp 
intron is removed from the mRNA causing a frame shift and initiates transcription.
Table 6.1 Primers for PCR the amplification of the XBPl DNA sequence
Primer Tm (°C) Sequence Role/ Restriction Sites
XBPl 76.5 CGCTTGGGGATGGATGCCCTG 5'
XBPl 72.9 ACCGCCAGAATCCATGGGGA 3'
The PCR products were run on a 4% agarose gel. As the spliced variant is 26 bp 
smaller than the unspliced variant, it runs slightly further down the gel. If XBPl is 
spliced as a result of ER stress, two bands should be visible.
In mock-infected cells, only one band was detected by PCR (Fig. 6.4 A) and two bands 
were detected in cells treated with BFA. In IBRS2 cells infected with OIBFS there was 
only one band detected by PCR at 0-2 h (Fig 6.4 B). At 3-4 h two bands could be 
detected by PCR and in cells treated with BFA. This indicates that infection of porcine 
cells may induce the splicing if XBPl, an indicator of ER stress. Two bands were also 
detected in the mock infected cells, while the reason behind this is unclear, stress may 
have been induced in these cells by the trypsin used to remove the cells from flask 
they were attached to.
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Figure 6.4 PCR analysis of XBPl splicing in IBRS2 cells. Cells were mock-infected with 
IBRS2 cell lysates (A) or infected with OIBFS with an MOI of 3 (B). Virus was adsorbed 
for 30 min in serum free media and then replaced with complete media. At 1 h 
intervals post-infection, mRNA was extracted. mRNA was DNase treated and reverse 
transcribed into cDNA with Superscript® III (Invitrogen). PCR products were amplified 
with XBPl primers shown in Table 6.1. The PCR products were resolved on a 4% 
agarose gel by electrophoresis. A) M: uninfected cells, B) M: mock infected cells, BFA: 
2 pg/ml Brefeldin A treatment of cells for 24 h. Arrow marks spliced XBPl.
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6.2 FMDV infection of Vero cells up-regulates expression of ER stress markers BiP, 
Erol and Sec31
As ER stress markers could not be detected by Western blot in IBRS2 cells, it was 
suspected that the antibodies could not detect the porcine epitope of the ER stress 
markers. Therefore, the effect of FMDV infection on ER stress markers in Vero cells 
was investigated. Vero cells were infected with FMDV OIBFS with a multiplicity of 
infection of (MOI) 20, the virus was adsorbed for 60 min at 37°C and cells were 
harvested at various times post infection. Cell lysates were examined by Western blot 
with antibodies specific for a range of ER stress markers.
To determine the level of FMDV infection at each time point post-infection, cells were 
labelled with an antibody specific for the non-structural protein FMDV 2C and 
analysed by immuno-fluorescent microscopy (Fig. 6.5). The proportion of cells 
expressing 2C increased over time and the number of cells attached to cover slips 
decreased as the virus killed the cells.
Protein loading of the Western blots was equalised by probing with an antibody to y- 
tubulin. Mock infection did not change the pattern of any of the ER stress proteins 
examined (Fig. 6.6). BFA treatment of cells led to an increase in BiP and CHOP 
expression (Fig. 6.6 and 6.7), whereas expression of calreticulin, Erol and PDI was 
similar to that in mock-infected control cells (Fig. 6.6 and 6.7). Sec31 levels were
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Figure 6.5 Infection time course infected with FMDV OIBFS. Vero cells were infected with FMDV OIBFS 
with an MOI of 20 for 1 h. Cells were fixed at 1 h time points then permiabilised and stained.
FMDV 2C was detected with a mouse anti-FMDV 2C antibody (3F7) followed by a goat anti-mouse 
antibody conjugated to Alexa-4888 (Green). The cells were counterstained with DAPI (Blue) to detect the 
nucleus. Scale Bar 20 pm.
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Figure 6.6 Western Blot analysis of ER stress markers in mock-infected Vero cells.
Cells were mock-infected with lysates of uninfected BHK cells for 1 h in serum free 
media, which was then replaced with complete media. At 1 h intervals after 
treatment, cell lysates were made and proteins were resolved on a 10% tricine gel. 
Protein loading was equalised by probing with antl-y-tubulin antibody. The lysates 
were then probed with antibodies to ER stress markers. M: uninfected cells, BFA: 2 
pg/ml Brefeldin A treatment of cells for 24 h.
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Figure 6.7 Western Blot analysis of ER stress markers in Vero cells infected with 
FMDV OIBFS. Cells were infected with OIBFS with an MOI of 20. Virus was adsorbed 
for 1 h in serum free media then replaced with complete media. At 1 h intervals after 
infection, cell lysates were made and proteins were resolved on a 10% tricine gel. 
Protein loading was equalised by probing with anti-y-tubulin antibody, and virus 
expression was monitored by probing with anti-FMDV 3A antibody. The lysates were 
then probed with antibodies specific for ER stress markers. M: mock infected cells, 
BFA: 2 pg/ml Brefeldin A treatment of cells for 24 h.
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reduced following BFA treatment, and calnexin was not detected in BFA-treated cells 
(Fig. 6.6 and 6.7).
In Vero cells infected with OIBFS it appeared the levels of the COP II marker Sec31 
while elevated at 1 h post adsorption were depleted at 2-4 h. However, the mock 
infected cells probed for Sec31A also had low levels of detectable Sec31 (Fig 6.7) so it 
is unclear while it may be the case that Sec31 is depleted over time. In virus-infected 
cells, Sec31 levels increased at 1 h post-infection and then decreased by 2 h to levels 
similar to that seen in mock-infected cells (Fig. 6.7).
Levels of calreticulin and PDI did not show any differences over the course of infection 
or when compared to mock-infected cells (Fig. 6.7). Erol expression levels were seen 
to increase at 1 h post infection and then to reduce to levels seen similar to the mock 
infected cells. As Erol plays an important role in maintaining the redox potential 
within the ER and is important for protein folding; the transient increase in Erol may 
be as a consequence of oxidative stress occuring early in FMDV infection. CHOP was 
not detected in Vero cells infected with FMDV OIBFS, but was induced in BFA-treated 
cells. To monitor the levels of virus expression over time, lysates were probed for 
expression of the FMDV non-structural protein 3A. FMDV 3A was detected from 
between 2 h and 4h post infection (Fig. 6.7). A number of other ER stress markers, 
including IREl, GRP94, ERp57 and PERK were also analysed but could not be detected 
by Western blot in Vero cells.
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6.2.1 FMDV infection of Vero cells does not activate the XBPl pathway
To determine if XBPl was spliced in Vero cells infected with FMDV OIBFS, mRNA, 
extracted from infected cells, was converted into cDNA and the cDNA was amplified 
with KOD DNA polymerase using the primers shown in Table 6.1.
The PCR products were run on a 4% agarose gel. If XBPl is spliced, two bands would 
be expected to be seen on the gel, with the spliced variant being 26 bp smaller than 
the unspliced variant and running slightly further down the gel. In mock-infected cells, 
two bands were detected by PCR (Fig. 6.8 A) and three bands were detected in cells 
treated with BFA. The same pattern of PCR products was also seen in cells infected 
with FMDV OIBFS as with mock-infected cells (Fig. 6.8 B), suggesting that infection 
with OIBFS did not result in the splicing of XBPl in Vero cells. Unexpectedly, three 
bands were seen in Vero cells treated with BFA the reason behind this is unclear. 
Sequence analysis would be required to determine the difference between the third 
smaller band and the expected spliced and unspliced XBPl fragments.
6.3 Effect of FMDV infection on the distribution of Sec31
Expression of 2BC in transfected Vero cells appeared to result in the dispersal of Sec31, 
a component of the COP II complex (see Fig. 3.13). Dispersal of Sec31 has also been 
seen in cells undergoing ER stress (Amodio et al., 2009). Therefore, the effects of 
FMDV infection on Sec31 was analysed by confocal microscopy. Vero cells were 
infected with FMDV OIBFS with an MOI of 20 and stained with rabbit anti-2C
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Figure 6.8 PCR analysis of XBPl splicing in Vero. Cells were mock-infected with IBRS2 
cell lysates (A) or infected with OIBFS with an MOI of 20 (B). Virus was adsorbed for 1 
h in serum free media and then replaced with complete media. At 1 h intervals post­
infection, mRNA was extracted. mRNA was DNase treated and reverse transcribed 
into cDNA with Superscript® III (Invitrogen). PCR products were amplified with XBPl 
primers shown in Table 6.1. The PCR products were resolved on a 4% agarose gel by 
electrophoresis. A) M: untreated cells, B) M: mock infected cells, BFA: 2 pg/ml 
Brefeldin A treatment of cells for 24 h. Arrow marks spliced XBPl.
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antibody, DM11, and anti-Sec31A antibody to detect the COP II complex. At 1 h and 2 
h post adsorption, FMDV 2C protein was not detected by immunofluorescence. Sec31 
staining was perinuclear and vesicular, and was uniform across all cells at these time 
points (data not shown). FMDV 2C was detected at 3h and 4 h post adsorption (Fig. 
6.9 A and D). Cells which did not express FMDV 2C contained Sec31 positive vesicles 
that were large and bright. In contrast, in cells expressing FMDV 2C Sec31 positive 
vesicles were small, less bright and less abundant (Fig.6.9 B and C, and E and F 
respectively). Thus, in cells infected with FMDV, there appeared to be a dispersal or 
reduction in labelling of Sec31.
6.4 Effect of FMDV infection on the distribution of calnexin
Expression of 2BC in transfected cells revealed that FMDV 2BC co-localised with 
calnexin and appeared to alter the distribution of calnexin within the transfected cell 
(Fig. 3.10). Calnexin, named after its ability to bind calcium (Wada et al., 1991) is 
embedded in the ER membrane where it retains newly synthesised glycoproteins 
inside the ER to ensure proper folding and quality control (Bergeron et al., 1994; 
Rajagopalan et al., 1994; Williams, 2006). The specificity of calnexin for a subset of 
glycoproteins is defined by a lectin site, which binds an oligosaccharide intermediate 
on the folding glycoproteins (Williams, 2006). Studies have shown that if induced ER 
stress is induced in the absence of calnexin there is an increased UPR (Coe et al., 
2008).
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Figure 6.9 FMDV infection depletes Sec31 labelling in Vero cells. Vero cells were infected with FMDV 
OIBFS with an MOI of 20 for 1 h. Cells were fixed at 1 h time points then permiabilised and stained.
FMDV 2C (A and D) was detected with a rabbit anti-FMDV 2C antibody (DM11) followed by a goat 
anti-rabbit antibody conjugated to Alexa-488 (Green). SecBl (B and D) was detected with mouse 
anti-Sec31A (Sigma) followed by a goat anti-mouse antibody conjugated to Alexa-568 (Red) The cells were 
counterstained with DAPI (Blue) to detect the nucleus. Panels C and F are digital merges of panels A and B 
and D and E respectivley. Panels A-C are 3h post infection Panels D-F are 4 h post infection.
Scale Bar 10 pm.
In order to determine if FMDV 2BC/2C co-localised with calnexin FMDV-infected cells, 
Vero cells were infected with FMDV OIBFS with an MOI of 20 and analysed by 
immuno-fluorescent microscopy. FMDV infection was detected using the mouse anti- 
2C antibody, 3F7, and calnexin was detected with an anti-calnexin antibody. At 1-2 h 
post adsorption, 2C was not detected, but at 3-4 h post adsorption FMDV could be 
seen (Fig. 6.10 A and D respectively). Calnexin was detected in infected and 
uninfected cells at 3 h and 4 h (Fig. 6.10 B and E). The staining pattern for calnexin was 
similar in both infected and uninfected cells. At 3 h post adsorption there was a small 
amount of overlap between the calnexin and the FMDV 2BC/2C (Fig. 6.10 C) although 
it is not clear if there was any redistribution of calnexin. By 4 h post adsorption there 
was no co-localisation of FMDV 2C.
6.5 Creation of a stable cell line expressing FMDV 2BC
In experiments to determine the effects of 2BC on the UPR, transfection rates to 
produce 2BC expressing cells were never greater than 15-20% and preliminary 
experiments examining the effects of FMDV 2BC expression on the UPR did not reveal 
significant changes in expression of ER stress markers. However, as transfection rates 
were low, any effects of 2BC on ER stress could be masked by cells not expressing 2BC. 
Therefore, in order to be able to investigate the effects of 2BC further, an inducible 
cell line was developed that expressed the 2BC protein following induction with 
doxycycline.
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Figure 6.10 FMDV 2C does not co-localise with calnexin in FMDV infected Vero cells. Vero cells were 
infected with FMDV OIBFS with an MOI of 10 for 1 h. Cells were fixed at 1 h time points then 
permeabilised and stained. FMDV 2C (A and D) was detected with a mouse anti-FMDV 2C antibody (3F7) 
followed by a goat anti-mouse antibody conjugated to Alexa-488 (Green). Calnexin (B and D) was 
detected with rabbit anti-calnexin (TW20) followed by a goat anti-rabbit antibody conjugated to Alexa-568 
(Red) The cells were counterstained with DAPI (Blue) to detect the nucleus. Panels C and F are digital 
merges of panels A and B and D and E respectivley. Panels A-C are 3h post infection Panels D-F are 4 h 
post infection. Scale Bar 10 pm.
Vero cells expressing a Tet repressor were obtained (Palm et al., 2010) and selection 
pressure was maintained with blasticidin. To create the stable cell lines expressing 
EYFP or 2BC, pcDNA4/T0 (Invitrogen) plasmids possessing either the EYFP or 2BC ORFs 
would be transfected into the Tet repressor cell line and selected with Zeocin 
(Invitrogen). Doxycycline would then be used to inactivate the Tet repressor and 
induce the expression of the protein of interest.
6.5.1 Cloning of EYFP and 2BC into pcDNA4/T0
The EYFP sequence from pEYFP-IRES-SEAP and the 2BC sequence from pT7S3 
(encoding FMDV OIK 2BC) were amplified by PCR using KOD polymerase and the 
corresponding primers in Table 6.2 that incorporate a Kozak sequence at the 5' end, a 
stop codon at the 3' end of the EYFP and 2BC sequences and the restriction site EcoRI.
Table 6.2 Primers for PCR amplification of the EYFP DNA sequence
Primer Tm (°C) Sequence Role/ Restriction 
Sites
TGIPDF-068 67.0 AAAGAATTCATGGTGAGCAAGGG EYFP 5' EcoRI
TGI PDF-069 67.1 AAAGAATTCTTACTCTTGTACAGCTCGTCC EYFP 3' EcoRI
TGIPDF-065 71.4 AAAGAATTCATGCCCTTCTTTTTCTCCGACGT 2BC 5' EcoRI
TGIPDF-066 71.2 AAAGAATTCTCACTGCTTGAAGATCGGG 2BC 3' EcoRI
The reaction conditions were as described in section 2.2.4.2 of Materials & Methods. 
The PCR products were inserted into pcDNA4T0 at the EcoRI restriction site (Fig. 6.11). 
The EYFP and 2BC PCR products and pcDNA4/TO-poMxlp were digested with EcoRI, 
the Mxlp fragment with a size of 1989 bp was removed and the plasmid and
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Figure 6.11 Insertion of EYFP or FMDV 2BC into pcDIMA4/T0 (A) pcDNA4/TO-poMxip 
was digested with EcoRI to remove Mxlp from the construct. The EYFP DNA sequence 
was amplified by PCR from pcDNA3.1-EYFP using specific primers TGIPDF-068 and 
TGIPDF-069. The FMDV 2BC DNA sequence was amplified by PCR from pT7S3 using 
specific primers TGIPDF-065 and TGIPDF-066. Restriction sites at the 5' ends of the 
primers incorporated EcoRI onto the 5' and 3' ends of the amplified 2BC. A start 
codon (ATG) and Kozak sequence was introduced at the 5' end of the 2BC sequence 
and a stop signal (TAA) was also introduced at the 3' end of the 2BC sequence. The 
2BC or EYFP ORF sequence is highlighted in orange. (B) The EYFP or 2BC PCR products 
were digested with EcoRI and purified on an agarose gel. The EYFP or 2BC ORFs were 
ligated into MCS B of pcDNA4/T0 at the EcoRI restriction site. (C) Restriction digest 
analysis of putative clones of pcDNA4/T0-EYFP and pcDNA4/TO-2BC. Lane 1 a clone 
screened negative for the EYFP insert, Lane 2 a positive clone containing a putative 
EYFP fragment. Lane 3 a clone screened negative for the 2BC insert, Lane 4 a clone 
containing a putative 2BC fragment.
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respective PCR products were purified and ligated with T4 DNA ligase (Fig. 6.11 A and 
B). Putative clones containing EYFP or 2BC ORFs were screened by EcoRI restriction 
digest. Putative clones containing EYFP were expected to produce fragments with 
sizes of 750 bp corresponding to the size of the EYFP ORF and a fragment with a size of 
5086 bp which corresponds to the size of pcDNA4/T0. Putative clones containing 2BC 
were expected to produce fragments with sizes of 1416 bp corresponding to the size 
of the 2BC ORF and a fragment with a size of 5086 bp which corresponds to the size of 
pcDNA4/T0.
The EcoRI restriction digest of putative pcDNA4/T0-EYFP clone (Fig. 6.11C, Lane 2) 
produced bands with sizes of approximately 5,500 bp and 750 bp, which correspond to 
the anticipated sizes of pcDNA4/T0 and the EYFP ORF respectively, indicating that the 
EYFP ORF was inserted into pcDNA4/T0. The EYFP sequence of pcDNA4/TO-2BC was 
analysed and was found to be identical to the published sequence. The EcoRI 
restriction digest of putative pcDNA4/TO-2BC clone (Fig. 6.11C Lane 4) produced 
bands with sizes of approximately 5,000 bp and 1,400 bp, which correspond to the 
anticipated sizes of pcDNA4/T0 and the 2BC ORF respectively, indicating that the 2BC 
ORF was inserted into pcDNA4/T0. The 2BC sequence of pcDNA4/TO-2BC was 
examined by sequence analysis and was found to be identical to the published 
sequence of FMDV OIK (GenBank: X00871.1).
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6.6.2 Production of Stable cell lines expressing EYFP or FMDV 2BC
A Vero cell line stably expressing a tetracycline repressor plasmid pcDNA6-TetR (Palm 
et al., 2010) was transfected with pcDNA4/TO-2BC or pcDNA4/T0-EYFP using 
Lipofectamine 2000. The following day, the transfected cells were cultured in the 
presence of 10 pg/ml Blasticidin to select for cells containing pcDNA6-TetR and 350 
pg/ml Zeocin (invitrogen) to select for plasmids containing pcDNA4/TO-2BC or 
pcDNA4/T0-EYFP. The cells were incubated for a further 24 h at 37°C.
The cells were trypsinised to form single cells suspension and limiting dilution was 
performed in 24-well plates. These cells were grown for 2 weeks to allow colonies to 
form. Cells from high dilutions were selected and grown on petri dishes (plated at 20 
cells per plate). Cells were grown for a further 2 weeks. Individual colonies were then 
selected. This was done by removal of media and placing a small glass cylinder (with a 
greased ring) over the single cell colony. Trypsin was added to the inner cylindrical 
hole and the cells were removed and plated into a well of a 4-well tissue culture plate. 
The cells were grown for 3 weeks, when 70% confluent, half the cells were induced 
with doxycycline (1 pg/ml) for 24 h at 37°C and the remainder were not induced. The 
cells were then examined by confocal microscopy. Approx. 80% of the EYFP cells were 
green and approx 50% of the 2BC cells stained positive for 2BC using an anti-2C 
antibody. The isolation of 2BC-transfected cells was repeated twice, using the cylinder 
method, on the previously isolated cells. By the third round of selection, ~100% of the 
2BC-inducible cells appeared to express 2BC when induced and the EYFP cell line also
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all expressed EYFP when induced (Figs. 6.12 and 6.13). The levels of expression varied 
within the cell population.
EYFP was expected to produce a band of 28 kDa, EYFP could be detected in non -  
induced and induced cells. When cells expressing EYFP were uninduced it was not 
expected to be able to detect any bands corresponding to the size of EYFP by Western 
blot but a band should be detectable in cells when induced with doxycycline. 
However, when induced and uninduced transfected cells were analysed by Western 
blot (Fig. 6.12) it was possible to detect a band with a size of 28 kDa corresponding to 
a size of EYFP. EYFP was also detected in cells that were induced. The FMDV 2BC 
proteins could not be detected in uninduced pcDNA4/TO-2BC transfected cells by 
Western blotting. In contrast, 2BC could be detected after induction with doxycycline 
for 24 h and produced a band with a size of 52 kDa corresponding to the size of 2BC 
(Fig. 6.13).
The two inducible cell lines were successfully produced and will allow examination of 
the effects of FMDV 2BC protein upon the UPR. Unfortunately due to lack of time it 
was not possible to investigate if there were any differences in the expression of ER 
stress markersin cells transfected with pcDNA4/TO-2BC following induction with 
doxycycline.
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Figure 6.12 Western Blot analysis of EYFP protein expressed by the EYFP-inducible 
stable cell line. Cell lysates were made of the EYFP inducible cell line when not 
induced with doxycycline (Lane 1) and when induced for 24 h (Lane 2). Proteins were 
resolved on a 10% tricine gel and probed with an anti-EYFP antibody.
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Figure 6.13 Western Blot analysis of 2BC protein expressed by the 2BC inducible 
stable cell line. Cell lysates were made of the 2BC inducible cell line when not induced 
with doxycycline (Lane 1) and when induced for 24 h (Lane 2). Lane 3 is a lysate from 
FMDV OlBFS-infected cells, 4 h after infection. Proteins were resolved on a 10% tricine 
gel and probed with an anti-FMDV 2C antibody.
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Figure 6.14 Inducible cell lines expressing FMDV 2BC and EYFP. Cells were induced with 1 pg/ml of 
doxycycline for 24 h. Cells were fixed and permiabilised. (A) The EYFP inducible cell line was visualised through 
the natural fluorescence of EYFP protein (green). (B) The 2BC protein of the 2BC inducible cell line was labelled 
with mouse anti-FMDV 2C antibody, followed by an Alexa-568 goat anti-mouse antibody (red). Cell nuclei were 
visualised by counterstaining with DAPI (Blue). Scale Bar 10 pm. Images used courtesy of K. Moffat lAH, 
Pirbright, U.K.
6.7 Discussion
The aim of this chapter was to investigate the effects of 2BC protein on UPR and 
examine specific ER stress responses. The UPR was examined to determine if this 
could contribute to the inhibition of translation of other genes co-transfected into cells 
with 2BC. Commercially available antibodies to ER stress markers recognise human 
epitopes and only a small proportion recognised the porcine homologues.
In both porcine and simian cell lines an increase in BiP expression when compared to 
control cells was observed at early time points post infection. BiP is known as a 
master regulator of the UPR initiating the activation of IREl, PERK and ATF6 pathways 
(Bertolotti et al., 2000; Shen et al., 2002; Sommer and Jarosch, 2002). BiP is 
upregulated early in the UPR (Kohno et al., 1993) as it responds to the accumulation of 
misfoded proteins by binding to unfolded regions of misfolded proteins and 
glycoproteins (Lindquist and Craig, 1988). It also has been shown to have a role in 
autophagy (Li et al., 2008) and controlling access to the ER by regulating the translocon 
(Hamman et al., 1998) and suppressing oxidative stress and maintaining calcium 
homeostasis (Yu et al., 1999). BiP is affected by other viruses such as HCV (von dem 
Bussche et al., 2010) and hantavirus (Li et al., 2005) this can suppress viral replication 
however also can restrict the induction of apoptosis (Rao et al., 2002).
While the levels of PDI expression overall did not change significantly in Vero cells, a 
decrease in the levels of PDI expression was observed early on in FMDV infection of
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IBRS2 . The down regulation of PDI may contribute to cytokine expression early in 
infection as PDI has been shown to be a negative regulator of the transcription factor 
NF-kB (Higuchi et al., 2004) and it has been suggested that suppression of PDI can lead 
to an increase of TNF-a (Zhou et al., 2008). The increase in levels of TNF-a in FMDV 
infection in cattle (Zhang et al., 2009b) correlate with this decrease in PDI expression.
At early time points of FMDV infection, Sec31 expression was up regulated but quickly 
returned to levels similar to that observed in mock transfected cells. Interestingly this 
pattern was also observed for the stress proteins Erol and BiP. It could be that these 
three proteins are being upregulated as part of the same UPR pathway, triggered by 
viral disruption of the ER or it could possibly be due to the host cell triggering an 
antiviral response to infection. The levels of FMDV 3A protein accumulated over time 
as shown from the confocal images for FMDV infection (Fig. 6.1 and 6.4) and the 
Western blot of FMDV 3A protein accumulating from 2-4 h post adsorption (Fig. 6.7), 
there appeared to be an initial increase in the levels of Sec31 expression at 1 h post 
adsorption of FMDV however as time progressed the levels of SecBl returned to the 
levels seen in mock infected cells. This correlates with the dispersal of immuno- 
fluorescent labelling of Sec31 (Fig. 6.9). However, as the levels of Sec31 did not 
decline below the levels seen in mock-infected cells (Fig. 6.7), it is likely that Sec31, 
and by association COP II, have been dispersed rather than depleted.
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XBPl binds to the ER stress response and unfolded response elements (Calfon et al., 
2002; Reimold et al., 2000; Yoshida et al., 2001) and up regulates ER chaperones 
including BiP. The XBPl protein is activated at a transcriptional level (Shamu and 
Walter, 1996; Welihinda and Kaufman, 1996). During ER stress, XBPl mRNA is cleaved 
and spliced by IREl, which is activated by the dissociation of BiP (Liu et al., 2002; 
Oikawa et al., 2009; Shamu and Walter, 1996; Welihinda and Kaufman, 1996). The 
cleavage of the 26 bp intron from XBPl mRNA results in a frame shift in the ORF of 
XBPl resulting in transcriptional activation of XBPl (Shamu and Walter, 1996; 
Welihinda and Kaufman, 1996).
XBPl could not be detected by RT-PCR in IBRS2 cells and this may be due to the 
variability of XBPl between different species. The XBPl primers used were selected 
based upon the sequence of human XBPl flanking the 26 bp intron. As a consequence 
XBPl could not be detected in porcine cells. In Vero cells, an additional band 
appeared in cells treated with BFA. The additional band seen in BFA-treated cells was 
not seen in infected or mock-infected cells (Fig. 6.8). These studies suggest that FMDV 
infection of Vero cells does not induce XBPl splicing. Similarly to FMDV infection, 
enterovirus 71 does not induce splicing of XBPl (Jheng et al., 2010), although XBPl 
mRNA was up-regulated by enterovirus 71.
Previous studies have shown that when expressed individually in Vero cells, FMDV 2BC 
protein locates to a punctuate perinuclear region which may be produced from
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modified ER structures whereas 2C locates to a Golgi-like region (Moffat et al., 2007). 
To detect FMDV 2BC an antibody against 2C is available. During infection 2BC, cannot 
be detected without also detecting 2C. Co-localisation studies examining the 
interactions of viral non-structural 2BC protein with calnexin and Sec31 during FMDV 
infection did not reveal much overlap between the cellular proteins and the 2C/2BC 
proteins although a small amount of overlap was detected with calnexin. Rust et al.,
(2001) discovered that poliovirus interacted with Sec proteins during infection. It 
could be the case that during FMDV infection, the 2BC protein interacts with the 
Sec31/Cop complex leading to its disruption with dispersal of Sec31.
There is preliminary evidence that some ER stress proteins are up-regulated early in 
FMDV infection. Transient transfection of 2BC into cells did not reveal an ER stress 
response. However, as 2BC expression was not detected and any ER stress response 
could have been masked by the low efficiency of transfection. To improve the rate of 
2BC expression in cells, an inducible 2BC cell line was successfully developed.
Inducible cell lines would allow us to analyse the effects of 2BC protein upon the cell 
with the confidence that there was a high level of 2BC expression. However, 
unfortunately the 2BC expression from the inducible cell line appeared to be lost when 
revived from cold storage. Although the EYFP inducible cell line appeared "leaky" as 
identified from the expression of EYFP by Western blot in uninduced cells (Fig. 6.12), it 
would still allow a comparison of ER stress proteins within the cells with those in 2BC- 
expressing cells induced with doxycycline. Although the cells used for the inducible
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cell lines were Vero cells, which are not derived from a natural host for FMDV, they 
have the advantage of being compatible with a wide range of reagents to detect ER 
stress proteins.
This inducible cell line should offer the ability to examine the responses of all cells to 
2BC expression. It would be interesting to see how the levels of Sec31, in particular, 
are affected by 2BC following induction. It would also be interesting to transfect 
pSEAP2-Control into the 2BC inducible cell line to see if it had the ability to silence 
SEAP expression.
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Chapter Seven: Discussion
Retention of host cells proteins within the secretory pathway may be advantageous to 
a virus as this could potentially suppress the immune response to infection by 
restricting the surface expression of MHC class I molecules (Andersson et al., 1985; 
Deitz et al., 2000; Dodd et al., 2001; Sanz-Parra et al., 1998). A reduction in MHC class 
I would reduce the level of viral peptides, complexed with MHC I, becoming displayed 
on the cell surface.
As a result, cytotoxic T-cells recognising this viral peptide-MHC complex may not 
become activated and kill the infected cells (Ljunggren and Karre, 1990). However, 
MHC I also acts an inhibitory ligand for NK cells and its depletion could lead to the 
activation of NK cells resulting in the NK cell killing of the MHC I depleted cell. 
Interestingly, FMDV infection of NK cells inhibits their action and y-IFN expression 
during the early stages of infection (Toka et al., 2009). Inhibition of protein trafficking 
may also delay the secretion of cytokines which could also be retained within the 
secretory pathway and hence limiting the anti-viral response.
Picornavirus non-structural proteins have been shown to inhibit trafficking through the 
secretory pathway and the non-structural proteins of poliovirus, coxsackievirus and 
enterovirus 71 are able to inhibit the trafficking of MHC class I molecules, cytokines 
and receptors such as the TNF receptor to the cell surface (Cornell et al., 2006; Cornell 
et al., 2007; Dodd et al., 2001; Neznanov et al., 2001). FMDV non-structural protein
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2BC has also been reported to block the movement of proteins to the cell surface 
(Moffat et al., 2005; Moffat et al., 2007).
The 2BC protein used in previous studies for monitoring the secretory pathway was 
identified as containing a K439Q substitution mutation. Repeat studies examining the 
effects of the correct wildtype FMDV 2BC on the secretory pathway showed that both 
FMDV proteins exerted a similar inhibitory effect on ER-to-Golgi trafficking.
The ER chaperone protein calnexin is required for the correct folding of tsVSV G and 
the inhibition of calnexin binding can lead to the incorrect folding of VSV G and cause 
its retention within the ER (Hammond and Helenius, 1994a). It is known that calnexin 
is utilised in MHC I peptide loading (Gao et al., 2002). Coincidently, my studies have 
revealed that FMDV 2BC protein co-localises with calnexin. Therefore, it may be 
possible that FMDV 2BC is interacting with calnexin and disrupting chaperone activates 
preventing the transport of tsVSV G and/or expression of SEAP.
Retention of host cell proteins within the secretory pathway may be advantageous to 
a virus as this could potentially suppress the immune response to infection by 
restricting the surface expression of MHC class I molecules (Andersson et al., 1985; 
Deitz et al., 2000; Dodd et al., 2001; Sanz-Parra et al., 1998). A reduction in MHC class 
I would reduce the level of viral peptides, complexed with MHC I, becoming displayed 
on the cell surface.
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ER stress can lead to the reduction in the surface expression of MHC I (Ulianich et al., 
2011) and interestingly, FMDV infection also leads to the reduction in surface 
expression of MHC I (Sanz-Parra et al., 1998). One could speculate that the reduced 
surface expression of MHC I seen in FMDV infection is due to the co-localisation of 
FMDV 2BC with calnexin making less calnexin available for MHC I peptide loading 
resulting in the retention of MHC I molecules in the ER as seen in FMDV infected cells 
(Sanz-Parra et al., 1998). Alternatively, the location of FMDV 2BC protein at the ER 
membrane and the ability of other picornaviral 2BC proteins to alter Ca^  ^
concentrations in the ER (Aldabe et al., 1997; de Jong et al., 2008; van Kuppeveld et al., 
2005) could suggest a role for FMDV 2BC in the induction of ER stress, resulting a 
down regulation of surface expression of MHC I (Ulianich et al., 2011).
Poliovirus 3A protein inhibits protein trafficking in poliovirus infection (Doedens and 
Kirkegaard, 1995) and leads to a reduction in the surface expression of MHC I (Deitz et 
al., 2000). The inhibition of surface expression of MHC I in poliovirus has been 
attributed to the inhibition of protein secretion (Choe et al., 2005).
Poliovirus 2BC protein is thought to recruit COP II membranes into the replication 
complex and confocal microscopy has shown a colocalisation of poliovirus 2BC with 
Secl3 (Rust et al., 2001). During FMDV infection and 2BC expression in cells, Sec31 
labelling was dispersed, however no co-localisation was detected between the 2BC
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protein and the Sec31 marker of the COPII vesicle. A reduction or dispersal of the COP 
II complex has been associated with ER stress (Amodio et al., 2009).
The co-localisation studies of FMDV 2BC with markers of the secretory pathway 
showed that the COP II marker Sec31 was dispersed and the ERGIC was also disrupted. 
It may be the case that COP II assembly is disrupted by ER stress caused by FMDV 2BC 
(Amodio et al., 2009; Rust et al., 2001). If COP II trafficking is inhibited this could 
explain the dispersal of the ERGIC as membranes and proteins trafficked to the ERGIC 
are restricted. Interestingly, there also appeared to be a reduction in the labelling of 
p-Cop, a COP I marker. A reduction in trafficking from the ER to ERGIC and 
subsequently the Golgi could result in a draining in components required for the ERGIC 
and COP I complexes and so resulting in their depletion. A depletion of COP II could be 
a useful response to ER stress preventing post ER compartments accumulating 
misfolded proteins.
Similarly to COP II, BiP expression increased early on during FMDV infection of cells, 
also this increase in expression was short lived. This early increase in BiP expression 
may have been in response to misfolded proteins in het ER and initiating the UPR. 
Erol plays an important role in maintaining the redox potential within the ER and is 
important for protein folding; the transient increase in Erol indicates that oxidative 
stress may occur early in FMDV infection. While it is not clear why there was an 
increase in Sec31 levels early in infection, it could be as a consequence of ATF6
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transport which can occur in the absence of protein synthesis and is activated by the 
disassociation of BiP in response to ER stress (Schindler and Schekman, 2009).
Calreticulin, like calnexin, is a calcium binding protein but also act as a chaperone 
protein ensuring the correct folding of glycoproteins (Ellgaard and Frickel, 2003; 
Ellgaard and Helenius, 2003; Michalak et al., 2002; Otteken and Moss, 1996). It has 
been shown that several picornaviral infections result in a release in calcium from the 
ER and intracellular stores leading to an increase in cytoplasmic calcium 
concentrations (de Jong et al., 2008; Irurzun et al., 1995; van Kuppeveld et al., 1997a). 
This disruption of calcium homeostasis could lead to an inhibition of the secretory 
pathway (de Jong et al., 2006), modulation of apoptosis (AgoI et al., 2000; Annis et al., 
2001; Campanella et al., 2004; Tolskaya et al., 1995) (van Kuppeveld et al., 2005) and 
potential induction of autophagy (Decuypere et al.; Gordon et al., 1993).
Poliovirus 2BC protein expression in cells can cause the release of Ca^  ^ (Aldabe et al., 
1997). A disturbance in calcium homeostasis has been attributed to 2B proteins of 
coxsackievirus, poliovirus, HRV 14 and ECMV (de Jong et al., 2008). A reduction of 
calcium ions within the ER results in the inhibition of trafficking of proteins through 
the secretory pathway (de Jong et al., 2006). During infection, coxsackieviruses have 
been shown to prevent apoptosis (Sa la ko et al., 2006) only for apoptosis to occur late 
in infection once replication is completed (Belov et al., 2003).
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De Jong (2008) examined the effects on 2B expression on Ca^  ^ levels in the ER and 
Golgi of cells. Whilst enteroviruses where found to disrupt Ca^  ^ levels, the effects of 
FMDV 2B on Ca^  ^ levels were inconclusive. FMDV 2BC protein has been detected in 
membrane fractions and is located with modified ER structures (Moffat et al., 2005). If 
FMDV 2BC functions as a viroporin, as with other picornavirus 2BC proteins (Madan et 
al., 2010a; Martinez-Gil et al., 2011; Nieva et al., 2003), its ER location could perturb 
Ca^  ^homeostasis and this in turn could trigger ER stress. It is still therefore of great 
interest to investigate if FMDV infection or intracellular expression of FMDV 2B or 2BC 
can induce pore formation within the ER like several other picornaviruses (Agirre et al., 
2002; de Jong et al., 2004; de Jong et al., 2003; Martinez-Gil et al., 2011; Nieva et al., 
2003) and to investigate if FMDV affects calcium homeostasis.
Increases in cytoplasmic calcium have been shown to induce autophagy (Grotemeier 
et al., 2010; Hoyer-Hansen and Jaattela, 2007) and a number of picornaviruses 
including FMDV induce autophagy during infection (Huang et al., 2009; Kemball et al., 
2010; O'Donnell et al., 2011; Taylor and Kirkegaard, 2007; Yoon et al., 2008; Zhang et 
al., 2011). The FMDV 2B, 2C and 2BC have been found to co-localise with the 
autophagasome marker light chain 3 (LC3) which suggests a role for FMDV 2BC in the 
induction of autophagy (Brooks, 2007; O'Donnell et al., 2011).
The induction of ER stress can lead to an autophagic response (Ogata et al., 2006; 
Yorimitsu et al., 2006) and the ER stress autophagic response has been shown to
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activate the IREl pathway leading to splicing of XBPl (Ogata et al., 2006). However, 
this IREl-XBPl pathway may be important to moderate the autophagic response 
induced by PERK during ER stress (Kroemer et al., 2010).
BiP is also important in the process of stress-induced autophagy and may play a role 
similar to IREl in controlling autophagy (Li et al., 2008). We showed that BiP is up 
regulated early in FMDV infection and this could potentially be important in the 
moderation of the autophagic response and that FMDV infection may induce XBPl 
splicing in porcine cells. Like the secreted reporter protein SEAP, (B-galactosidase was 
not detected in cells co-transfected with FMDV 2BC. As ectopic p-galactosidase can be 
found in the cytoplasm it is possible that (3-galactosidase levels were depleted as 
consequence of autophagy.
If it can conclusively be confirmed that FMDV or 2BC does upregulate ER stress related 
pathways this could be further evidence to point towards the pathway for the 
stimulation of autophagy. The sequestering of membranes for autophagy could 
reduce those available for the secretory pathway and decrease protein trafficking.
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7.1 Future Experiments
• To determine the location of 2BC during FMDV infection and its possible 
interactions with host proteins, it would be useful to develop an antibody 
spanning the 2B-2C junction. This would also enable the differentiation of the 
location of 2BC from 2C in infection.
• It is important to continue this work to identify the ER stress markers that are 
affected by FMDV infection and relate these back to any induced stress 
response pathway i.e. The UPR, ERAD autophagy and apoptosis. If a viral 
protein was identified that induced ER stress proteins and led to autophagy this 
may provide evidence for a triggering mechanism for FMDV induced 
autophagy.
• The relationship between FMDV 2BC and calnexin should be examined further, 
along with the effects on Ca^  ^ homeostasis in the ER. Co-fractionation studies 
would determine if there is a physical interaction between calnexin and FMDV 
2BC. If FMDV 2B leads to changes in Ca^  ^level in the ER this could also support 
the theory that FMDV 2BC could be inducing ER stress.
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Appendix II 
Transmembrane Predictions of 2BC
Schematic Diagram
c04310b2-68bb-4ael-9cf9-2b9fd9920e88.mem
MEMSAT-SVM
MEMSAT3
Kyte-Doolittle  
SVM H/L Raw
100 
I I I n
200
n z r
  ' V
SVM IL/oL Raw
SVM RE/!RE Raw
SVM SP/ISP Raw
y
Q  Signal Peptide | |Cytoplasmic | [Extrccel!
268
MEMSAT-SVM Prediction
Summary of MEMSAT-SVM Topology Analysis
Signal peptide 
Signal score 
Topology 
Re-entrant helices 
Helix count 
N-term inal
Score
Not detected. 
0
61-77,85-115 
Not detected. 
2 
out 
2.55977
MEMSAT-SVM Cartoon
c04310b2-68bb-4ael-fcf9-2b9fd9920e®.mem
N-Terrainal
C-Terminal
Membrane
269
MEMSAT3 Prediction
Summary of MEMSAT3 Topology Analysis 
NumberTypeDirectionScore
1 helix +  21 .459
1 helix - 21 .009
Final MEMSAT3 Prediction 
Segment Range Score
1 (In ) 58 -92  21 .46
Diagram
Key:
X Central transm em brane helix segm ent s Possible N-term lnal signal peptide 
+ Inside loop Inside helix cap
Outside loop o Outside helix cap
1 0  2 0  3 0  4 0  5 0  6 0
+ + + + + + + + + + + + + + + + + + + + + + + + 44 + + + + + + + + + + + + + + + + + + + + + +  + + + + + + + + + + + +
P F F F S D V R S N F S K L V E T I N Q M Q E D M S T K H G P D F N R L V S A F E E L A I G V K f l l R T G L D E A K P W
70  80  90  1 0 0  1 1 0  1 2 0
4 4 4 4 4 4 4 I I I I I I X X X X X X X X X X X X X C 0 C C 0 0 -----------------------------------------------
Y K L I K L L S R L S C M A A V A A R S K D P V L V A I M L A D T G L E I L D S T F V V K K I S D S L S S L F H V P A P
1 3 0  1 4 0  1 5 0  1 6 0  1 7 0  1 8 0
V F S F G A P V L L A G L V K V A S S F F R S T P E D L E R A E K Q L K A R D I N D I F A I L K N G E W L V K L I L A I  
1 9 0  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
R D W I K A W I A S E E K F V T M T D L V P G I L E K Q R D L N D P S K Y K E A K E W L D N A R Q A C L K S G N V H I A  
2 5 0  2 6 0  2 7 0  2 8 0  2 9 0  3 0 0
N L C K V V A P A P S K S R P E P V V V C L R G K S G Q G K S F L A N V L A Q A I S T H F T G R I D S V W Y C P P D P D
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3 1 0  3 2 0  3 3 0  3 4 0  3 5 0  3 6 0
H F D G Y N Q Q T V V V M D D L G Q N P D G K D F K Y F A Q M V S T T G F I  P P M A S L E D K G K P F N S K V I  l A T T
3 7 0  3 8 0  3 9 0  4 0 0  4 1 0
N L Y S G F T P R T M V C P D A L N R R F H F D I D V S A K D G Y K I N S K L D I I K A L E D T H A N P V A M F Q Y D C
4 5 0 4 6 0
A L L N G M A V E M K R M Q Q D M F K P Q P P L Q N V Y Q L V Q E V I D R V E L H E K V S S H P I F K Q
Key:
X Central transm em brane helix segm ent s Possible N-term inal signal peptide 
+ Inside loop Inside helix cap
Outside loop o Outside helix cap
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MEMSAT Cartoon
c04310b2-68bb-4æl-9cf9-2b9fd9920e88 .mem
C-Terminal
Membrane
Cytoplasmic
N-Terminal
ProtScale output for user sequence
3
H ph o b .
2
1
0
-1
-2
-3
450200150 250 300 35050 100
o 
Position
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oProtScale output for user sequence
11
b u r  i ed r e s i d u e s
10
50 100 150 200 250
Position
300 350 400 450
ProtScale output for user sequence
1.5
T r a n s m e m b r a n e  t e n d e n c y
0.5
-1
- 1.5
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—2 . 5
45035050 100
Position
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Helical Projections of Predicted Transmembrane Regions of 2BC
61-77 aa
274
85-115 aa
68-92 aa
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Appendix III 
Transmembrane Predictions of 2B
Schematic Diagram
lac8782f-i^l5-4245-ba5c-a7ed94345a35.*e#
MEMSAT-SVM
MEMSAT3
K yte-D oolittle
100
■  1
1
SVn H/L Raw
SVn iL/oL Raw
SVn RE/IRE Raw
SVn SP/ISP Raw
I |sigr>al Peptide | | Cytoplasmic | |Extracel:
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MEMSAT-SVM Prediction
Summary of MEMSAT-SVM Topology Analysis
Signal peptide 
Signal score 
Topology 
Re-entrant helices 
Helix count 
N-term inal 
Score
Not detected. 
0
122-137 
Not detected. 
1 
in
0.068198
MEMSAT-SVM Cartoon
lac8782f-abl5-4245-ba5c-a7ed94345a35. new
C-Teminal
Membrane
H-Teminal
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MEMSAT3 Prediction
Summary of MEMSAT3 Topology Analysis 
NumberType Direction Score
1 helix +  7 .92
1 helix - -0 .2 7 7
Final MEMSAT3 Prediction 
Segment Range Score
1 (in) 60 -7 9  -1 5 .01
Diagram
Key:
X Central transm em brane helix segment s Possible N-term inal signal peptide 
+ Inside loop Inside helix cap
Outside loop o Outside helix cap
1 0  2 0  3 0  4 0  5 0  6 0
+ + + + + + + + + + + + + + + + + + 4 + + + + + + + + + + + + + 4 + + + + + + + + + + + + + + + + + + + + + + + + + + I
L F L C S L K V F G C G P E E T R G N F D Q P G Q Q D R C S E T E D G G R H V K E T G E R V G D L L H D E G A V Q N L E
70  80  90  1 0 0  1 1 0  1 2 0
I I I I X X X X X X X X X X G C O O C ---------------------------------------------------------------------
T G V G Q H D G H K D W V L G P C C H S G H A R Q A A E L D K L V P G F G F V E T G S D G F H S N G Q L L K C G H P V K
V R P V F C H V L L H L V D G F H Q F G E V R P N V G E K E G
Key:
X Central transm em brane helix segment s Possibie N-term inal signal peptide 
+ Inside loop i  Inside helix cap
Outside loop o Outside helix cap
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MEMSAT Cartoon
lac8782f-abl5-4245-ba5c-a7ed94345a35.mem
C-Terminal
Membrane
Cytoplasmic
N-Termlnal
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P r o t S c a le  o u t p u t  f o r  u s e r  s e q u e n c e
2 . 5
H p h o b .  /  K y t e  & D o o l i t t l e
0 .5
*LOo
CO
- 0 . 5
-1
- 1 . 5
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- 2 . 5
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P r o t S c a le  o u t p u t  f o r  u s e r  s e q u e n c e
10
% b u r i e d  r e s i d u e s
14060 80 100 1204020
P o s it io n
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P r o t S c a le  o u t p u t  f o r  u s e r  s e q u e n c e
1
T r a n s m e m b r a n e  t e n d e n c y
0 .5
0
o - 0 . 5
-1
- 1 . 5
-2
14012040 60 80 10020
P o s i t io n
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Helical Projections of Predicted Transmembrane Regions of 2B
60-79 aa
122-179 aa
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Appendix IV 
Transmembrane Predictions of 2C
Schematic Diagram
dcdll673-ceeb-42el-a041-f4e5bc62d45e.mem
MEMSAT-SVM
MEMSAT3
K yte-D oolittle
100 200
1
1
SVM H/L Raw
SVM IL/oL Raw
SVM RE/IRE Raw
SVW SP/ISP Raw
v:
[21 Signal Peptide | jCytoplasmic | |E xtra :e l:
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MEMSAT-SVM Prediction
Summary of MEMSAT-SVM Topology Analysis
Signai peptide 
Signal score 
Topology 
Re-entrant helices 
Helix count 
N-term lnal 
Score
Not detected. 
0.042 
245-260 
Not detected. 
1 
in
0.978055
MEMSAT-SVM Cartoon
ctedll673-ceeb-42el-a041-f4e5te62d45e.nem
C-Teminal
Membrane
N-Teminal
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MEMSAT3 Prediction
Summary of MEMSAT3 Topology Analysis 
NumberType Direction Score
1 helix +  9 .3 83
1 helix - 13 .361
Final MEMSAT3 Prediction 
Segment Range Score
1 (o u t) 243 -26 1  -2 .4 0
Diagram
Key:
X  Centrai transm em brane helix segment s Possible N-term lnal signal peptide 
+ Inside loop Q  Inside helix cap
Outside loop o Outside helix cap
1 0  2 0  3 0  4 0  5 0  6 0
L L E D R V T R H F L V E L D P I D H L L N K L V H I L E G W L R L E H V L L H S L H F N G H A V E K G T V V L K H C H
70  80  90  1 0 0  1 1 0  1 2 0
W V G V G V F E C F D N V Q F A V N F V P I L S T H I D V K V K P P V Q C V G T Y H G P R G E A R V Q V G G R D D D F A
1 3 0  1 4 0  1 5 0  1 6 0  1 7 0  1 8 0
V E R F T F V L E C H G R D K P C G R D H L G K V F E V L A V R V L A Q I I H H N N G L L V V T V E V V R V R W A V P H
1 9 0  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
V D S A G E V G G N C L C K H V C K E A L A L A R F A A E A N N H G F G P R L A G C W C D H F A Q V G N V D V P A L Q T
2 5 0  2 6 0  2 7 0  2 8 0  2 9 0  3 0 0
 C O C O X X X X X X X X X X X I I I I  + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
R L A R V V E P L L G F L V L A R V V Q V P L L F K D A R H Q V C H G D K L L F G D P S L N P V A D G K D Q F D Q P L A
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3 1 0
+ + + + + + + + + + + + + + +
V L E N G E D V V D V T C F E
Key:
X Central transm em brane helix segm ent s Possible N-term lnal signal peptide
QInside loop 
Outside loop
Inside helix cap 
Outside helix cap
MEMSAT Cartoon
dcdll673-ceeb-42el-a041-f4e5bc62d4fe.mem
M-Terminal
Membrane
Cytoplasmic
C-Terminal
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P r o t S c a le  o u t p u t  f o r  u s e r  s e q u e n c e
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H p h o b .  K y t e  & D o o l i t t l e
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P r o t S c a le  o u t p u t  f o r  u s e r  s e q u e n c e
11
b u r i e d  r e s i d u e s
10
9
8
7
6
5
4
3
300250150 20010050
o 
P o s i t io n
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P r o t S c a le  o u t p u t  f o r  u s e r  s e q u e n c e
. 5
T r a n s m e m b r - a r i e  t e n d e n c y
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0
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Helical Projections of Predicted Transmembrane Regions of 2C
245-260 aa
243-261 aa
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Appendix V 
Immuno-fluorescent Microscopy solutions 
Paraformaldehyde: 4% (w/v) paraformaldehyde in PBS, pH7.5-8.0.
Blocking solution: 30% Normal Goat Serum, 0.2 % Fish Gelatin in TBS 
0.1 % Triton X-100: 0.1 % Triton X-100 in PBS
Thermosensitive Alkaline Phosphatase Storage Buffer (Ix): 10 mM Tris-HCI pH 
7.5,100 mM NaCI, 50 % glycerol.
4',6-diamidino-2-phenylindole (DAPI): working concentration 1 pg/ml (Sigma)
Promega Restriction Enzvme Buffers (Ix)
Buffer B (lOx): 6 mM Tris-HCI, pH7.5, 6 mM MgCIa, 50 mM NaCI, 1 mM DTT.
Buffer D (lOx): 6 mM Tris-HCI, pH7.9, 6 mM MgCb, 50 mM NaCI, 1 mM DTT.
Buffer H (lOx): 90 mM Tris-HCI, pH7.5,10 mM MgC^, 50 mM NaCI.
Multicore Buffer (lOx): 250 mM Tris-acetate (pH 7.8 at 25 °C), 1 M potassium 
acetate, 100 mM magnesium acetate and 10 mM DTT.
Promega Buffers
T4 DNA ligase Buffer (lOx): 300 mM Tris-HCI pH 7.8, 100 mM MgClz, 100 mM DTT, 
10 mM ATP.
T4 Polymerase Buffer (lOx): 250 mM Tris-Acetate pH 7.7,1 M potassium acetate, 
100 mM magnesium acetate, 10 mM DTT.
292
NEB Restriction Enzvme Buffers fix )
NEB 2 (lOx): 50 mM NaCI, 10 mM Tris-HCI, 10 mM MgClz, 1 mM DTT.
NEB 3 (lOx): 100 mM NaCI, 50 mM Tris-HCI, 10 mM MgCb, 1 mM DTT.
NEB 4 (lOx): 50 mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium 
acetate, 1 mM DTT.
Mammalian cell culture media
Dulbecco's Modified Eagle Medium (D-MEM) (Invitrogen): supplemented with 10 
% foetal calf serum (Autogen Bioclear), 20 mM glutamine, penicillin (100 SI 
units/ml), and streptomycin (100 pg/ml).
Serum free D-MEM: as with D-MEM but without foetal calf serum
Glasgow's modified Eagle's medium (Invitrogen): supplemented with 10 % adult 
bovine serum (Invitrogen), 20 mM glutamine, penicillin (100 SI units/ml), and 
streptomycin (100 pg/ml).
Serum free Glasgow's modified Eagle's medium: as with Glasgow's modified 
Eagle's medium but without adult bovine serum
Iscove's Modified Dulbecco's Medium (IMDM), (Invitrogen): supplemented with 
10 % foetal calf serum (Autogen Bioclear), 20 mM glutamine, penicillin (100 SI 
units/ml), and streptomycin (100 pg/ml).
Versine-trypsin: 136 mM NaCI, 5.3mM KCI, 5.5 mM NaHCOg, 0.02 % trypsin, 0.01 
% verse ne (EDTA) and 0.1 % phenol red.
Optimem®l Reduced Serum Medium (Invitrogen)
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Bacterial Growth media
LB Broth: 1 % Bacto tryptone, 0.5 % Bacto yeast extract, 86 mM NaCI in H2O.
LB Agar: 1.5 % Bacto agar in LB medium.
Ampicillin resistance: 100 pg/ml.
SOC Media: Tryptone (Oxoid) 2 % (w/v). Yeast Extract (Oxoid), 0.5 % (w/v). Sodium 
Chloride (BDH) 0.058 % (w/v). Potassium Chloride (BDH) 0.019 % (w/v).
Glucose (BDH) 0.36 % (w/v). Magnesium Chloride (BDH) 0.4 % (w/v). Magnesium 
Sulphate (BDH) 0.5 % (w/v). Deionised water 96.163 % (v/v).
Mammalian Cell lines
Vero: African Green monkey kidney cell line (ECACC, 84113001)
BHK-21: Baby hamster kidney cell line (ECACC, 93120842)
IBRS2: Porcine Kidney cell line (IZSBS, BS CL51)
Max: The Max cell line is from an inbred NIH minipig major histocompatibility 
complex d/d haplotype, (Pauly et al 1999) and was grown in Iscove's modified 
Dulbecco's medium (IMDM) (Invitrogen) with 10% foetal calf serum (PCS) (Autogen 
Bioclear, UK).
Plasmid Purification Buffers
PI (Resuspension buffer): 50 mM Tris-CI, pH 8.0; 10 mM EDTA; 100 pg/ml RNase 
A.
P2 (Lysis Buffer): 200 mM NaOH, 1 % SDS (w/v).
P3 (Neutralisation Buffer): 3.0 M potassium acetate, pH 5.5.
QBT (Equilibration Buffer): 750 mM NaCI; 50 mM MOPS, pH 7.0; 15 % isopropanol 
(v/v);
0.15% Triton X-100 (v/v).
QC (Wash Buffer): 1.0 M NaCI; 50 mM MOPS, pH 7.0,15 % isopropanol (v/v).
QF (Elution Buffer): 1.25 M NaCI; 50 mM Tris-CI, pH 8.5; 15 % isopropanol (v/v).
TE: 10 mM Tris-CI, pH 8.0; 1 mM EDTA.
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illustra GFX ™ PCR DNA and Gel Band Purification Kit (GE)
Capture Buffer Type 3: Proprietary Information contains a pH indicator.
Wash Buffer Type 1: Proprietary information 
Elution Buffer Type 4:10 mM Tris-HCI, pH 8.0 
Elution Buffer Type 6: Sterile nuclease free water
Virus strains
Foot and mouth disease virus: OIBFS was used to infect BHK-21, IBRS2 and Max 
cell lines.
01KB64 was used to infect Vero cells. Virus titres were determined by plaque 
assay as described in section 2.2.3.2.
For plague assay
Eagles overlay agarose: 20% Trypton phosphate buffer, 2% foetal calf serum, 0.6% 
indubidose agar
Proofstart^" DNA polymerase (Qiagen)
Proofstart™ DNA polymerase 2.5 U/pl
Proofstart storage and dilution buffer: 20 mM Tris-CI, 100 mM KCI, 1 mM DTT, 0.1 
mM EDTA, 0.5 % (v/v) Nonidet® P-40, 0.5 % (v/v) Tween® 20, 50 % (v/v) glycerol, 
stabilizer;
pH 9.0 (20°C).
Proofstart PCR Buffer (lOX): Tris-CI, KCI, (NH4 )2S0 4 , 15 mM MgS0 4 , bovine serum 
albumin, Triton® X-100; pH 8.7 (20°C).
25 mM MgS0 4  solution
Q Solution (5x): proprietary information.
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KOD Hot Start DNA polymerase (Novagen)
KOD Hot Start DNA Polymerase: 1 U/pl in 50 mM Tris-HCI, ImM DTT, 0.1 mM 
EDTA, 50 % glycerol, 0.001 % Nonidet P-40, 0.001 % Tween -20, pH 8.0.
PCR Buffer for KOD Hotstart (lOx): proprietary information.
25 mM MgSÜ4  solution 2mM dNTPs
GoTag® Hot Start Master Mix
GoTaq® Hot Start Green Master Mix (2X): GoTaq® Hot Start Polymerase supplied 
in 2x Green GoTaq® Reaction Buffer (pH 8.5), 400 pM dATP, 400 pM dGTP, 400 pM 
dCTP, 400 pM dTTP and 4 mM MgCI2. Green GoTaq® Reaction Buffer is a 
proprietary buffer containing a compound that increases sample density, and 
yellow and blue dyes, which function as loading dyes when reaction products are 
analyzed by agarose gel electrophoresis. The blue dye migrates at the same rate as 
3-5 kb DNA fragments, and the yellow dye migrates at a rate faster than primers 
(<50 bp), in a 1 % agarose gel.
DNA solutions
Tris acetate running buffer (TAB SOx): 2 M Tris-HCI, 5.5 % glacial acetic acid, 50 
mM EDTA
Ethidium bromide solution: 1.5 % ethidium bromide in dH20.
Protein Analysis Buffers and solutions
Protein Sample preparation buffer (Sx): 312.5 mM Tris-HCI (pH 6.8), 25 % (v/v) 
glycerol, 25 % (v/v) p-mercaptoethanol, 10 % (w/v) SDS, 0.1 % bromophenol blue.
Radio-lmmunoprecipitation Assay (RIPA) Buffer: 50 mM Tris-HCI (pH 7.4), 150
mM, 1 mM EDTA, 0.1 % (w/v) sodium dodecylsulphate, 1 % (w/v) sodium
deoxycholate, 1 % (v/v) IGEPAL CA-630.
Protease Inhibitor Cocktail (1000 x): Leopeptin 1 mg/ml, Pepstatin 1 mg/ml.
Antipain 1 mg/ml, Chymostatin 1 mg/ml, dH20 20 ml.
Phosphatase inhibitor cocktail (lOx): Sodium fluoride NaF, 500 mM, Sodium 
Orthovanadate Na3 V0 4 , 100 mM.
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Sodium-dodecylsulphate polyacrylamide electrophoresis (SDS-PAGE)
Ammonium Persulphate (APS): 15 % ammonium persulphate in dH20.
Laemmli resolving gel buffer (4x): 1.5 M Tris, 0.4 % (w/v) SDS, pH 8.8.
Laemmli stacking gel buffer (2x): 0.5 M Tris, 0.2 % (w/v) SDS, pH 6.8.
Laemmli running buffer (lOx): 250 mM Tris, 2 M glycine, 0.1 % (w/v) SDS, pH 8.3. 
Tricine gel buffer (3x): 3 M Tris, 0.3 % (w/v) SDS, pH 8.45.
Tricine anode buffer: 0.2 M Tris, pH 8.9.
Tricine cathode buffer (lOx): 1 M Tris, 1 M Tricine, 1 % (w/v) SDS.
Western Blot Low molecular weight blotting buffer: 25 mM Tris-HCI, 190 mM 
glycine, 20 % (v/v) methanol.
Western Blot High molecular weight blotting buffer: 50 mM Tris, 380 mM glycine, 
0.1 % (w/v) SDS, 20 % (w/v) methanol.
Western Blot Blocking Buffer: 5% marvel milk in PBS.
Western Blot Wash Buffer: 0.02% Tween-20 in PBS
Autoflourographv Solutions
Destain Solution: 10 % (v/v) acetic acid, 10 % (v/v) methanol in water.
Sodium Salicylate solution: 1 M Sodium Salicylate in dH20.
p-galactosidase assay buffer (2x): 200 mM sodium phosphate, buffer (pH 7.3), 2 
mM MgCb, 100 mM (3-mercaptoethanol, 1.33 mg/ml ONPG.
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